BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731-1740. [PMID: 15496622 DOI: 10.1056/nejmoa040694] [Cited by in Crossref: 3869] [Cited by in F6Publishing: 1381] [Article Influence: 227.6] [Reference Citation Analysis]
Number Citing Articles
1 Lee JW, Lee JH, Kim JG, Oh ST, Chung HJ, Lee MA, Chun HG, Jeong SM, Yoon SC, Jang HS. Comparison between preoperative and postoperative concurrent chemoradiotherapy for rectal cancer: an institutional analysis. Radiat Oncol J 2013;31:155-61. [PMID: 24137561 DOI: 10.3857/roj.2013.31.3.155] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
2 Leichman CG, McDonough SL, Smalley SR, Billingsley KG, Lenz HJ, Beldner MA, Hezel AF, Velasco MR, Guthrie KA, Blanke CD, Hochster HS. Cetuximab Combined With Induction Oxaliplatin and Capecitabine, Followed by Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer: SWOG 0713. Clin Colorectal Cancer 2018;17:e121-5. [PMID: 29233486 DOI: 10.1016/j.clcc.2017.10.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
3 Song SH, Park JS, Kang MK, Choi GS, Park SY, Kim HJ, Kim JG, Kang BW, Baek JH, Baek DW, Kim JC, Park SH, Cho SH, Seo AN. Initial experience of preoperative short-course radiotherapy followed by oxaliplatin-based consolidation chemotherapy for locally advanced rectal cancer. Int J Colorectal Dis 2021;36:1279-86. [PMID: 33547945 DOI: 10.1007/s00384-021-03875-0] [Reference Citation Analysis]
4 Vaios EJ, Wo JY. Proton beam radiotherapy for anal and rectal cancers. J Gastrointest Oncol 2020;11:176-86. [PMID: 32175121 DOI: 10.21037/jgo.2019.04.03] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Yang X, Zhu F, Yu C, Lu J, Zhang L, Lv Y, Sun J, Zheng M. N-myc downstream-regulated gene 1 promotes oxaliplatin-triggered apoptosis in colorectal cancer cells via enhancing the ubiquitination of Bcl-2. Oncotarget 2017;8:47709-24. [PMID: 28537875 DOI: 10.18632/oncotarget.17711] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
6 Belluco C, De Paoli A, Canzonieri V, Sigon R, Fornasarig M, Buonadonna A, Boz G, Innocente R, Perin T, Cossaro M, Polesel J, De Marchi F. Long-term outcome of patients with complete pathologic response after neoadjuvant chemoradiation for cT3 rectal cancer: implications for local excision surgical strategies. Ann Surg Oncol 2011;18:3686-93. [PMID: 21691880 DOI: 10.1245/s10434-011-1822-0] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 6.0] [Reference Citation Analysis]
7 Wahba HA, El-Hadaad HA, Roshdy S. Combination of irinotecan and 5-fluorouracil with radiation in locally advanced rectal adenocarcinoma. J Gastrointest Cancer 2012;43:467-71. [PMID: 22147447 DOI: 10.1007/s12029-011-9350-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Sager O, Dincoglan F, Demiral S, Uysal B, Gamsiz H, Dirican B, Beyzadeoglu M. A Concise Review of Pelvic Radiation Therapy (RT) for Rectal Cancer with Synchronous Liver Metastases. Int J Surg Oncol 2019;2019:5239042. [PMID: 31139467 DOI: 10.1155/2019/5239042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Sandra-Petrescu F, Herrle F, Hinke A, Rossion I, Suelberg H, Post S, Hofheinz RD, Kienle P. CoCStom trial: study protocol for a randomised trial comparing completeness of adjuvant chemotherapy after early versus late diverting stoma closure in low anterior resection for rectal cancer. BMC Cancer 2015;15:923. [PMID: 26589718 DOI: 10.1186/s12885-015-1838-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
10 Kupsch J, Jackisch T, Matzel KE, Zimmer J, Schreiber A, Sims A, Witzigmann H, Stelzner S. Outcome of bowel function following anterior resection for rectal cancer-an analysis using the low anterior resection syndrome (LARS) score. Int J Colorectal Dis. 2018;33:787-798. [PMID: 29541896 DOI: 10.1007/s00384-018-3006-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 8.3] [Reference Citation Analysis]
11 Souadka A, Majbar MA, Benkabbou A, Serji B, Souiki T, Bouchentouf SM, Abid M, El Khannousi B, El Harroudi T, El Malki HO, Raiss M, Ifrine L, Mazaz K, Zentar A, Mohsine R, Souadka A, Belkouchi A, Ahallat M, Hrora A; Moroccan Society of Surgery. Predictive factors of disease-free survival after complete pathological response to neoadjuvant radiotherapy for rectal adenocarcinoma: retrospective case series. BMC Cancer 2019;19:1008. [PMID: 31660903 DOI: 10.1186/s12885-019-6239-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Huang CM, Huang CW, Huang MY, Lin CH, Chen CF, Yeh YS, Ma CJ, Huang CJ, Wang JY. Coexistence of perineural invasion and lymph node metastases is a poor prognostic factor in patients with locally advanced rectal cancer after preoperative chemoradiotherapy followed by radical resection and adjuvant chemotherapy.Med Princ Pract. 2014;23:465-470. [PMID: 25012611 DOI: 10.1159/000363604] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
13 Delitto D, George TJ Jr, Loftus TJ, Qiu P, Chang GJ, Allegra CJ, Hall WA, Hughes SJ, Tan SA, Shaw CM, Iqbal A. Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy. J Natl Cancer Inst 2018;110:460-6. [PMID: 29165692 DOI: 10.1093/jnci/djx228] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
14 Yoo GS, Park HC, Yu JI, Choi DH, Cho WK, Park YS, Park JO, Lim HY, Kang WK, Lee WY, Kim HC, Yun SH, Cho YB, Park YA, Song KD, Kim SH, Ha SY. Carcinoembryonic Antigen Improves the Performance of Magnetic Resonance Imaging in the Prediction of Pathologic Response after Neoadjuvant Chemoradiation for Patients with Rectal Cancer. Cancer Res Treat 2020;52:446-54. [PMID: 31588705 DOI: 10.4143/crt.2019.261] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Phan K, Oh L, Ctercteko G, Pathma-Nathan N, El Khoury T, Azam H, Wright D, Toh JWT. Does a stoma reduce the risk of anastomotic leak and need for re-operation following low anterior resection for rectal cancer: systematic review and meta-analysis of randomized controlled trials. J Gastrointest Oncol 2019;10:179-87. [PMID: 31032083 DOI: 10.21037/jgo.2018.11.07] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
16 Delli Pizzi A, Chiarelli AM, Chiacchiaretta P, d'Annibale M, Croce P, Rosa C, Mastrodicasa D, Trebeschi S, Lambregts DMJ, Caposiena D, Serafini FL, Basilico R, Cocco G, Di Sebastiano P, Cinalli S, Ferretti A, Wise RG, Genovesi D, Beets-Tan RGH, Caulo M. MRI-based clinical-radiomics model predicts tumor response before treatment in locally advanced rectal cancer. Sci Rep 2021;11:5379. [PMID: 33686147 DOI: 10.1038/s41598-021-84816-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Marques CF, Nahas CS, Ribeiro U Jr, Bustamante LA, Pinto RA, Mory EK, Cecconello I, Nahas SC. Postoperative complications in the treatment of rectal neoplasia by transanal endoscopic microsurgery: a prospective study of risk factors and time course. Int J Colorectal Dis 2016;31:833-41. [PMID: 26861635 DOI: 10.1007/s00384-016-2527-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
18 Yan H, Yu J, Wang R, Jiang S, Zhu K, Mu D, Xu Z. Prognostic value of Smac expression in rectal cancer patients treated with neoadjuvant therapy. Med Oncol. 2012;29:168-173. [PMID: 21264534 DOI: 10.1007/s12032-011-9819-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
19 Kim CH, Yeom SS, Lee SY, Kim HR, Kim YJ, Lee KH, Lee JH. Prognostic Impact of Perineural Invasion in Rectal Cancer After Neoadjuvant Chemoradiotherapy. World J Surg. 2019;43:260-272. [PMID: 30151676 DOI: 10.1007/s00268-018-4774-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
20 Sato H, Maeda K, Maruta M. Prognostic significance of lateral lymph node dissection in node positive low rectal carcinoma. Int J Colorectal Dis 2011;26:881-9. [DOI: 10.1007/s00384-011-1170-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
21 Reddy SS, Handorf B, Farma JM, Sigurdson ER. Trends with neoadjuvant radiotherapy and clinical staging for those with rectal malignancies. World J Gastrointest Surg 2017; 9(4): 97-102 [PMID: 28503257 DOI: 10.4240/wjgs.v9.i4.97] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
22 Park YY, Lee KY, Kim NK, Lee SB, Kim GR, Min BS, Oh ST. Impact of Adjuvant Chemotherapy Completion on Oncologic Outcomes in ypTNMstage 2 Rectal Cancer Patients. Ann Coloproctol 2019;35:335-41. [PMID: 31937073 DOI: 10.3393/ac.2019.03.10] [Reference Citation Analysis]
23 Yu M, Lee JH, Jang HS, Jeon DM, Cheon JS, Lee HC, Lee JH. A comparison of dosimetric parameters between tomotherapy and three-dimensional conformal radiotherapy in rectal cancer. Radiat Oncol 2013;8:181. [PMID: 23866263 DOI: 10.1186/1748-717X-8-181] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
24 Kim CH, Lee SY, Kim HR, Kim YJ. Nomogram Prediction of Anastomotic Leakage and Determination of an Effective Surgical Strategy for Reducing Anastomotic Leakage after Laparoscopic Rectal Cancer Surgery. Gastroenterol Res Pract 2017;2017:4510561. [PMID: 28592967 DOI: 10.1155/2017/4510561] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
25 Morimoto M, Miyakura Y, Lefor AT, Takahashi K, Horie H, Koinuma K, Tanaka H, Ito H, Shimizu T, Kono Y, Sata N, Fukushima N, Sakatani T, Yasuda Y. Reduction in the size of enlarged pelvic lymph nodes after chemoradiation therapy is associated with fewer lymph node metastases in locally advanced rectal carcinoma. Surg Today 2015;45:834-40. [PMID: 25119163 DOI: 10.1007/s00595-014-1007-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
26 Fitzgerald TL, Zervos E, Wong JH. Patterns of Pelvic Radiotherapy in Patients with Stage II/III Rectal Cancer. J Cancer Epidemiol 2013;2013:408460. [PMID: 24223589 DOI: 10.1155/2013/408460] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
27 Riesco-Martinez MC, Fernandez-Martos C, Gravalos-Castro C, Espinosa-Olarte P, La Salvia A, Robles-Diaz L, Modrego-Sanchez A, Garcia-Carbonero R. Impact of Total Neoadjuvant Therapy vs. Standard Chemoradiotherapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis of Randomized Trials. Cancers (Basel) 2020;12:E3655. [PMID: 33291454 DOI: 10.3390/cancers12123655] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
28 Byun JH, Ahn JB, Kim SY, Kang JH, Zang DY, Kang SY, Kang MJ, Shim BY, Baek SK, Kim BS, Lee KH, Lee SI, Cho SH, Sohn BS, Kim S, Hwang IG, Nam EM, Seo BG, Oh SC, Lee MA, Lee SC, Hong JH, Park YS. The impact of primary tumor location in patients with metastatic colorectal cancer: a Korean Cancer Study Group CO12-04 study. Korean J Intern Med 2019;34:165-77. [PMID: 29172407 DOI: 10.3904/kjim.2016.348] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
29 Chan GHJ, Chee CE. Making sense of adjuvant chemotherapy in colorectal cancer. J Gastrointest Oncol 2019;10:1183-92. [PMID: 31949938 DOI: 10.21037/jgo.2019.06.03] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
30 Okuyama T, Sameshima S, Takeshita E, Yoshioka R, Yamagata Y, Ono Y, Tagaya N, Noie T, Oya M. Therapeutic effects of oxaliplatin-based neoadjuvant chemotherapy and chemoradiotherapy in patients with locally advanced rectal cancer: a single-center, retrospective cohort study.World J Surg Oncol. 2018;16:105. [PMID: 29871650 DOI: 10.1186/s12957-018-1403-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
31 Spitzner M, Emons G, Kramer F, Gaedcke J, Rave-Fränk M, Scharf JG, Burfeind P, Becker H, Beissbarth T, Ghadimi BM, Ried T, Grade M. A gene expression signature for chemoradiosensitivity of colorectal cancer cells. Int J Radiat Oncol Biol Phys 2010;78:1184-92. [PMID: 20970032 DOI: 10.1016/j.ijrobp.2010.06.023] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 4.6] [Reference Citation Analysis]
32 Jhaveri J, Rayfield L, Liu Y, Chowdhary M, Cassidy RJ, Madden NA, Tanenbaum DG, Gillespie TW, Patel PR, Patel KR, Landry JC. Prognostic relevance of human papillomavirus infection in anal squamous cell carcinoma: analysis of the national cancer data base. J Gastrointest Oncol 2017;8:998-1008. [PMID: 29299360 DOI: 10.21037/jgo.2017.10.05] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
33 Fernández-Martos C, Nogué M, Cejas P, Moreno-García V, Machancoses AH, Feliu J. The role of capecitabine in locally advanced rectal cancer treatment: an update. Drugs. 2012;72:1057-1073. [PMID: 22621694 DOI: 10.2165/11633870-000000000-00000] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
34 Wolf M, Zehentmayr F, Belka C. [Radiotherapy of rectal cancer]. Radiologe 2012;52:545-9. [PMID: 22618627 DOI: 10.1007/s00117-011-2286-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
35 Elliott SP, Malaeb BS. Long-term urinary adverse effects of pelvic radiotherapy. World J Urol 2011;29:35-41. [PMID: 20959990 DOI: 10.1007/s00345-010-0603-x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
36 Zhou C, Liu HS, Liu XH, Zheng XB, Hu T, Liang ZX, He XW, He XS, Hu JC, Wu XJ, Wu XR, Lan P. Preoperative assessment of lymph node metastasis in clinically node-negative rectal cancer patients based on a nomogram consisting of five clinical factors. Ann Transl Med 2019;7:543. [PMID: 31807525 DOI: 10.21037/atm.2019.09.127] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
37 Chablani P, Nguyen P, Pan X, Robinson A, Walston S, Wu C, Frankel WL, Chen W, Bekaii-Saab T, Chakravarti A, Wuthrick E, Williams TM. Perineural Invasion Predicts for Distant Metastasis in Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiation and Surgery. Am J Clin Oncol 2017;40:561-8. [PMID: 26703815 DOI: 10.1097/COC.0000000000000214] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
38 Langrand-Escure J, Diao P, Garcia MA, Wang G, Guy JB, Espenel S, Guillaume E, Rehailia-Blanchard A, Pigné G, de Laroche G, Kaczmarek D, Muron T, Porcheron J, Phelip JM, Vallard A, Magné N. Outcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional survey. Sci Rep 2018;8:10708. [PMID: 30013090 DOI: 10.1038/s41598-018-29040-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Francescutti V, Coates A, Thabane L, Goldsmith CH, Levine MN, Simunovic M. Patterns of use and outcomes for radiation therapy in the Quality Initiative in Rectal Cancer (QIRC) trial. Can J Surg 2013;56:E148-53. [PMID: 24284154 DOI: 10.1503/cjs.019012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Strassburg J, Lewin A, Ludwig K, Kilian L, Linke J, Loy V, Knuth P, Püttcher O, Ruehl U, Stöckmann F, Hackenthal M, Hopfenmüller W, Huppertz A. Optimised surgery (so-called TME surgery) and high-resolution MRI in the planning of treatment of rectal carcinoma. Langenbecks Arch Surg 2007;392:179-88. [PMID: 17279430 DOI: 10.1007/s00423-007-0149-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
41 Kye BH, Kim HJ, Kim JG, Kim SH, Shim BY, Lee NS, Cho HM. Short-term effects of neoadjuvant chemoradiation therapy on anorectal function in rectal cancer patients: a pilot study. Radiat Oncol 2013;8:203. [PMID: 23961877 DOI: 10.1186/1748-717X-8-203] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
42 Frank F, Hecht M, Loy F, Rutzner S, Fietkau R, Distel L. Differences in and Prognostic Value of Quality of Life Data in Rectal Cancer Patients with and without Distant Metastases. Healthcare (Basel) 2020;9:E1. [PMID: 33374955 DOI: 10.3390/healthcare9010001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Bergquist JR, Thiels CA, Shubert CR, Habermann EB, Hayman AV, Zielinski MD, Mathis KL. Is Chemotherapy or Radiation Therapy in Addition to Surgery Beneficial for Locally Advanced Rectal Cancer in the Elderly? A National Cancer Data Base (NCDB) Study. World J Surg 2016;40:447-55. [PMID: 26566779 DOI: 10.1007/s00268-015-3319-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
44 Kim MS, Keum KC, Rhee WJ, Kim H, Kim M, Choi S, Nam KC, Koom WS. The location of locoregional recurrence in pathologic T3N0, non-irradiated lower rectal cancer. Radiat Oncol J 2013;31:97-103. [PMID: 23865006 DOI: 10.3857/roj.2013.31.2.97] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
45 Chee CE, Sinicrope FA. Targeted therapeutic agents for colorectal cancer. Gastroenterol Clin North Am 2010;39:601-13. [PMID: 20951919 DOI: 10.1016/j.gtc.2010.08.017] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
46 陆忠华, 王建华, 许锡元, 周健. Ⅱ、Ⅲ期直肠癌根治术后放疗同步希罗达化疗的疗效. 世界华人消化杂志 2009; 17(32): 3351-3354 [DOI: 10.11569/wcjd.v17.i32.3351] [Reference Citation Analysis]
47 Krishnamurthi SS, Seo Y, Kinsella TJ. Adjuvant therapy for rectal cancer. Clin Colon Rectal Surg 2007;20:167-81. [PMID: 20011198 DOI: 10.1055/s-2007-984861] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
48 Guillem JG, Chessin DB, Shia J, Suriawinata A, Riedel E, Moore HG, Minsky BD, Wong WD. A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy: implications for sphincter preservation. Ann Surg. 2007;245:88-93. [PMID: 17197970 DOI: 10.1097/01.sla.0000232540.82364.43] [Cited by in Crossref: 100] [Cited by in F6Publishing: 79] [Article Influence: 7.1] [Reference Citation Analysis]
49 Treder M, Vogelsang RP, Janssen S, Schild SE, Holländer NH, Rades D. Potential Prognostic Factors of Downstaging Following Preoperative Chemoradiation for High Rectal Cancer. In Vivo 2018;32:1481-4. [PMID: 30348705 DOI: 10.21873/invivo.11403] [Reference Citation Analysis]
50 Witek M, Blomain ES, Magee MS, Xiang B, Waldman SA, Snook AE. Tumor radiation therapy creates therapeutic vaccine responses to the colorectal cancer antigen GUCY2C. Int J Radiat Oncol Biol Phys 2014;88:1188-95. [PMID: 24661671 DOI: 10.1016/j.ijrobp.2013.12.043] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
51 Banerjee CM. Dr. K.C. Chaudhuri--reminiscences. Indian J Pediatr. 1974;41:89-90. [PMID: 4609421 DOI: 10.1155/2015/921435] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 0.6] [Reference Citation Analysis]
52 Billakanti R, Seshadri RA, Soma S, Makineni H, Sundersingh S. Lymph Node Harvest After Neoadjuvant Treatment for Rectal Cancer and Its Impact on Oncological Outcomes. Indian J Surg Oncol 2020;11:692-8. [PMID: 33281409 DOI: 10.1007/s13193-020-01162-y] [Reference Citation Analysis]
53 Conradi LC, Spitzner M, Metzger AL, Kisly M, Middel P, Bohnenberger H, Gaedcke J, Ghadimi MB, Liersch T, Rüschoff J, Beißbarth T, König A, Grade M. Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer. BMC Cancer 2019;19:880. [PMID: 31488078 DOI: 10.1186/s12885-019-6051-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
54 Roxburgh CS, Weiser MR. Selective use of radiation for locally advanced rectal cancer: one size does not fit all. Minerva Chir 2018;73:592-600. [PMID: 29806758 DOI: 10.23736/S0026-4733.18.07791-X] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Harris DA, Thorne K, Hutchings H, Islam S, Holland G, Hatcher O, Gwynne S, Jenkins I, Coyne P, Duff M, Feldman M, Winter DC, Gollins S, Quirke P, West N, Brown G, Fitzsimmons D, Brown A, Beynon J. Protocol for a multicentre randomised feasibility trial evaluating early Surgery Alone In LOw Rectal cancer (SAILOR). BMJ Open 2016;6:e012496. [PMID: 27872117 DOI: 10.1136/bmjopen-2016-012496] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
56 Farid M, Lee MJ, Chew MH, Ong WS, Sairi AN, Foo KF, Choo SP, Koo WH, Ong S, Koh PK, Quek R. Localized gastrointestinal stromal tumor of the rectum: An uncommon primary site with prominent disease and treatment-related morbidities. Mol Clin Oncol 2013;1:190-4. [PMID: 24649146 DOI: 10.3892/mco.2012.25] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
57 Yang CC, Lin LC, Lin YW, Tian YF, Lin CY, Sheu MJ, Li CF, Tai MH. Higher nuclear EGFR expression is a better predictor of survival in rectal cancer patients following neoadjuvant chemoradiotherapy than cytoplasmic EGFR expression. Oncol Lett 2019;17:1551-8. [PMID: 30675212 DOI: 10.3892/ol.2018.9756] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
58 Glynne-Jones R, Chau I. Neoadjuvant therapy before surgical treatment. EJC Suppl 2013;11:45-59. [PMID: 26217113 DOI: 10.1016/j.ejcsup.2013.07.032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
59 Yang YC, Wu GC, Jin L, Wang KL, Bai ZG, Wang J, Zhang ZT. Association of thymidylate synthase polymorphisms with the tumor response to preoperative chemoradiotherapy in rectal cancer: a systematic review and meta-analysis. Pharmacogenomics J 2017;17:265-73. [PMID: 27001118 DOI: 10.1038/tpj.2016.11] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
60 Agha A, Benseler V, Hornung M, Gerken M, Iesalnieks I, Fürst A, Anthuber M, Jauch KW, Schlitt HJ. Long-term oncologic outcome after laparoscopic surgery for rectal cancer. Surg Endosc. 2014;28:1119-1125. [PMID: 24202710 DOI: 10.1007/s00464-013-3286-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
61 Lee JL, Lim SB, Yu CS, Park IJ, Yoon YS, Kim CW, Park SH, Lee JS, Hong YS, Kim SY, Kim JE, Kim JH, Park JH, Kim J, Han M. Local excision in mid-to-low rectal cancer patients who revealed clinically total or near-total regression after preoperative chemoradiotherapy; a proposed trial. BMC Cancer 2019;19:404. [PMID: 31035949 DOI: 10.1186/s12885-019-5581-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
62 He X, Zhong X, Hu Z, Zhao S, Wei P, Li D. An insight into small extracellular vesicles: Their roles in colorectal cancer progression and potential clinical applications. Clin Transl Med 2020;10:e249. [PMID: 33377655 DOI: 10.1002/ctm2.249] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
63 Wang XJ, Zheng ZR, Chi P, Lin HM, Lu XR, Huang Y. Effect of Interval between Neoadjuvant Chemoradiotherapy and Surgery on Oncological Outcome for Rectal Cancer: A Systematic Review and Meta-Analysis. Gastroenterol Res Pract 2016;2016:6756859. [PMID: 27190505 DOI: 10.1155/2016/6756859] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
64 Delishaj D, Fumagalli IC, Ursino S, Cristaudo A, Colangelo F, Stefanelli A, Alghisi A, De Nobili G, D’Amico R, Cocchi A, Ardizzoia A, Soatti CP. Neoadjuvant radiotherapy dose escalation for locally advanced rectal cancers in the new era of radiotherapy: A review of literature. World J Clin Cases 2021; 9(30): 9077-9089 [DOI: 10.12998/wjcc.v9.i30.9077] [Reference Citation Analysis]
65 Huang CM, Huang MY, Tsai HL, Huang CW, Ma CJ, Yeh YS, Juo SH, Huang CJ, Wang JY. An observational study of extending FOLFOX chemotherapy, lengthening the interval between radiotherapy and surgery, and enhancing pathological complete response rates in rectal cancer patients following preoperative chemoradiotherapy. Therap Adv Gastroenterol. 2016;9:702-712. [PMID: 27582883 DOI: 10.1177/1756283x16656690] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
66 Ogura A, Konishi T, Cunningham C, Garcia-Aguilar J, Iversen H, Toda S, Lee IK, Lee HX, Uehara K, Lee P, Putter H, van de Velde CJH, Beets GL, Rutten HJT, Kusters M; Lateral Node Study Consortium. Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer. J Clin Oncol 2019;37:33-43. [PMID: 30403572 DOI: 10.1200/JCO.18.00032] [Cited by in Crossref: 110] [Cited by in F6Publishing: 51] [Article Influence: 36.7] [Reference Citation Analysis]
67 Wong RK, Jang R, Darling G. Postoperative chemoradiotherapy vs. preoperative chemoradiotherapy for locally advanced (operable) gastric cancer: clarifying the role and technique of radiotherapy. J Gastrointest Oncol. 2015;6:89-107. [PMID: 25642342 DOI: 10.3978/j.issn.2078-6891.2014.089] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
68 Jensen G, Tao R, Eng C, Skibber JM, Rodriguez-Bigas M, Chang GJ, You YN, Bednarski BK, Minsky BD, Koay E, Taniguchi C, Krishnan S, Das P. Treatment of primary rectal adenocarcinoma after prior pelvic radiation: The role of hyperfractionated accelerated reirradiation. Adv Radiat Oncol 2018;3:595-600. [PMID: 30370360 DOI: 10.1016/j.adro.2018.07.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
69 O'Neill B, Brown G, Wotherspoon A, Burton S, Norman A, Tait D. Successful downstaging of high rectal and recto-sigmoid cancer by neo-adjuvant chemo-radiotherapy. Clin Med Oncol 2008;2:135-44. [PMID: 21892276 DOI: 10.4137/cmo.s348] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
70 Song O, Kim KH, Lee SY, Kim CH, Kim YJ, Kim HR. Risk factors of stoma re-creation after closure of diverting ileostomy in patients with rectal cancer who underwent low anterior resection or intersphincteric resection with loop ileostomy. Ann Surg Treat Res 2018;94:203-8. [PMID: 29629355 DOI: 10.4174/astr.2018.94.4.203] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
71 Sun G, Tang Y, Li X, Meng J, Liang G. Analysis of 116 cases of rectal cancer treated by transanal local excision. World J Surg Oncol. 2014;12:202. [PMID: 25008129 DOI: 10.1186/1477-7819-12-202] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
72 Torres-Roca JF. A molecular assay of tumor radiosensitivity: a roadmap towards biology-based personalized radiation therapy. Per Med 2012;9:547-57. [PMID: 23105945 DOI: 10.2217/pme.12.55] [Cited by in Crossref: 48] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
73 Perez RO, Habr-Gama A, Proscurshim I, Campos FG, Kiss D, Gama-Rodrigues J, Cecconello I. Local excision for ypT2 rectal cancer--much ado about something. J Gastrointest Surg. 2007;11:1431-1438; discussion 1431-1438. [PMID: 17805938 DOI: 10.1007/s11605-007-0271-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
74 Sinukumar S, Mehta S, Ostwal V, Jatal S, Saklani A. Impact of type of surgery (laparoscopic versus open) on the time to initiation of adjuvant chemotherapy in operable rectal cancers. Indian J Gastroenterol 2015;34:310-3. [PMID: 26245505 DOI: 10.1007/s12664-015-0579-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
75 Dewdney A, Cunningham D. Toward the non-surgical management of locally advanced rectal cancer. Curr Oncol Rep 2012;14:267-76. [PMID: 22460631 DOI: 10.1007/s11912-012-0234-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
76 Patel SA, Chen YH, Hornick JL, Catalano P, Nowak JA, Zukerberg LR, Bleday R, Shellito PC, Hong TS, Mamon HJ. Early-stage rectal cancer: clinical and pathologic prognostic markers of time to local recurrence and overall survival after resection. Dis Colon Rectum 2014;57:449-59. [PMID: 24608301 DOI: 10.1097/DCR.0b013e3182a70709] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 3.6] [Reference Citation Analysis]
77 Zheng L, Zhang Y, Liu Y, Zhou M, Lu Y, Yuan L, Zhang C, Hong M, Wang S, Li X. MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer. J Transl Med 2015;13:252. [PMID: 26238857 DOI: 10.1186/s12967-015-0592-z] [Cited by in Crossref: 92] [Cited by in F6Publishing: 99] [Article Influence: 15.3] [Reference Citation Analysis]
78 Chan J, Kinsella MT, Willis JE, Hu H, Reynolds H Jr, Delaney C, McCulla A, Deharo S, Ahdesmäki M, Allen WL, Johnston PG, Kinsella TJ. A Predictive Genetic Signature for Response to Fluoropyrimidine-Based Neoadjuvant Chemoradiation in Clinical Stage II and III Rectal Cancer. Front Oncol 2013;3:288. [PMID: 24324931 DOI: 10.3389/fonc.2013.00288] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
79 Hasnis E, Dahan A, Khoury W, Duek D, Fisher Y, Beny A, Shaked Y, Chowers Y, Half EE. Intratumoral HLA-DR-/CD33+/CD11b+ Myeloid-Derived Suppressor Cells Predict Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. Front Oncol 2020;10:1375. [PMID: 32903466 DOI: 10.3389/fonc.2020.01375] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Nishigori H, Ito M, Nishizawa Y, Nishizawa Y, Kobayashi A, Sugito M, Saito N. Effectiveness of a transanal tube for the prevention of anastomotic leakage after rectal cancer surgery. World J Surg. 2014;38:1843-1851. [PMID: 24378550 DOI: 10.1007/s00268-013-2428-4] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
81 Zoltan L, Farkas R, Schally AV, Pozsgai E, Papp A, Bognár L, Tornoczki T, Mangel L, Bellyei S. Possible Predictive Markers of Response to Therapy in Esophageal Squamous Cell Cancer. Pathol Oncol Res 2019;25:279-88. [PMID: 29103201 DOI: 10.1007/s12253-017-0342-z] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
82 Arenas M, Sabater S, Gascón M, Henríquez I, Bueno MJ, Rius À, Rovirosa À, Gómez D, Lafuerza A, Biete A, Colomer J. Quality assurance in radiotherapy: analysis of the causes of not starting or early radiotherapy withdrawal. Radiat Oncol 2014;9:260. [PMID: 25472662 DOI: 10.1186/s13014-014-0260-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
83 De Felice F, Benevento I, Magnante AL, Musio D, Bulzonetti N, Caiazzo R, Tombolini V. Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis : Oxaliplatin in neoadjuvant treatment for rectal cancer. BMC Cancer 2017;17:325. [PMID: 28499428 DOI: 10.1186/s12885-017-3323-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
84 Jeong DH, Lee HB, Hur H, Min BS, Baik SH, Kim NK. Optimal timing of surgery after neoadjuvant chemoradiation therapy in locally advanced rectal cancer. J Korean Surg Soc 2013;84:338-45. [PMID: 23741691 DOI: 10.4174/jkss.2013.84.6.338] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
85 Guerin O, Gal J, Francois E, Jacqueme B, Sciortino V, Gerard JP. Clinical outcome of rectal cancer in patients ≥ 80 years treated in southern France (PACA region) between 2002 and 2005. Strahlenther Onkol 2012;188:383-7. [PMID: 22410833 DOI: 10.1007/s00066-012-0076-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
86 Stelzner S, Koehler C, Stelzer J, Sims A, Witzigmann H. Extended abdominoperineal excision vs. standard abdominoperineal excision in rectal cancer--a systematic overview. Int J Colorectal Dis. 2011;26:1227-1240. [PMID: 21603901 DOI: 10.1007/s00384-011-1235-3] [Cited by in Crossref: 99] [Cited by in F6Publishing: 78] [Article Influence: 9.9] [Reference Citation Analysis]
87 Miyamoto R, Kikuchi K, Uchida A, Ozawa M, Sano N, Tadano S, Inagawa S, Oda T, Ohkohchi N. Pathological complete response after preoperative chemotherapy including FOLFOX plus bevacizumab for locally advanced rectal cancer: A case report and literature review. Int J Surg Case Rep 2019;62:85-8. [PMID: 31476559 DOI: 10.1016/j.ijscr.2019.08.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
88 Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, Hamaguchi T, Hyodo I, Igarashi M, Ishida H, Ishihara S, Ishiguro M, Kanemitsu Y, Kokudo N, Muro K, Ochiai A, Oguchi M, Ohkura Y, Saito Y, Sakai Y, Ueno H, Yoshino T, Boku N, Fujimori T, Koinuma N, Morita T, Nishimura G, Sakata Y, Takahashi K, Tsuruta O, Yamaguchi T, Yoshida M, Yamaguchi N, Kotake K, Sugihara K; Japanese Society for Cancer of the Colon and Rectum. Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol. 2015;20:207-239. [PMID: 25782566 DOI: 10.1007/s10147-015-0801-z] [Cited by in Crossref: 379] [Cited by in F6Publishing: 363] [Article Influence: 63.2] [Reference Citation Analysis]
89 Zhong X, Wu Z, Gao P, Shi J, Sun J, Guo Z, Wang Z, Song Y. The efficacy of adding targeted agents to neoadjuvant therapy for locally advanced rectal cancer patients: a meta-analysis. Cancer Med 2018;7:565-82. [PMID: 29464874 DOI: 10.1002/cam4.1298] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
90 Chauvin A, Wang CS, Geha S, Garde-Granger P, Mathieu AA, Lacasse V, Boisvert FM. The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature. Clin Proteomics 2018;15:16. [PMID: 29681787 DOI: 10.1186/s12014-018-9192-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
91 Suppiah A, Hartley JE, Monson JR. Advances in radiotherapy in operable rectal cancer. Dig Surg 2009;26:187-99. [PMID: 19494494 DOI: 10.1159/000219931] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
92 Fiore M, Trodella L, Valeri S, Borzomati D, Floreno B, Ippolito E, Trecca P, Trodella LE, D'Angelillo RM, Ramella S, Coppola R. Prospective study of cetuximab and gemcitabine in combination with radiation therapy: feasibility and efficacy in locally advanced pancreatic head cancer. Radiat Oncol 2015;10:255. [PMID: 26670587 DOI: 10.1186/s13014-015-0564-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
93 Shen L, Sun Y, Zhang H, Zhang J, Deng W, Wang Y, Yao Y, Yang L, Zhu J, Tong T, Liang L, Zhang Z. T3 subclassification using the EMD/mesorectum ratio predicts neoadjuvant chemoradiation outcome in T3 rectal cancer patients. Br J Radiol 2018;91:20170617. [PMID: 29072488 DOI: 10.1259/bjr.20170617] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
94 Nelson JW, Ghafoori AP, Willett CG, Tyler DS, Pappas TN, Clary BM, Hurwitz HI, Bendell JC, Morse MA, Clough RW, Czito BG. Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys 2009;73:148-53. [PMID: 18805651 DOI: 10.1016/j.ijrobp.2008.07.008] [Cited by in Crossref: 96] [Cited by in F6Publishing: 80] [Article Influence: 7.4] [Reference Citation Analysis]
95 Liberman D, Mehus B, Elliott SP. Urinary adverse effects of pelvic radiotherapy. Transl Androl Urol 2014;3:186-95. [PMID: 26813159 DOI: 10.3978/j.issn.2223-4683.2014.04.01] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
96 Rödel C. Radiotherapy: Preoperative chemoradiotherapy for rectal cancer. Nat Rev Clin Oncol. 2010;7:129-130. [PMID: 20190793 DOI: 10.1038/nrclinonc.2010.10] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
97 Kitayama J, Yasuda K, Kawai K, Sunami E, Nagawa H. Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer. BMC Cancer. 2011;11:64. [PMID: 21306650 DOI: 10.1186/1471-2407-11-64] [Cited by in Crossref: 60] [Cited by in F6Publishing: 65] [Article Influence: 6.0] [Reference Citation Analysis]
98 Siewert JR, Lordick F, Ott K, Brücher BL, Rosenberg R. [Curative vs palliative strategies in locoregional recurrence of gastrointestinal malignancies]. Chirurg. 2006;77:227-235. [PMID: 16511688 DOI: 10.1007/s00104-006-1163-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
99 Brunner TB, Scott-Brown M. The role of radiotherapy in multimodal treatment of pancreatic carcinoma. Radiat Oncol. 2010;5:64. [PMID: 20615227 DOI: 10.1186/1748-717x-5-64] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
100 Kamran SC, Lennerz JK, Margolis CA, Liu D, Reardon B, Wankowicz SA, Van Seventer EE, Tracy A, Wo JY, Carter SL, Willers H, Corcoran RB, Hong TS, Van Allen EM. Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal Cancer. Clin Cancer Res. 2019;25:5561-5571. [PMID: 31253631 DOI: 10.1158/1078-0432.ccr-19-0908] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 12.5] [Reference Citation Analysis]
101 Guckenberger M, Saur G, Wehner D, Sweeney RA, Thalheimer A, Germer CT, Flentje M. Comparison of preoperative short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer. Strahlenther Onkol 2012;188:551-7. [PMID: 22638934 DOI: 10.1007/s00066-012-0131-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
102 Lichthardt S, Zenorini L, Wagner J, Baur J, Kerscher A, Matthes N, Kastner C, Pelz J, Kunzmann V, Germer CT, Wiegering A. Impact of adjuvant chemotherapy after neoadjuvant radio- or radiochemotherapy for patients with locally advanced rectal cancer. J Cancer Res Clin Oncol 2017;143:2363-73. [PMID: 28756493 DOI: 10.1007/s00432-017-2483-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
103 Glynne-Jones R, Falk S, Maughan TS, Meadows HM, Sebag-Montefiore D. A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study. Br J Cancer 2007;96:551-8. [PMID: 17262086 DOI: 10.1038/sj.bjc.6603570] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
104 Ryu YJ, Kim CH, Kim HJ, Kang H, Lim SW, Huh JW, Ju JK, Kim YJ, Kim HR. Clinical significance of serial serum carcinoembryonic antigen values for treating rectal cancer with preoperative chemoradiotherapy. J Korean Soc Coloproctol 2012;28:205-12. [PMID: 22993707 DOI: 10.3393/jksc.2012.28.4.205] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
105 Gallego-Plazas J, Menarguez-Pina F, Martinez-Banaclocha N, Pons-Sanz V, Mingol-Navarro F, Ruiz-Macia JA, Macia-Escalante S. Early distant relapse after optimal local control in locally advanced rectal cancer. Int Semin Surg Oncol 2008;5:18. [PMID: 18620609 DOI: 10.1186/1477-7800-5-18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
106 Sun Z, Adam MA, Kim J, Czito B, Mantyh C, Migaly J. Intensity-Modulated Radiation Therapy Is Not Associated with Perioperative or Survival Benefit over 3D-Conformal Radiotherapy for Rectal Cancer. J Gastrointest Surg 2017;21:106-11. [PMID: 27510332 DOI: 10.1007/s11605-016-3242-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
107 Dreussi E, Pucciarelli S, De Paoli A, Polesel J, Canzonieri V, Agostini M, Friso ML, Belluco C, Buonadonna A, Lonardi S, Zanusso C, De Mattia E, Toffoli G, Cecchin E. Predictive role of microRNA-related genetic polymorphisms in the pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients. Oncotarget 2016;7:19781-93. [PMID: 26934318 DOI: 10.18632/oncotarget.7757] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
108 Brown LC, Atherton PJ, Neben-Wittich MA, Wender DB, Behrens RJ, Kozelsky TF, Loprinzi CL, Haddock MG, Martenson JA. Assessment of long-term rectal function in patients who received pelvic radiotherapy: a pooled North Central Cancer Treatment Group trial analysis, N09C1. Support Care Cancer 2013;21:2869-77. [PMID: 23748483 DOI: 10.1007/s00520-013-1853-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
109 Iannacone E, Dionisi F, Musio D, Caiazzo R, Raffetto N, Banelli E. Chemoradiation as definitive treatment for primary squamous cell cancer of the rectum. World J Radiol 2010; 2(8): 329-333 [PMID: 21160687 DOI: 10.4329/wjr.v2.i8.329] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
110 Jung W, Kim K, Kim J, Shim SJ. Prognostic Impact of Lymph Node Ratio in Patients Undergoing Preoperative Chemoradiotherapy Followed by Curative Resection for Locally Advanced Rectal Cancer. In Vivo 2020;34:1247-53. [PMID: 32354915 DOI: 10.21873/invivo.11898] [Reference Citation Analysis]
111 Baek JY, Yu JI, Park HC, Choi DH, Yoo GS, Cho WK, Lee WY, Yun SH, Cho YB, Park YA, Kim HC. Risk factors for locoregional recurrence in patients with pathologic T3N0 rectal cancer with negative resection margin treated by surgery alone. Radiat Oncol J 2019;37:110-6. [PMID: 31266292 DOI: 10.3857/roj.2019.00199] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
112 Karagkounis G, DeVecchio J, Ferrandon S, Kalady MF. Simvastatin enhances radiation sensitivity of colorectal cancer cells. Surg Endosc 2018;32:1533-9. [PMID: 28916945 DOI: 10.1007/s00464-017-5841-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
113 Kang SB, Cho JR, Jeong SY, Oh JH, Ahn S, Choi S, Kim DW, Lee BH, Youk EG, Park SC, Heo SC, Lee DS, Ryoo SB, Park JW, Park HC, Lee SM, Kang SI, Kim MH, Oh HK, Shin R, Kim MJ, Lee KH, Kim YH, Kim JS, Lee KW, Lee HS, Kim HJ, Park YS, Sohn DK, Park KJ; Seoul Colorectal Research Group (SECOG). Quality of life after sphincter preservation surgery or abdominoperineal resection for low rectal cancer (ASPIRE): A long-term prospective, multicentre, cohort study. Lancet Reg Health West Pac 2021;6:100087. [PMID: 34327411 DOI: 10.1016/j.lanwpc.2020.100087] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
114 Petersen SH, Harling H, Kirkeby LT, Wille-Jørgensen P, Mocellin S. Postoperative adjuvant chemotherapy in rectal cancer operated for cure. Cochrane Database Syst Rev. 2012;CD004078. [PMID: 22419291 DOI: 10.1002/14651858.cd004078.pub2] [Cited by in Crossref: 48] [Cited by in F6Publishing: 71] [Article Influence: 5.3] [Reference Citation Analysis]
115 Akagi Y, Kinugasa T, Shirouzu K. Intersphincteric resection for very low rectal cancer: a systematic review. Surg Today. 2013;43:838-847. [PMID: 23139048 DOI: 10.1007/s00595-012-0394-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
116 Jankarashvili N, Kakhadze S, Topeshashvili M, Turkiasvili L, Tchiabrishvili M. Neoadjuvant volumetric modulated arc radiochemotherapy with a simultaneous integrated boost technique compared to standard chemoradiation for locally advanced rectal cancer. Turk J Med Sci 2019;49:1484-9. [PMID: 31651118 DOI: 10.3906/sag-1812-185] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
117 Sugano H, Shirai Y, Horiuchi T, Saito N, Shimada Y, Eto K, Uwagawa T, Ohashi T, Yanaga K. Nafamostat Mesilate Enhances the Radiosensitivity and Reduces the Radiation-Induced Invasive Ability of Colorectal Cancer Cells. Cancers (Basel) 2018;10:E386. [PMID: 30336548 DOI: 10.3390/cancers10100386] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
118 Peca S, Sinha RS, Brown DW, Smith WL. In vivo Portal Imaging Dosimetry Identifies Delivery Errors in Rectal Cancer Radiotherapy on the Belly Board Device. Technol Cancer Res Treat 2017;16:956-63. [PMID: 28585490 DOI: 10.1177/1533034617711519] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
119 Ferrari L, Fichera A. Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer.Gastroenterol Rep (Oxf). 2015;3:277-288. [PMID: 26290512 DOI: 10.1093/gastro/gov039] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
120 Gasser M, Kim M, Rehder R, Frank N, Frank M, Grimmig T, Moench R, Ribas C, Illert B, Germer CT, Rosenwald A, Waaga-Gasser AM. Clinical Significance of Disseminated Pluripotent Tumor Cell Signature Expression in the Bone Marrow from Patients with Colorectal Cancer. J Cancer Sci Ther 2017;9:669-74. [PMID: 34221246 DOI: 10.4172/1948-5956.1000490] [Reference Citation Analysis]
121 Hacker U, Hallek M, Kubicka S. [Multimodality therapy of colorectal cancer]. Internist (Berl) 2010;51:1366-73. [PMID: 20967408 DOI: 10.1007/s00108-010-2671-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
122 Klautke G, Feyerherd P, Ludwig K, Prall F, Foitzik T, Fietkau R. Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer. Br J Cancer. 2005;92:1215-1220. [PMID: 15785742 DOI: 10.1038/sj.bjc.6602492] [Cited by in Crossref: 59] [Cited by in F6Publishing: 51] [Article Influence: 3.7] [Reference Citation Analysis]
123 Lee W, Nelson R, Akmal Y, Mailey B, McKenzie S, Artinyan A, Ashing-Giwa KT, Chen YJ, Garcia-Aguilar J, Kim J. Racial and ethnic disparities in outcomes with radiation therapy for rectal adenocarcinoma. Int J Colorectal Dis. 2012;27:737-749. [PMID: 22159751 DOI: 10.1007/s00384-011-1378-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
124 Babar L, Bakalov V, Abel S, Ashraf O, Finley GG, Raj MS, Lundeen K, Monga DK, Kirichenko AV, Wegner RE. Retrospective review of total neoadjuvant therapy. World J Gastrointest Oncol 2019; 11(10): 857-865 [PMID: 31662824 DOI: 10.4251/wjgo.v11.i10.857] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
125 Del Carmen S, Corchete LA, González Velasco C, Sanz J, Alcazar JA, García J, Rodríguez AI, Vidal Tocino R, Rodriguez A, Pérez-Romasanta LA, Sayagués JM, Abad M. High-Risk Clinicopathological and Genetic Features and Outcomes in Patients Receiving Neoadjuvant Radiochemotherapy for Locally Advanced Rectal Cancer. Cancers (Basel) 2021;13:3166. [PMID: 34202891 DOI: 10.3390/cancers13133166] [Reference Citation Analysis]
126 Park IJ, You YN, Skibber JM, Rodriguez-Bigas MA, Das P, Eng C, Kopetz S, Wolff RA, Crane CH, Krishnan S, Minsky B, Hu CY, Nguyen S, Chang GJ. Oncologic and Functional Hazards of Obesity Among Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiation Therapy. Am J Clin Oncol 2017;40:277-82. [PMID: 27028350 DOI: 10.1097/COC.0000000000000150] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
127 Agostini M, Zangrando A, Pastrello C, D'Angelo E, Romano G, Giovannoni R, Giordan M, Maretto I, Bedin C, Zanon C, Digito M, Esposito G, Mescoli C, Lavitrano M, Rizzolio F, Jurisica I, Giordano A, Pucciarelli S, Nitti D. A functional biological network centered on XRCC3: a new possible marker of chemoradiotherapy resistance in rectal cancer patients. Cancer Biol Ther 2015;16:1160-71. [PMID: 26023803 DOI: 10.1080/15384047.2015.1046652] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
128 Sakuyama N, Kojima M, Kawano S, Matsuda Y, Mino-Kenudson M, Ochiai A, Ito M. Area of residual tumor is a robust prognostic marker for patients with rectal cancer undergoing preoperative therapy. Cancer Sci 2018;109:871-8. [PMID: 29388280 DOI: 10.1111/cas.13521] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
129 Burton S, Brown G, Daniels IR, Norman AR, Mason B, Cunningham D. MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins? Br J Cancer. 2006;94:351-357. [PMID: 16465171 DOI: 10.1038/sj.bjc.6602947] [Cited by in Crossref: 197] [Cited by in F6Publishing: 162] [Article Influence: 13.1] [Reference Citation Analysis]
130 Palma P, Cuadros M, Conde-Muíño R, Olmedo C, Cano C, Segura-Jiménez I, Blanco A, Bueno P, Ferrón JA, Medina P. Microarray profiling of mononuclear peripheral blood cells identifies novel candidate genes related to chemoradiation response in rectal cancer. PLoS One 2013;8:e74034. [PMID: 24040155 DOI: 10.1371/journal.pone.0074034] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
131 Cai X, Wu H, Peng J, Zhu J, Cai S, Cai G, Zhang Z. Tolerability and outcomes of radiotherapy or chemoradiotherapy for rectal cancer in elderly patients aged 70 years and older. Radiat Oncol 2013;8:86. [PMID: 23574985 DOI: 10.1186/1748-717X-8-86] [Cited by in Crossref: 28] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
132 Garajová I, Di Girolamo S, de Rosa F, Corbelli J, Agostini V, Biasco G, Brandi G. Neoadjuvant treatment in rectal cancer: actual status. Chemother Res Pract 2011;2011:839742. [PMID: 22295206 DOI: 10.1155/2011/839742] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
133 Qiu B, Ding PR, Cai L, Xiao WW, Zeng ZF, Chen G, Lu ZH, Li LR, Wu XJ, Mirimanoff RO, Pan ZZ, Xu RH, Gao YH. Outcomes of preoperative chemoradiotherapy followed by surgery in patients with unresectable locally advanced sigmoid colon cancer. Chin J Cancer. 2016;35:65. [PMID: 27389519 DOI: 10.1186/s40880-016-0126-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
134 Gao P, Song YX, Sun JX, Chen XW, Xu YY, Zhao JH, Huang XZ, Xu HM, Wang ZN. Which is the best postoperative chemotherapy regimen in patients with rectal cancer after neoadjuvant therapy? BMC Cancer. 2014;14:888. [PMID: 25428401 DOI: 10.1186/1471-2407-14-888] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
135 Habermehl D, Kessel K, Welzel T, Hof H, Abdollahi A, Bergmann F, Rieken S, Weitz J, Werner J, Schirmacher P. Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer. Radiat Oncol. 2012;7:28. [PMID: 22385572 DOI: 10.1186/1748-717x-7-28] [Cited by in Crossref: 67] [Cited by in F6Publishing: 34] [Article Influence: 7.4] [Reference Citation Analysis]
136 Smith JA, Wild AT, Singhi A, Raman SP, Qiu H, Kumar R, Hacker-Prietz A, Hruban RH, Kamel IR, Efron J, Wick EC, Azad NS, Diaz LA Jr, Le Y, Armour EP, Gearhart SL, Herman JM. Clinicopathologic Comparison of High-Dose-Rate Endorectal Brachytherapy versus Conventional Chemoradiotherapy in the Neoadjuvant Setting for Resectable Stages II and III Low Rectal Cancer. Int J Surg Oncol 2012;2012:406568. [PMID: 22830003 DOI: 10.1155/2012/406568] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
137 Koch J, Mönch D, Maaß A, Gromoll C, Hehr T, Leibold T, Schlitt HJ, Dahlke MH, Renner P. Three dimensional cultivation increases chemo- and radioresistance of colorectal cancer cell lines. PLoS One 2021;16:e0244513. [PMID: 33395433 DOI: 10.1371/journal.pone.0244513] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
138 Florczynski MM, Sanatani MS, Mai L, Fisher B, Moulin DE, Cao J, Louie AV, Pope JE, Leung E. Severe myositis of the hip flexors after pre-operative chemoradiation therapy for locally advanced rectal cancer: case report. BMC Cancer 2016;16:243. [PMID: 27000107 DOI: 10.1186/s12885-016-2269-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
139 Neibart SS, Manne SL, Jabbour SK. Quality of Life After Radiotherapy for Rectal and Anal Cancer. Curr Colorectal Cancer Rep 2020;16:1-10. [PMID: 32632345 DOI: 10.1007/s11888-019-00448-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
140 Belluco C, Forlin M, Olivieri M, Cannizzaro R, Canzonieri V, Buonadonna A, Bidoli E, Matrone F, Bertola G, De Paoli A. Long-Term Outcome of Rectal Cancer With Clinically (EUS/MRI) Metastatic Mesorectal Lymph Nodes Treated by Neoadjuvant Chemoradiation: Role of Organ Preservation Strategies in Relation to Pathologic Response. Ann Surg Oncol 2016;23:4302-9. [PMID: 27489059 DOI: 10.1245/s10434-016-5451-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
141 Avallone A, Aloj L, Caracò C, Delrio P, Pecori B, Tatangelo F, Scott N, Casaretti R, Di Gennaro F, Montano M, Silvestro L, Budillon A, Lastoria S. Early FDG PET response assessment of preoperative radiochemotherapy in locally advanced rectal cancer: correlation with long-term outcome. Eur J Nucl Med Mol Imaging 2012;39:1848-57. [PMID: 23053320 DOI: 10.1007/s00259-012-2229-2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 5.0] [Reference Citation Analysis]
142 Andreyev HJ, Davidson SE, Gillespie C, Allum WH, Swarbrick E; British Society of Gastroenterology; Association of Colo-Proctology of Great Britain and Ireland; Association of Upper Gastrointestinal Surgeons; Faculty of Clinical Oncology Section of the Royal College of Radiologists. Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer. Gut. 2012;61:179-192. [PMID: 22057051 DOI: 10.1136/gutjnl-2011-300563] [Cited by in Crossref: 149] [Cited by in F6Publishing: 135] [Article Influence: 14.9] [Reference Citation Analysis]
143 Min BS, Kim NK, Pyo JY, Kim H, Seong J, Keum KC, Sohn SK, Cho CH. Clinical impact of tumor regression grade after preoperative chemoradiation for locally advanced rectal cancer: subset analyses in lymph node negative patients. J Korean Soc Coloproctol. 2011;27:31-40. [PMID: 21431095 DOI: 10.3393/jksc.2011.27.1.31] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
144 Qian C, Yang LJ, Cui H. Recent Advances in Nanotechnology for Dendritic Cell-Based Immunotherapy. Front Pharmacol 2020;11:960. [PMID: 32694998 DOI: 10.3389/fphar.2020.00960] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
145 Marks JH, Valsdottir EB, DeNittis A, Yarandi SS, Newman DA, Nweze I, Mohiuddin M, Marks GJ. Transanal endoscopic microsurgery for the treatment of rectal cancer: comparison of wound complication rates with and without neoadjuvant radiation therapy. Surg Endosc. 2009;23:1081-1087. [PMID: 19263164 DOI: 10.1007/s00464-009-0326-5] [Cited by in Crossref: 94] [Cited by in F6Publishing: 66] [Article Influence: 7.8] [Reference Citation Analysis]
146 Cellier P, Leduc B, Martin L, Vié B, Chevelle C, Vendrely V, Salemkour A, Carrie C, Calais G, Burtin P, Campion L, Boisdron-Celle M, Morel A, Berger V, Gamelin E. Phase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin for locally advanced rectal cancer. BMC Cancer 2011;11:98. [PMID: 21410976 DOI: 10.1186/1471-2407-11-98] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
147 Glimelius B. Neo-adjuvant radiotherapy in rectal cancer. World J Gastroenterol 2013; 19(46): 8489-8501 [PMID: 24379566 DOI: 10.3748/wjg.v19.i46.8489] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
148 Gunnlaugsson A, Nilsson P, Kjellén E, Johnsson A. The effect on the small bowel of 5-FU and oxaliplatin in combination with radiation using a microcolony survival assay. Radiat Oncol 2009;4:61. [PMID: 20003187 DOI: 10.1186/1748-717X-4-61] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
149 Nogué M, Salud A, Vicente P, Arriví A, Roca JM, Losa F, Ponce J, Safont MJ, Guasch I, Moreno I. Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: the AVACROSS study. Oncologist. 2011;16:614-620. [PMID: 21467148 DOI: 10.1634/theoncologist.2010-0285] [Cited by in Crossref: 100] [Cited by in F6Publishing: 86] [Article Influence: 10.0] [Reference Citation Analysis]
150 Engels B, Gevaert T, Sermeus A, De Ridder M. Current status of intensified neo-adjuvant systemic therapy in locally advanced rectal cancer. Front Oncol 2012;2:47. [PMID: 22655273 DOI: 10.3389/fonc.2012.00047] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
151 Li Y, Wang J, Ma X, Tan L, Yan Y, Xue C, Hui B, Liu R, Ma H, Ren J. A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer. Int J Biol Sci. 2016;12:1022-1031. [PMID: 27489505 DOI: 10.7150/ijbs.15438] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 13.6] [Reference Citation Analysis]
152 Haynes AB, You YN, Hu CY, Eng C, Kopetz ES, Rodriguez-Bigas MA, Skibber JM, Cantor SB, Chang GJ. Postoperative chemotherapy use after neoadjuvant chemoradiotherapy for rectal cancer: Analysis of Surveillance, Epidemiology, and End Results-Medicare data, 1998-2007. Cancer 2014;120:1162-70. [PMID: 24474245 DOI: 10.1002/cncr.28545] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
153 Yu SK, Bhangu A, Tait DM, Tekkis P, Wotherspoon A, Brown G. Chemoradiotherapy response in recurrent rectal cancer. Cancer Med. 2014;3:111-117. [PMID: 24403010 DOI: 10.1002/cam4.169] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
154 Clifford R, Govindarajah N, Parsons JL, Gollins S, West NP, Vimalachandran D. Systematic review of treatment intensification using novel agents for chemoradiotherapy in rectal cancer. Br J Surg 2018;105:1553-72. [PMID: 30311641 DOI: 10.1002/bjs.10993] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
155 Monsellato I, Alongi F, Bertocchi E, Gori S, Ruffo G, Cassinotti E, Baldari L, Boni L, Pernazza G, Pulighe F, De Nisco C, Perinotti R, Morpurgo E, Contardo T, Mammano E, Elmore U, Delpini R, Rosati R, Perna F, Coratti A, Menegatti B, Gentilli S, Baroffio P, Buccianti P, Balestri R, Ceccarelli C, Torri V, Cavaliere D, Solaini L, Ercolani G, Traverso E, Fusco V, Rossi M, Priora F, Numico G, Franzone P, Orecchia S. Standard (8 weeks) vs long (12 weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR).BMC Cancer. 2019;19:1215. [PMID: 31842784 DOI: 10.1186/s12885-019-6271-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
156 Podda M, Sylla P, Baiocchi G, Adamina M, Agnoletti V, Agresta F, Ansaloni L, Arezzo A, Avenia N, Biffl W, Biondi A, Bui S, Campanile FC, Carcoforo P, Commisso C, Crucitti A, De'Angelis N, De'Angelis GL, De Filippo M, De Simone B, Di Saverio S, Ercolani G, Fraga GP, Gabrielli F, Gaiani F, Guerrieri M, Guttadauro A, Kluger Y, Leppaniemi AK, Loffredo A, Meschi T, Moore EE, Ortenzi M, Pata F, Parini D, Pisanu A, Poggioli G, Polistena A, Puzziello A, Rondelli F, Sartelli M, Smart N, Sugrue ME, Tejedor P, Vacante M, Coccolini F, Davies J, Catena F. Multidisciplinary management of elderly patients with rectal cancer: recommendations from the SICG (Italian Society of Geriatric Surgery), SIFIPAC (Italian Society of Surgical Pathophysiology), SICE (Italian Society of Endoscopic Surgery and new technologies), and the WSES (World Society of Emergency Surgery) International Consensus Project. World J Emerg Surg 2021;16:35. [PMID: 34215310 DOI: 10.1186/s13017-021-00378-9] [Reference Citation Analysis]
157 Li Q, Liang L, Gan L, Cai G, Li X, Cai S. Effect of Lymph Node Count on Pathological Stage III Rectal Cancer with Preoperative Radiotherapy. Sci Rep 2015;5:16990. [PMID: 26582242 DOI: 10.1038/srep16990] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
158 Wang Y, Chen L, Zhang B, Song W, Zhou G, Xie L, Yu D. Pretreatment Inflammatory-Nutritional Biomarkers Predict Responses to Neoadjuvant Chemoradiotherapy and Survival in Locally Advanced Rectal Cancer. Front Oncol 2021;11:639909. [PMID: 33816284 DOI: 10.3389/fonc.2021.639909] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
159 García M, Martinez-Villacampa M, Santos C, Navarro V, Teule A, Losa F, Pisa A, Cambray M, Soler G, Lema L, Kreisler E, Figueras A, Juan XS, Viñals F, Biondo S, Salazar R. Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer. BMC Cancer 2015;15:59. [PMID: 25886275 DOI: 10.1186/s12885-015-1052-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
160 Lee EM, Hong YS, Kim KP, Lee JL, Kim SY, Park YS, Choi DH, Kim JH, Lim SB, Yu CS, Kim JC, Lee JH, Kim AY, Kim TW. Phase II study of preoperative chemoradiation with S-1 plus oxaliplatin in patients with locally advanced rectal cancer. Cancer Sci 2013;104:111-5. [PMID: 23057495 DOI: 10.1111/cas.12041] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
161 Gaertner WB, Kwaan MR, Madoff RD, Melton GB. Rectal cancer: An evidence-based update for primary care providers. World J Gastroenterol 2015; 21(25): 7659-7671 [PMID: 26167068 DOI: 10.3748/wjg.v21.i25.7659] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
162 Vojtíšek R, Korčáková E, Mařan J, Šorejs O, Fínek J. Neoadjuvant chemoradiotherapy of the rectal carcinoma - The correlation between the findings on the restaging multiparametric 3T MRI scanning and the surgical findings. Rep Pract Oncol Radiother 2017;22:265-76. [PMID: 28507455 DOI: 10.1016/j.rpor.2017.02.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
163 Huang WS, Kuan FC, Lin MH, Chen MF, Chen WC. Prognostic Significance of Neoadjuvant Rectal Scores in Preoperative Short-Course Radiotherapy and Long-Course Concurrent Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer. Ann Surg Oncol 2020;27:4309-18. [PMID: 32794029 DOI: 10.1245/s10434-020-09018-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
164 Horisberger K, Hofheinz RD, Palma P, Volkert AK, Rothenhoefer S, Wenz F, Hochhaus A, Post S, Willeke F. Tumor response to neoadjuvant chemoradiation in rectal cancer: predictor for surgical morbidity? Int J Colorectal Dis. 2008;23:257-264. [PMID: 18071720 DOI: 10.1007/s00384-007-0408-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
165 Kornmann M, Staib L, Wiegel T, Kreuser ED, Kron M, Baumann W, Henne-Bruns D, Link KH. Adjuvant chemoradiotherapy of advanced resectable rectal cancer: results of a randomised trial comparing modulation of 5-fluorouracil with folinic acid or with interferon-α. Br J Cancer 2010;103:1163-72. [PMID: 20877353 DOI: 10.1038/sj.bjc.6605871] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
166 Colaco RJ, Nichols RC, Huh S, Getman N, Ho MW, Li Z, Morris CG, Mendenhall WM, Mendenhall NP, Hoppe BS. Protons offer reduced bone marrow, small bowel, and urinary bladder exposure for patients receiving neoadjuvant radiotherapy for resectable rectal cancer. J Gastrointest Oncol 2014;5:3-8. [PMID: 24490037 DOI: 10.3978/j.issn.2078-6891.2013.041] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
167 Fernández-Aceñero MJ, Granja M, Sastre J, García-Paredes B, Estrada L. Prognostic significance of tumor regression in lymph nodes after neoadjuvant therapy for rectal carcinoma. Virchows Arch 2016;468:425-30. [PMID: 26754675 DOI: 10.1007/s00428-015-1901-x] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
168 Wang Y, Zhou M, Yang J, Sun X, Zou W, Zhang Z, Zhang J, Shen L, Yang L, Zhang Z. Increased lymph node yield indicates improved survival in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. Cancer Med. 2019;8:4615-4625. [PMID: 31250569 DOI: 10.1002/cam4.2372] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
169 Shiraishi T, Sasaki T, Ikeda K, Tsukada Y, Nishizawa Y, Ito M. Predicting prognosis according to preoperative chemotherapy response in patients with locally advanced lower rectal cancer. BMC Cancer 2019;19:1222. [PMID: 31842797 DOI: 10.1186/s12885-019-6424-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
170 Tong T, Sun Y, Cai S, Zhang Z, Gu Y. Extramural depth of rectal cancer tumor invasion at thin-section MRI: predicting treatment response to neoadjuvant chemoradiation. Oncotarget 2015;6:30277-86. [PMID: 26309163 DOI: 10.18632/oncotarget.4623] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
171 Buchs NC, Gervaz P, Secic M, Bucher P, Mugnier-Konrad B, Morel P. Incidence, consequences, and risk factors for anastomotic dehiscence after colorectal surgery: a prospective monocentric study. Int J Colorectal Dis. 2008;23:265-270. [PMID: 18034250 DOI: 10.1007/s00384-007-0399-3] [Cited by in Crossref: 262] [Cited by in F6Publishing: 229] [Article Influence: 18.7] [Reference Citation Analysis]
172 Davies ML, Harris D, Davies M, Lucas M, Drew P, Beynon J. Selection criteria for the radical treatment of locally advanced rectal cancer. Int J Surg Oncol 2011;2011:678506. [PMID: 22312517 DOI: 10.1155/2011/678506] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
173 Guan X, Jiang Z, Ma T, Liu Z, Hu H, Zhao Z, Song D, Chen Y, Wang G, Wang X. Radiotherapy dose led to a substantial prolongation of survival in patients with locally advanced rectosigmoid junction cancer: a large population based study. Oncotarget 2016;7:28408-19. [PMID: 27070089 DOI: 10.18632/oncotarget.8630] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
174 Spiegle G, Leon-Carlyle M, Schmocker S, Fruitman M, Milot L, Gagliardi AR, Smith AJ, McLeod RS, Kennedy ED. Development of a synoptic MRI report for primary rectal cancer. Implement Sci 2009;4:79. [PMID: 19954526 DOI: 10.1186/1748-5908-4-79] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
175 Xiao YT, Zhao X, Chang Y, Lu X, Wang Y, Zhang H, Ren S. Assessing the safety and feasibility of neoadjuvant hormone and radiation therapy followed by robot-assisted radical prostatectomy for treating locally advanced prostate cancer: protocol for an open-label, dose-escalation, single-centre, phase I clinical trial. BMJ Open 2020;10:e038678. [PMID: 33148738 DOI: 10.1136/bmjopen-2020-038678] [Reference Citation Analysis]
176 Fu J, Wang CY, Wang CG, Li HL, Yang XJ, Sun Y, Shao YH, Zhang LH, Yang XM, Zhang XL. Efficacy and Side Effects of Combined Capecitabine Plus Intensity Modulated Radiotherapy as an Effective Adjuvant Therapy for Gastric Cancers. Iran J Pharm Res 2020;19:365-71. [PMID: 33841549 DOI: 10.22037/ijpr.2019.14622.12542] [Reference Citation Analysis]
177 Shim BY, Sun S, Won HS, Lee MA, Hong SU, Jung JH, Cho HM, Ko YH. Role of autophagy-related protein expression in patients with rectal cancer treated with neoadjuvant chemoradiotherapy. BMC Cancer 2016;16:207. [PMID: 26965179 DOI: 10.1186/s12885-016-2250-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
178 Gani C, Grosse U, Clasen S, Kirschniak A, Goetz M, Rödel C, Zips D. Cost analysis of a wait-and-see strategy after radiochemotherapy in distal rectal cancer. Strahlenther Onkol 2018;194:985-90. [PMID: 29987338 DOI: 10.1007/s00066-018-1327-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
179 Ohue M, Hamaguchi T, Ito Y, Sakai D, Noura S, Kinugasa Y, Fujita S, Shimada Y, Saito N, Moriya Y. A phase I trial of preoperative S-1 in combination with oxaliplatin and pelvic radiation for lower rectal cancer with T4 and lateral pelvic lymph node metastasis. Int J Clin Oncol 2015;20:338-44. [PMID: 24839048 DOI: 10.1007/s10147-014-0705-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
180 Liu Z, Wang S, Dong D, Wei J, Fang C, Zhou X, Sun K, Li L, Li B, Wang M, Tian J. The Applications of Radiomics in Precision Diagnosis and Treatment of Oncology: Opportunities and Challenges. Theranostics. 2019;9:1303-1322. [PMID: 30867832 DOI: 10.7150/thno.30309] [Cited by in Crossref: 149] [Cited by in F6Publishing: 146] [Article Influence: 74.5] [Reference Citation Analysis]
181 Berger MD, Yang D, Sunakawa Y, Zhang W, Ning Y, Matsusaka S, Okazaki S, Miyamoto Y, Suenaga M, Schirripa M, Lenz AM, Bohanes P, Barzi A, Figueiredo JC, Hanna DL, Lenz HJ. Impact of sex, age, and ethnicity/race on the survival of patients with rectal cancer in the United States from 1988 to 2012. Oncotarget 2016;7:53668-78. [PMID: 27449091 DOI: 10.18632/oncotarget.10696] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
182 Smith FM, Stephens RB, Kennedy MJ, Reynolds JV. P53 abnormalities and outcomes in colorectal cancer: a systematic review. Br J Cancer 2005;92:1813. [PMID: 15856032 DOI: 10.1038/sj.bjc.6602589] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
183 Kim Y, Kim DY, Kim TH, Kim SY, Baek JY, Kim MJ, Chang HJ, Cha Y, Park SC, Oh JH. Patterns of failure in rectal cancer with positive circumferential resection margin after surgery following preoperative chemoradiation: a propensity score matching analysis. Br J Radiol 2018;91:20180143. [PMID: 30129789 DOI: 10.1259/bjr.20180143] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
184 Myerson RJ, Garofalo MC, El Naqa I, Abrams RA, Apte A, Bosch WR, Das P, Gunderson LL, Hong TS, Kim JJ, Willett CG, Kachnic LA. Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys 2009;74:824-30. [PMID: 19117696 DOI: 10.1016/j.ijrobp.2008.08.070] [Cited by in Crossref: 305] [Cited by in F6Publishing: 244] [Article Influence: 23.5] [Reference Citation Analysis]
185 Kruschewski M, Rieger H, Pohlen U, Hotz HG, Buhr HJ. Risk factors for clinical anastomotic leakage and postoperative mortality in elective surgery for rectal cancer. Int J Colorectal Dis. 2007;22:919-927. [PMID: 17260142 DOI: 10.1007/s00384-006-0260-0] [Cited by in Crossref: 82] [Cited by in F6Publishing: 75] [Article Influence: 5.9] [Reference Citation Analysis]
186 Sohn B, Lim JS, Kim H, Myoung S, Choi J, Kim NK, Kim MJ. MRI-detected extramural vascular invasion is an independent prognostic factor for synchronous metastasis in patients with rectal cancer. Eur Radiol. 2015;25:1347-1355. [PMID: 25500963 DOI: 10.1007/s00330-014-3527-9] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 10.3] [Reference Citation Analysis]
187 Jo P, Nietert M, Gusky L, Kitz J, Conradi LC, Müller-Dornieden A, Schüler P, Wolff HA, Rüschoff J, Ströbel P, Grade M, Liersch T, Beißbarth T, Ghadimi MB, Sax U, Gaedcke J. Neoadjuvant Therapy in Rectal Cancer - Biobanking of Preoperative Tumor Biopsies. Sci Rep 2016;6:35589. [PMID: 27752113 DOI: 10.1038/srep35589] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
188 Isa N. Evidence based radiation oncology with existing technology. Rep Pract Oncol Radiother. 2014;19:259-266. [PMID: 25061519 DOI: 10.1016/j.rpor.2013.09.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
189 Hong TS, Moughan J, Garofalo MC, Bendell J, Berger AC, Oldenburg NB, Anne PR, Perera F, Lee RJ, Jabbour SK, Nowlan A, DeNittis A, Crane C. NRG Oncology Radiation Therapy Oncology Group 0822: A Phase 2 Study of Preoperative Chemoradiation Therapy Using Intensity Modulated Radiation Therapy in Combination With Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer. Int J Radiat Oncol Biol Phys 2015;93:29-36. [PMID: 26163334 DOI: 10.1016/j.ijrobp.2015.05.005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 7.5] [Reference Citation Analysis]
190 Habr-Gama A, São Julião GP, Vailati BB, Castro I, Raffaele D. Management of the Complete Clinical Response. Clin Colon Rectal Surg 2017;30:387-94. [PMID: 29184475 DOI: 10.1055/s-0037-1606116] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
191 Heo J, Oh YT, Noh OK, Chun M, Park JE, Cho SR. Nodal tumor response according to the count of peripheral blood lymphocyte subpopulations during preoperative chemoradiotherapy in locally advanced rectal cancer. Radiat Oncol J 2016;34:305-12. [PMID: 27927012 DOI: 10.3857/roj.2016.01914] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
192 Dickman R, Kundel Y, Levy-Drummer R, Purim O, Wasserberg N, Fenig E, Sulkes A, Brenner B. Restaging locally advanced rectal cancer by different imaging modalities after preoperative chemoradiation: a comparative study. Radiat Oncol. 2013;8:278. [PMID: 24286200 DOI: 10.1186/1748-717x-8-278] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
193 Campayo M, Navarro A, Benítez JC, Santasusagna S, Ferrer C, Monzó M, Cirera L. miR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancer. PLoS One 2018;13:e0206542. [PMID: 30388154 DOI: 10.1371/journal.pone.0206542] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
194 Body A, Prenen H, Latham S, Lam M, Tipping-Smith S, Raghunath A, Segelov E. The Role of Neoadjuvant Chemotherapy in Locally Advanced Colon Cancer. Cancer Manag Res 2021;13:2567-79. [PMID: 33762848 DOI: 10.2147/CMAR.S262870] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
195 Kim YB, Jeung HC, Jeong I, Lee K, Rha SY, Chung HC, Kim GE. Mechanism of enhancement of radiation-induced cytotoxicity by sorafenib in colorectal cancer. J Radiat Res 2013;54:52-60. [PMID: 22923745 DOI: 10.1093/jrr/rrs074] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
196 Roeder F. Neoadjuvant radiotherapeutic strategies in pancreatic cancer. World J Gastrointest Oncol 2016; 8(2): 186-197 [PMID: 26909133 DOI: 10.4251/wjgo.v8.i2.186] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
197 Papaccio F, Roselló S, Huerta M, Gambardella V, Tarazona N, Fleitas T, Roda D, Cervantes A. Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer. Cancers (Basel) 2020;12:E3611. [PMID: 33287114 DOI: 10.3390/cancers12123611] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
198 Yorio JT, Bhadkamkar NA, Kee BK, Garrett CR. A Primer on the Current State-of-the-Science Neoadjuvant and Adjuvant Therapy for Patients with Locally Advanced Rectal Adenocarcinomas. Int J Surg Oncol 2012;2012:863034. [PMID: 22666572 DOI: 10.1155/2012/863034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
199 Petresc B, Lebovici A, Caraiani C, Feier DS, Graur F, Buruian MM. Pre-Treatment T2-WI Based Radiomics Features for Prediction of Locally Advanced Rectal Cancer Non-Response to Neoadjuvant Chemoradiotherapy: A Preliminary Study. Cancers (Basel) 2020;12:E1894. [PMID: 32674345 DOI: 10.3390/cancers12071894] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
200 Kitayama J, Yasuda K, Kawai K, Sunami E, Nagawa H. Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer. Radiat Oncol. 2010;5:47. [PMID: 20525293 DOI: 10.1186/1748-717x-5-47] [Cited by in Crossref: 78] [Cited by in F6Publishing: 52] [Article Influence: 7.1] [Reference Citation Analysis]
201 Morris KA, Haboubi NY. Pelvic radiation therapy: Between delight and disaster. World J Gastrointest Surg 2015; 7(11): 279-288 [PMID: 26649150 DOI: 10.4240/wjgs.v7.i11.279] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 35] [Article Influence: 7.8] [Reference Citation Analysis]
202 Schrag D, Weiser MR, Goodman KA, Gonen M, Hollywood E, Cercek A, Reidy-Lagunes DL, Gollub MJ, Shia J, Guillem JG, Temple LK, Paty PB, Saltz LB. Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial. J Clin Oncol 2014;32:513-8. [PMID: 24419115 DOI: 10.1200/JCO.2013.51.7904] [Cited by in Crossref: 272] [Cited by in F6Publishing: 102] [Article Influence: 38.9] [Reference Citation Analysis]
203 Runau F, Collins A, Fenech GA, Ford E, Dimitriou N, Chaudhri S, Yeung JM. A single institution's long-term follow-up of patients with pathological complete response in locally advanced rectal adenocarcinoma following neoadjuvant chemoradiotherapy. Int J Colorectal Dis. 2017;32:341-348. [PMID: 27885480 DOI: 10.1007/s00384-016-2712-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
204 Zhao J, Hu W, Cai G, Wang J, Xie J, Peng J, Zhang Z. Dosimetric comparisons of VMAT, IMRT and 3DCRT for locally advanced rectal cancer with simultaneous integrated boost. Oncotarget 2016;7:6345-51. [PMID: 26621840 DOI: 10.18632/oncotarget.6401] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
205 Dapper H, Rodríguez I, Münch S, Peeken JC, Borm K, Combs SE, Habermehl D. Impact of VMAT-IMRT compared to 3D conformal radiotherapy on anal sphincter dose distribution in neoadjuvant chemoradiation of rectal cancer. Radiat Oncol 2018;13:237. [PMID: 30509284 DOI: 10.1186/s13014-018-1187-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
206 van Rees JM, Hartman W, Nuyttens JJME, Oomen-de Hoop E, van Vugt JLA, Rothbarth J, Verhoef C, van Meerten E. Relation between body composition and severe diarrhea in patients treated with preoperative chemoradiation with capecitabine for rectal cancer: a single-centre cohort study. BMC Gastroenterol 2021;21:313. [PMID: 34348673 DOI: 10.1186/s12876-021-01886-3] [Reference Citation Analysis]
207 Golcher H, Brunner TB, Witzigmann H, Marti L, Bechstein WO, Bruns C, Jungnickel H, Schreiber S, Grabenbauer GG, Meyer T, Merkel S, Fietkau R, Hohenberger W. Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer: results of the first prospective randomized phase II trial. Strahlenther Onkol. 2015;191:7-16. [PMID: 25252602 DOI: 10.1007/s00066-014-0737-7] [Cited by in Crossref: 167] [Cited by in F6Publishing: 138] [Article Influence: 23.9] [Reference Citation Analysis]
208 Walsh LG, Kenny BJ, El Bassiouni M, Coffey JC. Cancer arising from the remnant mucosa of the ileoanal anastomosis leading to pouchectomy. BMJ Case Rep 2016;2016:bcr2015212802. [PMID: 27481261 DOI: 10.1136/bcr-2015-212802] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
209 Yeo SG, Kim DY. An update on preoperative radiotherapy for locally advanced rectal cancer. J Korean Soc Coloproctol 2012;28:179-87. [PMID: 22993703 DOI: 10.3393/jksc.2012.28.4.179] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
210 Stevic I, Buescher G, Ricklefs FL. Monitoring Therapy Efficiency in Cancer through Extracellular Vesicles. Cells 2020;9:E130. [PMID: 31935901 DOI: 10.3390/cells9010130] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
211 Drebber U, Madeja M, Odenthal M, Wedemeyer I, Mönig SP, Brabender J, Bollschweiler E, Hölscher AH, Schneider PM, Dienes HP, Vallböhmer D. β-catenin and Her2/neu expression in rectal cancer: association with histomorphological response to neoadjuvant therapy and prognosis. Int J Colorectal Dis 2011;26:1127-34. [DOI: 10.1007/s00384-011-1213-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
212 Silberfein EJ, Kattepogu KM, Hu CY, Skibber JM, Rodriguez-Bigas MA, Feig B, Das P, Krishnan S, Crane C, Kopetz S, Eng C, Chang GJ. Long-term survival and recurrence outcomes following surgery for distal rectal cancer. Ann Surg Oncol 2010;17:2863-9. [PMID: 20552409 DOI: 10.1245/s10434-010-1119-8] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 6.3] [Reference Citation Analysis]
213 Agostini M, Janssen KP, Kim IJ, D'Angelo E, Pizzini S, Zangrando A, Zanon C, Pastrello C, Maretto I, Digito M, Bedin C, Jurisica I, Rizzolio F, Giordano A, Bortoluzzi S, Nitti D, Pucciarelli S. An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer. Oncotarget. 2015;6:32561-32574. [PMID: 26359356 DOI: 10.18632/oncotarget.4935] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 6.4] [Reference Citation Analysis]
214 Versteijne E, Suker M, Groothuis K, Akkermans-Vogelaar JM, Besselink MG, Bonsing BA, Buijsen J, Busch OR, Creemers GM, van Dam RM, Eskens FALM, Festen S, de Groot JWB, Groot Koerkamp B, de Hingh IH, Homs MYV, van Hooft JE, Kerver ED, Luelmo SAC, Neelis KJ, Nuyttens J, Paardekooper GMRM, Patijn GA, van der Sangen MJC, de Vos-Geelen J, Wilmink JW, Zwinderman AH, Punt CJ, van Eijck CH, van Tienhoven G;  Dutch Pancreatic Cancer Group. Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial. J Clin Oncol. 2020;38:1763-1773. [PMID: 32105518 DOI: 10.1200/jco.19.02274] [Cited by in Crossref: 174] [Cited by in F6Publishing: 90] [Article Influence: 174.0] [Reference Citation Analysis]
215 Arlen M, Arlen P, Coppa G, Crawford J, Wang X, Saric O, Dubeykovskiy A, Molmenti E. Monoclonal antibodies that target the immunogenic proteins expressed in colorectal cancer. World J Gastrointest Oncol 2014; 6(6): 170-176 [PMID: 24936227 DOI: 10.4251/wjgo.v6.i6.170] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
216 Nerad E, Delli Pizzi A, Lambregts DMJ, Maas M, Wadhwani S, Bakers FCH, van den Bosch HCM, Beets-Tan RGH, Lahaye MJ. The Apparent Diffusion Coefficient (ADC) is a useful biomarker in predicting metastatic colon cancer using the ADC-value of the primary tumor. PLoS One 2019;14:e0211830. [PMID: 30721268 DOI: 10.1371/journal.pone.0211830] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
217 Wang D, Jiao C, Zhu Y, Liang D, Zao M, Meng X, Gao J, He Y, Liu W, Hou J, Zhong Z, Cheng Z. Activation of CXCL12/CXCR4 renders colorectal cancer cells less sensitive to radiotherapy via up-regulating the expression of survivin. Exp Biol Med (Maywood) 2017;242:429-35. [PMID: 27798120 DOI: 10.1177/1535370216675068] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
218 Loi S, Ngan SY, Hicks RJ, Mukesh B, Mitchell P, Michael M, Zalcberg J, Leong T, Lim-Joon D, Mackay J. Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trial. Br J Cancer. 2005;92:655-661. [PMID: 15700033 DOI: 10.1038/sj.bjc.6602413] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
219 McKeown E, Nelson DW, Johnson EK, Maykel JA, Stojadinovic A, Nissan A, Avital I, Brücher BL, Steele SR. Current approaches and challenges for monitoring treatment response in colon and rectal cancer. J Cancer 2014;5:31-43. [PMID: 24396496 DOI: 10.7150/jca.7987] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 6.3] [Reference Citation Analysis]
220 Gouvas N, Tsiaoussis J, Pechlivanides G, Zervakis N, Tzortzinis A, Avgerinos C, Dervenis C, Xynos E. Laparoscopic or open surgery for the cancer of the middle and lower rectum short-term outcomes of a comparative non-randomised study. Int J Colorectal Dis. 2009;24:761-769. [PMID: 19221764 DOI: 10.1007/s00384-009-0671-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
221 Gaedcke J, Grade M, Jung K, Schirmer M, Jo P, Obermeyer C, Wolff HA, Herrmann MK, Beissbarth T, Becker H, Ried T, Ghadimi M. KRAS and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapy. Radiother Oncol 2010;94:76-81. [PMID: 19913317 DOI: 10.1016/j.radonc.2009.10.001] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 6.0] [Reference Citation Analysis]
222 Böyük A, Aday U, Gültürk B, Bozdağ A, Aksu A, Kutluer N. Effect of splenic flexure mobilization performed via medial-to-lateral and superior-to-inferior approach on early clinical outcomes in elective laparoscopic resection of rectal cancer. Wideochir Inne Tech Maloinwazyjne 2019;14:509-15. [PMID: 31908696 DOI: 10.5114/wiitm.2019.85224] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
223 Hofmann S, Vetter J, Wachter C, Henne-Bruns D, Porzsolt F, Kornmann M. Visual AIDS for multimodal treatment options to support decision making of patients with colorectal cancer. BMC Med Inform Decis Mak 2012;12:118. [PMID: 23092310 DOI: 10.1186/1472-6947-12-118] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
224 Rizzo G, Pafundi DP, Sionne F, D'Agostino L, Pietricola G, Gambacorta MA, Valentini V, Coco C. Preoperative chemoradiotherapy affects postoperative outcomes and functional results in patients treated with transanal endoscopic microsurgery for rectal neoplasms. Tech Coloproctol 2021;25:319-31. [PMID: 33459969 DOI: 10.1007/s10151-020-02394-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
225 Marks J, Mizrahi B, Dalane S, Nweze I, Marks G. Laparoscopic transanal abdominal transanal resection with sphincter preservation for rectal cancer in the distal 3 cm of the rectum after neoadjuvant therapy. Surg Endosc. 2010;24:2700-2707. [PMID: 20414681 DOI: 10.1007/s00464-010-1028-8] [Cited by in Crossref: 73] [Cited by in F6Publishing: 54] [Article Influence: 6.6] [Reference Citation Analysis]
226 Raldow AC, Chen AB, Russell M, Lee PP, Hong TS, Ryan DP, Cusack JC, Wo JY. Cost-effectiveness of Short-Course Radiation Therapy vs Long-Course Chemoradiation for Locally Advanced Rectal Cancer. JAMA Netw Open. 2019;2:e192249. [PMID: 30977859 DOI: 10.1001/jamanetworkopen.2019.2249] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
227 Yeo SG, Kim MJ, Kim DY, Chang HJ, Kim MJ, Baek JY, Kim SY, Kim TH, Park JW, Oh JH. Patterns of failure in patients with locally advanced rectal cancer receiving pre-operative or post-operative chemoradiotherapy. Radiat Oncol 2013;8:114. [PMID: 23647920 DOI: 10.1186/1748-717X-8-114] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
228 Wang Y, Zhang J, Zhou M, Yang L, Wan J, Shen L, Liang L, Yao Y, Zhang H, Zhang Z. Poor prognostic and staging value of tumor deposit in locally advanced rectal cancer with neoadjuvant chemoradiotherapy. Cancer Med 2019;8:1508-20. [PMID: 30790459 DOI: 10.1002/cam4.2034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
229 Siegel R, Burock S, Wernecke KD, Kretzschmar A, Dietel M, Loy V, Koswig S, Budach V, Schlag PM. Preoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: a multi-centre prospectively randomised study of the Berlin Cancer Society. BMC Cancer. 2009;9:50. [PMID: 19200365 DOI: 10.1186/1471-2407-9-50] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 4.8] [Reference Citation Analysis]
230 Sebag-Montefiore D, Glynne-Jones R, Falk S, Meadows HM, Maughan T. A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) study. Br J Cancer 2005;93:993-8. [PMID: 16249791 DOI: 10.1038/sj.bjc.6602818] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
231 Akiyoshi T, Kobunai T, Watanabe T. Predicting the response to preoperative radiation or chemoradiation by a microarray analysis of the gene expression profiles in rectal cancer. Surg Today. 2012;42:713-719. [PMID: 22706722 DOI: 10.1007/s00595-012-0223-8] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
232 Onal C, Kayaselcuk F, Topkan E, Yavuz M, Bacanli D, Yavuz A. Protective effects of melatonin and octreotide against radiation-induced intestinal injury. Dig Dis Sci 2011;56:359-67. [PMID: 20652743 DOI: 10.1007/s10620-010-1322-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
233 Lim YJ, Kim Y, Kong M. Comparative survival analysis of preoperative and postoperative radiotherapy in stage II-III rectal cancer on the basis of long-term population data. Sci Rep 2018;8:17153. [PMID: 30464308 DOI: 10.1038/s41598-018-35493-2] [Reference Citation Analysis]
234 Huang B, Feng Y, Mo SB, Cai SJ, Huang LY. Smaller tumor size is associated with poor survival in T4b colon cancer. World J Gastroenterol 2016; 22(29): 6726-6735 [PMID: 27547015 DOI: 10.3748/wjg.v22.i29.6726] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
235 Schiffmann L, Wedermann N, Gock M, Prall F, Klautke G, Fietkau R, Rau B, Klar E. Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications. BMC Surg 2013;13:43. [PMID: 24073705 DOI: 10.1186/1471-2482-13-43] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
236 Okamura R, Hida K, Yamaguchi T, Akagi T, Konishi T, Yamamoto M, Ota M, Matoba S, Bando H, Goto S, Sakai Y, Watanabe M, Watanabe K, Otsuka K, Takemasa I, Tanaka K, Ikeda M, Matsuda C, Fukuda M, Hasegawa J, Akamoto S, Shiozawa M, Tsuruta A, Akiyoshi T, Kato T, Tsukamoto S, Ito M, Naito M, Kanazawa A, Takahashi T, Ueki T, Hayashi Y, Morita S, Yamaguchi T, Nakanishi M, Hasegawa H, Okamoto K, Teraishi F, Sumi Y, Tashiro J, Yatsuoka T, Nishimura Y, Okita K, Kobatake T, Horie H, Miyakura Y, Ro H, Nagakari K, Hidaka E, Umemoto T, Nishigori H, Murata K, Wakayama F, Makizumi R, Fujii S, Sunami E, Kobayashi H, Nakagawa R, Enomoto T, Ohnuma S, Higashijima J, Ozawa H, Ashida K, Fujita F, Uehara K, Maruyama S, Ohyama M, Yamamoto S, Hinoi T, Yoshimitsu M, Okajima M, Tanimura S, Kawasaki M, Ide Y, Hazama S, Watanabe J, Inagaki D, Toyokawa A; Japan Society of Laparoscopic Colorectal Surgery. Local control of sphincter-preserving procedures and abdominoperineal resection for locally advanced low rectal cancer: Propensity score matched analysis. Ann Gastroenterol Surg 2017;1:199-207. [PMID: 29863157 DOI: 10.1002/ags3.12032] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
237 DI Tommaso M, Rosa C, Caravatta L, Augurio A, Borzillo V, DI Santo S, Perrotti F, Taraborrelli M, Cianci R, Innocenti P, DI Sebastiano P, Colasante A, Angelucci D, Basti M, Sindici G, Mazzola L, Pizzicannella G, DI Bartolomeo N, Marchioni M, DI Nicola M, Genovesi D. Treatment Intensification for Locally Advanced Rectal Cancer: Impact on Pathological Complete Response and Outcomes. In Vivo 2020;34:1223-33. [PMID: 32354913 DOI: 10.21873/invivo.11896] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
238 Wang Z, Loh KY, Tan KY, Woo EC. The role of lateral lymph node dissection in the management of lower rectal cancer. Langenbecks Arch Surg. 2012;397:353-361. [PMID: 22105772 DOI: 10.1007/s00423-011-0864-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
239 Beppu N, Yanagi H, Tomita N. A review of preoperative chemoradiotherapy for lower rectal cancer. J Anus Rectum Colon 2017;1:65-73. [PMID: 31583303 DOI: 10.23922/jarc.2017-013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
240 Mondaca S, Yaeger R. Genetics of rectal cancer and novel therapies: primer for radiologists. Abdom Radiol (NY) 2019;44:3743-50. [PMID: 31073721 DOI: 10.1007/s00261-019-02051-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
241 Lim YK, Law WL, Liu R, Poon JT, Fan JF, Lo OS. Impact of neoadjuvant treatment on total mesorectal excision for ultra-low rectal cancers. World J Surg Oncol. 2010;8:23. [PMID: 20346160 DOI: 10.1186/1477-7819-8-23] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
242 Chen YH, Wang CW, Wei MF, Tzeng YS, Lan KH, Cheng AL, Kuo SH. Maintenance BEZ235 Treatment Prolongs the Therapeutic Effect of the Combination of BEZ235 and Radiotherapy for Colorectal Cancer. Cancers (Basel) 2019;11:E1204. [PMID: 31430901 DOI: 10.3390/cancers11081204] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
243 Zhu Y, Wang C, Becker SA, Hurst K, Nogueira LM, Findlay VJ, Camp ER. miR-145 Antagonizes SNAI1-Mediated Stemness and Radiation Resistance in Colorectal Cancer. Mol Ther 2018;26:744-54. [PMID: 29475734 DOI: 10.1016/j.ymthe.2017.12.023] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 11.0] [Reference Citation Analysis]
244 Shetty GS, Bodhankar YD, Ingle S, Thakkar RG, Goel M, Shukla PJ, Shrikhande SV. Complications as indicators of quality assurance after 401 consecutive colorectal cancer resections: the importance of surgeon volume in developing colorectal cancer units in India. World J Surg Oncol 2012;10:15. [PMID: 22257531 DOI: 10.1186/1477-7819-10-15] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
245 Obias VJ, Reynolds HL Jr. Multidisciplinary teams in the management of rectal cancer. Clin Colon Rectal Surg 2007;20:143-7. [PMID: 20011195 DOI: 10.1055/s-2007-984858] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
246 Bai X, Li S, Yu B, Su H, Jin W, Chen G, DU J, Zuo F. Sphincter-preserving surgery after preoperative radiochemotherapy for T3 low rectal cancers. Oncol Lett. 2012;3:1336-1340. [PMID: 22783445 DOI: 10.3892/ol.2012.656] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
247 Wijenayake W, Perera M, Balawardena J, Deen R, Wijesuriya SR, Kumarage SK, Deen KI. Proximal and distal rectal cancers differ in curative resectability and local recurrence. World J Gastrointest Surg 2011; 3(8): 113-118 [PMID: 22007278 DOI: 10.4240/wjgs.v3.i8.113] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
248 Tilson L, Sharp L, Usher C, Walsh C, S W, O'Ceilleachair A, Stuart C, Mehigan B, John Kennedy M, Tappenden P, Chilcott J, Staines A, Comber H, Barry M. Cost of care for colorectal cancer in Ireland: a health care payer perspective. Eur J Health Econ 2012;13:511-24. [PMID: 21638069 DOI: 10.1007/s10198-011-0325-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
249 Creavin B, Ryan E, Martin ST, Hanly A, O'Connell PR, Sheahan K, Winter DC. Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer. Br J Cancer. 2017;116:169-174. [PMID: 27997526 DOI: 10.1038/bjc.2016.417] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 10.4] [Reference Citation Analysis]
250 Bernier L, Balyasnikova S, Tait D, Brown G. Watch-and-Wait as a Therapeutic Strategy in Rectal Cancer. Curr Colorectal Cancer Rep. 2018;14:37-55. [PMID: 29576755 DOI: 10.1007/s11888-018-0398-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 10.0] [Reference Citation Analysis]
251 Colaiácovo R, Assef MS, Ganc RL, Carbonari AP, Silva FA, Bin FC, Rossini LG. Rectal cancer staging: Correlation between the evaluation with radial echoendoscope and rigid linear probe. Endosc Ultrasound 2014;3:161-6. [PMID: 25184122 DOI: 10.4103/2303-9027.138786] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
252 Styczen H, Nagelmeier I, Beissbarth T, Nietert M, Homayounfar K, Sprenger T, Boczek U, Stanek K, Kitz J, Wolff HA, Ghadimi BM, Middel P, Liersch T, Rüschoff J, Conradi LC. HER-2 and HER-3 expression in liver metastases of patients with colorectal cancer. Oncotarget 2015;6:15065-76. [PMID: 25915155 DOI: 10.18632/oncotarget.3527] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
253 Denoya P, Wang H, Sands D, Nogueras J, Weiss E, Wexner SD. Short-term outcomes of laparoscopic total mesorectal excision following neoadjuvant chemoradiotherapy. Surg Endosc. 2010;24:933-938. [PMID: 19851807 DOI: 10.1007/s00464-009-0702-1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
254 Chetty R, Gill P, Govender D, Bateman A, Chang HJ, Driman D, Duthie F, Gomez M, Jaynes E, Lee CS. A multi-centre pathologist survey on pathological processing and regression grading of colorectal cancer resection specimens treated by neoadjuvant chemoradiation. Virchows Arch. 2012;460:151-155. [PMID: 22241181 DOI: 10.1007/s00428-012-1193-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
255 Noh JM, Park W, Kim JS, Koom WS, Kim JH, Choi DH, Park HC. Outcome of Local Excision Following Preoperative Chemoradiotherapy for Clinically T2 Distal Rectal Cancer: A Multicenter Retrospective Study (KROG 12-06). Cancer Res Treat 2014;46:243-9. [PMID: 25038759 DOI: 10.4143/crt.2014.46.3.243] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
256 Andre N, Schmiegel W. Chemoradiotherapy for colorectal cancer. Gut 2005;54:1194-202. [PMID: 16009693 DOI: 10.1136/gut.2004.062745] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 3.5] [Reference Citation Analysis]
257 Bautista-Quach MA, Ake CD, Chen M, Wang J. Gastrointestinal lymphomas: Morphology, immunophenotype and molecular features. J Gastrointest Oncol 2012;3:209-25. [PMID: 22943012 DOI: 10.3978/j.issn.2078-6891.2012.024] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
258 Pietrantonio F, Biondani P, Ciurlia E, Fanetti G, Tessari A, Bertarelli G, Bossi I, Musella V, Melotti F, Di Bartolomeo M, Valvo F, Pellegrinelli A, Milione M, Perrone F, de Braud F. Role of BAX for outcome prediction in gastrointestinal malignancies. Med Oncol 2013;30:610. [PMID: 23700226 DOI: 10.1007/s12032-013-0610-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
259 Ogawa S, Itabashi M, Inoue Y, Ohki T, Bamba Y, Koshino K, Nakagawa R, Tani K, Aihara H, Kondo H, Yamaguchi S, Yamamoto M. Lateral pelvic lymph nodes for rectal cancer: A review of diagnosis and management. World J Gastrointest Oncol 2021; 13(10): 1412-1424 [PMID: 34721774 DOI: 10.4251/wjgo.v13.i10.1412] [Reference Citation Analysis]
260 Cassidy RJ, Switchenko JM, Cheng E, Jiang R, Jhaveri J, Patel KR, Tanenbaum DG, Russell MC, Steuer CE, Gillespie TW, McDonald MW, Landry JC. Health care disparities among octogenarians and nonagenarians with stage II and III rectal cancer. Cancer 2017;123:4325-36. [PMID: 28759121 DOI: 10.1002/cncr.30896] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
261 Bisceglia G, Mastrodonato N, Tardio B, Mazzoccoli G, Corsa P, Troiano M, Parisi S. Intermediate neoadjuvant radiotherapy for T3 low/middle rectal cancer: postoperative outcomes of a non-controlled clinical trial. Oncotarget 2014;5:11143-53. [PMID: 25373926 DOI: 10.18632/oncotarget.2603] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
262 Glimelius B. Multidisciplinary treatment of patients with rectal cancer: Development during the past decades and plans for the future. Ups J Med Sci 2012;117:225-36. [PMID: 22512246 DOI: 10.3109/03009734.2012.658974] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
263 Napolitano M, D'Alterio C, Cardone E, Trotta AM, Pecori B, Rega D, Pace U, Scala D, Scognamiglio G, Tatangelo F, Cacciapuoti C, Pacelli R, Delrio P, Scala S. Peripheral myeloid-derived suppressor and T regulatory PD-1 positive cells predict response to neoadjuvant short-course radiotherapy in rectal cancer patients. Oncotarget 2015;6:8261-70. [PMID: 25823653 DOI: 10.18632/oncotarget.3014] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 7.6] [Reference Citation Analysis]
264 Stintzing S. Management of colorectal cancer. F1000Prime Rep 2014;6:108. [PMID: 25580262 DOI: 10.12703/P6-108] [Cited by in Crossref: 51] [Cited by in F6Publishing: 31] [Article Influence: 7.3] [Reference Citation Analysis]
265 Tian X, Nguyen M, Foote HP, Caster JM, Roche KC, Peters CG, Wu P, Jayaraman L, Garmey EG, Tepper JE, Eliasof S, Wang AZ. CRLX101, a Nanoparticle-Drug Conjugate Containing Camptothecin, Improves Rectal Cancer Chemoradiotherapy by Inhibiting DNA Repair and HIF1α. Cancer Res 2017;77:112-22. [PMID: 27784746 DOI: 10.1158/0008-5472.CAN-15-2951] [Cited by in Crossref: 35] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
266 Moslim MA, Bastawrous AL, Jeyarajah DR. Neoadjuvant Pelvic Radiotherapy in the Management of Rectal Cancer with Synchronous Liver Metastases: Is It Worth It? J Gastrointest Surg 2021. [PMID: 34100244 DOI: 10.1007/s11605-021-05042-w] [Reference Citation Analysis]
267 Rao SX, Zeng MS, Xu JM, Qin XY, Chen CZ, Li RC, Hou YY. Assessment of T staging and mesorectal fascia status using high-resolution MRI in rectal cancer with rectal distention. World J Gastroenterol 2007; 13(30): 4141-4146 [PMID: 17696238 DOI: 10.3748/wjg.v13.i30.4141] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
268 MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ. 2006;333:779. [PMID: 16984925 DOI: 10.1136/bmj.38937.647400.56] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
269 Findlay VJ, Moretz RE, Wang C, Vaena SG, Bandurraga SG, Ashenafi M, Marshall DT, Watson DK, Camp ER. Slug expression inhibits calcitriol-mediated sensitivity to radiation in colorectal cancer. Mol Carcinog 2014;53 Suppl 1:E130-9. [PMID: 23996472 DOI: 10.1002/mc.22054] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
270 Rosa C, Di Tommaso M, Caravatta L, Taraborrelli M, Gasparini L, Di Guglielmo FC, Delli Pizzi A, Cinalli S, Marchioni M, Di Nicola M, Lanci C, Ausili Cefaro G, Genovesi D. Clinical outcomes in elderly rectal cancer patients treated with neoadjuvant chemoradiotherapy: impact of tumor regression grade : Tumor regression grade after neoadjuvant chemoradiotherapy in elderly rectal cancer patients. J Cancer Res Clin Oncol 2021;147:1179-88. [PMID: 33026518 DOI: 10.1007/s00432-020-03403-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
271 Yu H, Luo Y, Peng H, Kang L, Huang M, Luo S, Chen W, Yang Z, Wang J. The predicting value of postoperative body temperature on long-term survival in patients with rectal cancer. Tumour Biol 2015;36:8055-63. [PMID: 25976505 DOI: 10.1007/s13277-015-3535-7] [Reference Citation Analysis]
272 Siewert JR, Stein HJ, von Rahden BH. Multimodal treatment of gastrointestinal tract tumors: consequences for surgery. World J Surg. 2005;29:940-948. [PMID: 15988623 DOI: 10.1007/s00268-005-0010-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
273 Verrijssen AS, Guillem J, Perez R, Bujko K, Guedj N, Habr-Gama A, Houben R, Goudkade D, Melenhorst J, Buijsen J, Vanneste B, Grabsch HI, Bellezzo M, Paiva Fonseca G, Verhaegen F, Berbee M, Van Limbergen EJ. Microscopic intramural extension of rectal cancer after neoadjuvant chemoradiation: A meta-analysis based on individual patient data. Radiother Oncol 2020;144:37-45. [PMID: 31710942 DOI: 10.1016/j.radonc.2019.10.003] [Reference Citation Analysis]
274 Takenami T, Tsujinaka S, Takahashi J, Tamaki S, Maemoto R, Fukuda R, Ishikawa H, Kakizawa N, Hasegawa F, Kikugawa R, Miyakura Y, Suzuki K, Tanaka A, Rikiyama T. Efficacy of Neoadjuvant Chemotherapy with Capecitabine plus Oxaliplatin in the Treatment of Locally Advanced Sigmoid Colon Cancer Invading the Urinary Bladder: A Report of Three Cases. Case Rep Surg 2019;2019:8129358. [PMID: 31049241 DOI: 10.1155/2019/8129358] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
275 Kakizoe M, Watanabe J, Goto K, Suwa Y, Nakagawa K, Suwa H, Ozawa M, Ishibe A, Ota M, Kunisaki C, Endo I. Identification of Patients with Locally Advanced Rectal Cancer in Whom Preoperative Radiotherapy Can Be Omitted: A Multicenter Retrospective Study at Yokohama Clinical Oncology Group (YCOG1307). J Anus Rectum Colon 2021;5:173-80. [PMID: 33937558 DOI: 10.23922/jarc.2020-084] [Reference Citation Analysis]
276 Peng H, Wang C, Xiao W, Lin X, You K, Dong J, Wang Z, Yu X, Zeng Z, Zhou T, Gao Y, Wen B. Analysis of Clinical characteristics to predict pathologic complete response for patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. J Cancer. 2018;9:2687-2692. [PMID: 30087709 DOI: 10.7150/jca.25493] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
277 Wang J, Guan Y, Gu W, Yan S, Zhou J, Huang D, Tong T, Li C, Cai S, Zhang Z, Zhu J. Long-course neoadjuvant chemoradiotherapy with versus without a concomitant boost in locally advanced rectal cancer: a randomized, multicenter, phase II trial (FDRT-002). Radiat Oncol. 2019;14:215. [PMID: 31783766 DOI: 10.1186/s13014-019-1420-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
278 Siegel EM, Jacobsen PB, Malafa M, Fulp W, Fletcher M, Lee JH, Smith JC, Brown R, Levine R, Cartwright T, Abesada-Terk G Jr, Kim G, Alemany C, Faig D, Sharp P, Markham MJ, Shibata D. Evaluating the quality of colorectal cancer care in the state of Florida: results from the Florida Initiative for Quality Cancer Care. J Oncol Pract 2012;8:239-45. [PMID: 23180990 DOI: 10.1200/JOP.2011.000477] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
279 Dijkstra EA, Mul VEM, Hemmer PHJ, Havenga K, Hospers GAP, Muijs CT, van Etten B. Re-Irradiation in Patients with Recurrent Rectal Cancer is Safe and Feasible. Ann Surg Oncol 2021;28:5194-204. [PMID: 34023946 DOI: 10.1245/s10434-021-10070-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
280 Lovinfosse P, Polus M, Van Daele D, Martinive P, Daenen F, Hatt M, Visvikis D, Koopmansch B, Lambert F, Coimbra C, Seidel L, Albert A, Delvenne P, Hustinx R. FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer. Eur J Nucl Med Mol Imaging. 2018;45:365-375. [PMID: 29046927 DOI: 10.1007/s00259-017-3855-5] [Cited by in Crossref: 67] [Cited by in F6Publishing: 57] [Article Influence: 16.8] [Reference Citation Analysis]
281 Arya S, Das D, Engineer R, Saklani A. Imaging in rectal cancer with emphasis on local staging with MRI. Indian J Radiol Imaging 2015;25:148-61. [PMID: 25969638 DOI: 10.4103/0971-3026.155865] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
282 Dietz DW. Multidisciplinary management of rectal cancer: the OSTRICH. J Gastrointest Surg. 2013;17:1863-1868. [PMID: 23884558 DOI: 10.1007/s11605-013-2276-4] [Cited by in Crossref: 57] [Cited by in F6Publishing: 44] [Article Influence: 7.1] [Reference Citation Analysis]
283 Mulla M, Deb R, Singh R. MRI in T staging of rectal cancer: How effective is it? Indian J Radiol Imaging 2010;20:118-21. [PMID: 20607023 DOI: 10.4103/0971-3026.63055] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
284 Govindarajan A, Gönen M, Weiser MR, Shia J, Temple LK, Guillem JG, Paty PB, Nash GM. Challenging the feasibility and clinical significance of current guidelines on lymph node examination in rectal cancer in the era of neoadjuvant therapy. J Clin Oncol 2011;29:4568-73. [PMID: 21990400 DOI: 10.1200/JCO.2011.37.2235] [Cited by in Crossref: 60] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
285 Garcia-Aguilar J, Smith DD, Avila K, Bergsland EK, Chu P, Krieg RM; Timing of Rectal Cancer Response to Chemoradiation Consortium. Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trial. Ann Surg. 2011;254:97-102. [PMID: 21494121 DOI: 10.1097/sla.0b013e3182196e1f] [Cited by in Crossref: 196] [Cited by in F6Publishing: 78] [Article Influence: 19.6] [Reference Citation Analysis]
286 Assifi MM, Lu X, Eibl G, Reber HA, Li G, Hines OJ. Neoadjuvant therapy in pancreatic adenocarcinoma: a meta-analysis of phase II trials. Surgery. 2011;150:466-473. [PMID: 21878232 DOI: 10.1016/j.surg.2011.07.006] [Cited by in Crossref: 138] [Cited by in F6Publishing: 121] [Article Influence: 13.8] [Reference Citation Analysis]
287 Saklani AP, Bae SU, Clayton A, Kim NK. Magnetic resonance imaging in rectal cancer: A surgeon’s perspective. World J Gastroenterol 2014; 20(8): 2030-2041 [PMID: 24616572 DOI: 10.3748/wjg.v20.i8.2030] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
288 Simunovic M, Urbach DR, Fahim C, O'Brien MA, Earle CC, Brouwers M, Gatov E, Grubac V, McCormack D, Baxter N. High-Intensity vs Low-Intensity Knowledge Translation Interventions for Surgeons and Their Association With Process and Outcome Measures Among Patients Undergoing Rectal Cancer Surgery. JAMA Netw Open 2021;4:e2117536. [PMID: 34269805 DOI: 10.1001/jamanetworkopen.2021.17536] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
289 Jarosch A, Sommer U, Bogner A, Reißfelder C, Weitz J, Krause M, Folprecht G, Baretton GB, Aust DE. Neoadjuvant radiochemotherapy decreases the total amount of tumor infiltrating lymphocytes, but increases the number of CD8+/Granzyme B+ (GrzB) cytotoxic T-cells in rectal cancer. Oncoimmunology 2018;7:e1393133. [PMID: 29308324 DOI: 10.1080/2162402X.2017.1393133] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
290 Uehara K, Nagino M. Neoadjuvant treatment for locally advanced rectal cancer: a systematic review. Surg Today 2016;46:161-8. [PMID: 26170102 DOI: 10.1007/s00595-015-1218-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
291 Lin AY, Wong WD, Shia J, Minsky BD, Temple LK, Guillem JG, Paty PB, Weiser MR. Predictive clinicopathologic factors for limited response of T3 rectal cancer to combined modality therapy. Int J Colorectal Dis. 2008;23:243-249. [PMID: 18046561 DOI: 10.1007/s00384-007-0406-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
292 da Luz Moreira A, Mor I, Geisler DP, Remzi FH, Kiran RP. Laparoscopic resection for rectal cancer: a case-matched study. Surg Endosc. 2011;25:278-283. [PMID: 20585962 DOI: 10.1007/s00464-010-1174-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
293 Anderson JD, Wan W, Kaplan BJ, Myers J, Fields EC. Changing paradigm in pancreatic cancer: from adjuvant to neoadjuvant chemoradiation. J Gastrointest Oncol 2016;7:1004-10. [PMID: 28078125 DOI: 10.21037/jgo.2016.11.09] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
294 Roeder F, Goetz JM, Habl G, Bischof M, Krempien R, Buechler MW, Hensley FW, Huber PE, Weitz J, Debus J. Intraoperative Electron Radiation Therapy (IOERT) in the management of locally recurrent rectal cancer. BMC Cancer 2012;12:592. [PMID: 23231663 DOI: 10.1186/1471-2407-12-592] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 3.2] [Reference Citation Analysis]
295 Enríquez-Navascués JM, Borda N, Lizerazu A, Placer C, Elosegui JL, Ciria JP, Lacasta A, Bujanda L. Patterns of local recurrence in rectal cancer after a multidisciplinary approach. World J Gastroenterol 2011; 17(13): 1674-1684 [PMID: 21483626 DOI: 10.3748/wjg.v17.i13.1674] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
296 Tural D, Selcukbiricik F, Yıldız Ö, Elcin O, Erdamar S, Güney S, Demireli F, Büyükünal E, Serdengeçti S. Preoperative versus postoperative chemoradiotherapy in stage T3, N0 rectal cancer. Int J Clin Oncol 2014;19:889-96. [PMID: 24218281 DOI: 10.1007/s10147-013-0636-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
297 Yoo BC, Yeo SG. Clinical utility of pretreatment prediction of chemoradiotherapy response in rectal cancer: a review. EPMA J 2017;8:61-7. [PMID: 28620444 DOI: 10.1007/s13167-017-0082-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
298 Morino M, Risio M, Bach S, Beets-tan R, Bujko K, Panis Y, Quirke P, Rembacken B, Rullier E, Saito Y, Young-fadok T, Allaix ME. Early rectal cancer: the European Association for Endoscopic Surgery (EAES) clinical consensus conference. Surg Endosc 2015;29:755-73. [DOI: 10.1007/s00464-015-4067-3] [Cited by in Crossref: 75] [Cited by in F6Publishing: 54] [Article Influence: 12.5] [Reference Citation Analysis]
299 Nguyen NP, Ceizyk M, Vock J, Vos P, Chi A, Vinh-Hung V, Pugh J, Khan R, Truong C, Albala G, Locke A, Karlsson U, Gelumbauskas S, Smith-Raymond L. Feasibility of image-guided radiotherapy for elderly patients with locally advanced rectal cancer. PLoS One 2013;8:e71250. [PMID: 23967173 DOI: 10.1371/journal.pone.0071250] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
300 Blaszkowsky LS, Ryan DP, Szymonifka J, Borger DR, Zhu AX, Clark JW, Kwak EL, Mamon HJ, Allen JN, Vasudev E, Shellito PC, Cusack JC, Berger DL, Hong TS. Phase I/II study of neoadjuvant bevacizumab, erlotinib and 5-fluorouracil with concurrent external beam radiation therapy in locally advanced rectal cancer. Ann Oncol 2014;25:121-6. [PMID: 24356623 DOI: 10.1093/annonc/mdt516] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
301 Glynne-Jones R, Hadaki M, Harrison M. The status of targeted agents in the setting of neoadjuvant radiation therapy in locally advanced rectal cancers. J Gastrointest Oncol 2013;4:264-84. [PMID: 23997939 DOI: 10.3978/j.issn.2078-6891.2013.037] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
302 Sterzing F, Hoehle F, Ulrich A, Jensen A, Debus J, Muenter M. Clinical results and toxicity for short-course preoperative radiotherapy and total mesorectal excision in rectal cancer patients. J Radiat Res 2015;56:169-76. [PMID: 25341424 DOI: 10.1093/jrr/rru089] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
303 Jalilian M, Davis S, Mohebbi M, Sugamaran B, Porter IW, Bell S, Warrier SK, Wale R. Pathologic response to neoadjuvant treatment in locally advanced rectal cancer and impact on outcome. J Gastrointest Oncol. 2016;7:603-608. [PMID: 27563451 DOI: 10.21037/jgo.2016.05.03] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
304 Wanis KN, Pineda-Solis K, Tun-Abraham ME, Yeoman J, Welch S, Vogt K, Van Koughnett JAM, Ott M, Hernandez-Alejandro R. Management of colorectal cancer with synchronous liver metastases: impact of multidisciplinary case conference review. Hepatobiliary Surg Nutr. 2017;6:162-169. [PMID: 28652999 DOI: 10.21037/hbsn.2017.01.01] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
305 Somashekhar SP, Deshpande AY, Ashwin KR, Gangasani R, Kumar R, Shetty S. Comparative Evaluation of the Short-Term Treatment Outcomes Between Open, Laparoscopic- and Robotic-Assisted Surgical Approaches for Rectal Cancer Treatment. Indian J Surg Oncol 2020;11:649-52. [PMID: 33299282 DOI: 10.1007/s13193-020-01137-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
306 Koroulakis A, Molitoris J, Kaiser A, Hanna N, Bafford A, Jiang Y, Bentzen S, Regine WF. Reirradiation for Rectal Cancer Using Pencil Beam Scanning Proton Therapy: A Single Institutional Experience. Adv Radiat Oncol 2021;6:100595. [PMID: 33490730 DOI: 10.1016/j.adro.2020.10.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
307 Zhang Q, Liang J, Chen J, Mei S, Wang Z. Predictive Factors for Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer. Asian Pac J Cancer Prev 2021;22:1607-11. [PMID: 34048192 DOI: 10.31557/APJCP.2021.22.5.1607] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
308 Guo S, Reddy CA, Kolar M, Woody N, Mahadevan A, Deibel FC, Dietz DW, Remzi FH, Suh JH. Intraoperative radiation therapy with the photon radiosurgery system in locally advanced and recurrent rectal cancer: retrospective review of the Cleveland clinic experience. Radiat Oncol. 2012;7:110. [PMID: 22817880 DOI: 10.1186/1748-717x-7-110] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
309 Anderson BJ, Wahlquist AE, Hill EG, Marshall DT, Kimchi ET, Staveley O'Carroll KF, Camp ER. The impact of metabolic syndrome on outcome and response to neoadjuvant chemoradiation in locally advanced rectal cancer patients. Int J Surg 2016;33 Pt A:8-12. [PMID: 27432024 DOI: 10.1016/j.ijsu.2016.07.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
310 Park EJ. Shifting Treatment Strategies to Prevent Early Relapse of Locally Advanced Rectal Cancer After Preoperative Chemoradiotherapy. Ann Coloproctol 2020;36:357-8. [PMID: 33486905 DOI: 10.3393/ac.2020.11.21] [Reference Citation Analysis]
311 Gillespie MA, Steele CW, Lannagan TRM, Sansom OJ, Roxburgh CSD. Pre-clinical modelling of rectal cancer to develop novel radiotherapy-based treatment strategies. Oncol Rev 2021;15:511. [PMID: 34249240 DOI: 10.4081/oncol.2021.511] [Reference Citation Analysis]
312 Campos-Lobato LF, Alves-Ferreira PC, Lavery IC, Kiran RP. Abdominoperineal resection does not decrease quality of life in patients with low rectal cancer. Clinics (Sao Paulo). 2011;66:1035-1040. [PMID: 21808871 DOI: 10.1590/S1807-59322011000600019] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
313 Williamson JS, Jones HG, Williams N, Griffiths AP, Jenkins G, Beynon J, Harris DA. Extramural vascular invasion and response to neoadjuvant chemoradiotherapy in rectal cancer: Influence of the CpG island methylator phenotype. World J Gastrointest Oncol 2017; 9(5): 209-217 [PMID: 28567185 DOI: 10.4251/wjgo.v9.i5.209] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
314 Gaedcke J, Grade M, Camps J, Søkilde R, Kaczkowski B, Schetter AJ, Difilippantonio MJ, Harris CC, Ghadimi BM, Møller S. The rectal cancer microRNAome--microRNA expression in rectal cancer and matched normal mucosa. Clin Cancer Res. 2012;18:4919-4930. [PMID: 22850566 DOI: 10.1158/1078-0432.ccr-12-0016] [Cited by in Crossref: 120] [Cited by in F6Publishing: 97] [Article Influence: 13.3] [Reference Citation Analysis]
315 Sánchez-Alcoholado L, Laborda-Illanes A, Otero A, Ordóñez R, González-González A, Plaza-Andrades I, Ramos-Molina B, Gómez-Millán J, Queipo-Ortuño MI. Relationships of Gut Microbiota Composition, Short-Chain Fatty Acids and Polyamines with the Pathological Response to Neoadjuvant Radiochemotherapy in Colorectal Cancer Patients. Int J Mol Sci 2021;22:9549. [PMID: 34502456 DOI: 10.3390/ijms22179549] [Reference Citation Analysis]
316 田含含, 王海峰, 张瑾熔, 阿衣古丽·哈热, 伊斯刊达尔·阿布力米提. 术前放化疗与手术时间间隔对ⅢA、ⅢB期直肠癌的影响. 世界华人消化杂志 2014; 22(26): 3918-3924 [DOI: 10.11569/wcjd.v22.i26.3918] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
317 Zachariah B, Gwede CK, James J, Ajani J, Chin LJ, Donath D, Rosenthal SA, Kane BL, Rotman M, Berk L, Kachnic LA. Octreotide acetate in prevention of chemoradiation-induced diarrhea in anorectal cancer: randomized RTOG trial 0315. J Natl Cancer Inst 2010;102:547-56. [PMID: 20339140 DOI: 10.1093/jnci/djq063] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
318 Hartman RI, Chang CY, Wo JY, Eisenberg JD, Hong TS, Harisinghani MG, Gazelle GS, Pandharipande PV. Optimizing adjuvant treatment decisions for stage t2 rectal cancer based on mesorectal node size: a decision analysis. Acad Radiol 2013;20:79-89. [PMID: 22947271 DOI: 10.1016/j.acra.2012.07.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
319 Li Y, Liu H, Zhou Y, Zhou Z, Liu W, Zhao L, Güngör C, Wang D, Pei Q, Pei H, Tan F. The Survival Effect of Radiotherapy on Stage II/III Rectal Cancer in Different Age Groups: Formulating Radiotherapy Decision-Making Based on Age. Front Oncol 2021;11:695640. [PMID: 34395261 DOI: 10.3389/fonc.2021.695640] [Reference Citation Analysis]
320 Pérez-Ruiz E, Berraondo P. Immunological Landscape and Clinical Management of Rectal Cancer. Front Immunol. 2016;7:61. [PMID: 26941741 DOI: 10.3389/fimmu.2016.00061] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
321 Kim JG, Song KD, Cha DI, Kim HC, Yu JI. Indistinguishable T2/T3-N0 rectal cancer on rectal magnetic resonance imaging: comparison of surgery-first and neoadjuvant chemoradiation therapy-first strategies. Int J Colorectal Dis 2018;33:1359-66. [PMID: 30003363 DOI: 10.1007/s00384-018-3131-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
322 Petersen SH, Harling H, Kirkeby LT, Wille-Jørgensen P, Mocellin S. Postoperative adjuvant chemotherapy in rectal cancer operated for cure. Cochrane Database Syst Rev. 2012;3:CD004078. [PMID: 22419291 DOI: 10.1002/14651858.cd004078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
323 Li J, Yuan J, Liu H, Yin J, Liu S, Du F, Hu J, Li C, Niu X, Lv B, Xing S. Lymph nodes regression grade is a predictive marker for rectal cancer after neoadjuvant therapy and radical surgery. Oncotarget 2016;7:16975-84. [PMID: 26934651 DOI: 10.18632/oncotarget.7703] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
324 de las Heras M, Arias F, del Moral-Avila R, Gómez-Millán J, Jiménez E, Wals A, Tisaire JL, Alcantara MP. Multicenter phase II clinical trial of preoperative capecitabine with concurrent radiotherapy in patients with locally advanced rectal cancer. Clin Transl Oncol 2013;15:294-9. [PMID: 22855196 DOI: 10.1007/s12094-012-0915-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
325 Yang TJ, Goodman KA. Predicting complete response: is there a role for non-operative management of rectal cancer? J Gastrointest Oncol 2015;6:241-6. [PMID: 25830042 DOI: 10.3978/j.issn.2078-6891.2014.110] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
326 Lee SY, Kim CH, Kim YJ, Kim HR. Anastomotic stricture after ultralow anterior resection or intersphincteric resection for very low-lying rectal cancer. Surg Endosc 2018;32:660-6. [PMID: 28726144 DOI: 10.1007/s00464-017-5718-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
327 Zhao D, Li Y, Wang S, Huang Z. Laparoscopic versus open surgery for rectal cancer: a meta-analysis of 3-year follow-up outcomes. Int J Colorectal Dis. 2016;31:805-811. [PMID: 26847617 DOI: 10.1007/s00384-016-2506-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
328 Narayanan S, Attwood K, Gabriel E, Nurkin S. Pathologic Complete Response Despite Nodal Yield Has Best Survival in Locally Advanced Rectal Cancer. J Surg Res 2020;251:220-7. [PMID: 32172008 DOI: 10.1016/j.jss.2020.01.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
329 González JEB, Lavernia HC, Fraga JGP, Lemus SQ. Long-term outcomes of transanal endoscopic microsurgery for clinical complete response after neoadjuvant treatment in T2-3 rectal cancer. Surg Endosc 2021. [PMID: 34231071 DOI: 10.1007/s00464-021-08583-y] [Reference Citation Analysis]
330 Thariat J, Hannoun-Levi JM, Sun Myint A, Vuong T, Gérard JP. Past, present, and future of radiotherapy for the benefit of patients. Nat Rev Clin Oncol 2013;10:52-60. [PMID: 23183635 DOI: 10.1038/nrclinonc.2012.203] [Cited by in Crossref: 160] [Cited by in F6Publishing: 139] [Article Influence: 17.8] [Reference Citation Analysis]
331 Champagne BJ, Delaney CP. Laparoscopic approaches to rectal cancer. Clin Colon Rectal Surg 2007;20:237-48. [PMID: 20011205 DOI: 10.1055/s-2007-984868] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
332 Dewdney A, Cunningham D, Chau I. Selecting patients with locally advanced rectal cancer for neoadjuvant treatment strategies. Oncologist. 2013;18:833-842. [PMID: 23821325 DOI: 10.1634/theoncologist.2013-0022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
333 Ahn DH, Wu C, Wei L, Williams TM, Wuthrick E, Abdel-Misih S, Harzman A, Husain S, Schmidt C, Goldberg RM, Bekaii-Saab T. The Efficacy of Adjuvant Chemotherapy in Patients With Stage II/III Resected Rectal Cancer Treated With Neoadjuvant Chemoradiation Therapy. Am J Clin Oncol 2017;40:531-4. [PMID: 25723741 DOI: 10.1097/COC.0000000000000185] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
334 Zhang K, Wang Y, Yu X, Shi Y, Yao Y, Wei X, Ma X. Recombinant human endostatin combined with radiotherapy inhibits colorectal cancer growth. BMC Cancer 2017;17:899. [PMID: 29282026 DOI: 10.1186/s12885-017-3903-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
335 Chitapanarux I, Chitapanarux T, Tharavichitkul E, Mayurasakorn S, Siriwittayakorn P, Yamada S, Lorvidhaya V. A phase II study of oxaliplatin with 5-FU/folinic acid and concomitant radiotherapy as a preoperative treatment in patients with locally advanced rectal cancer. Biomed Imaging Interv J 2011;7:e25. [PMID: 22279502 DOI: 10.2349/biij.7.4.e25] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
336 Peng HH, You KY, Wang CT, Huang R, Shan HB, Zhou JH, Pei XQ, Gao YH, Wen BX, Liu MZ. Value of transrectal ultrasonography for tumor node metastasis restaging in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy. Gastroenterol Rep (Oxf) 2013;1:186-92. [PMID: 24759964 DOI: 10.1093/gastro/got028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
337 Routman DM, Yan E, Vora S, Peterson J, Mahajan A, Chaichana KL, Laack N, Brown PD, Parney IF, Burns TC, Trifiletti DM. Preoperative Stereotactic Radiosurgery for Brain Metastases. Front Neurol 2018;9:959. [PMID: 30542316 DOI: 10.3389/fneur.2018.00959] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
338 Jäger T, Neureiter D, Fallaha M, Schredl P, Kiesslich T, Urbas R, Klieser E, Holzinger J, Sedlmayer F, Emmanuel K, Dinnewitzer A. The potential predictive value of tumor budding for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer. Strahlenther Onkol 2018;194:991-1006. [PMID: 30069738 DOI: 10.1007/s00066-018-1340-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
339 Kodama H, Terazawa T, Ishizuka Y, Yukami H, Aoki M, Miyamoto T, Yamaguchi T, Shimamoto F, Kii T, Goto M, Hamamoto H, Osumi W, Yamamoto M, Tanaka K, Okuda J, Uchiyama K, Higuchi K. Retrospective Comparison of mFOLFOXIRI With XELOX/SOX as Neoadjuvant Chemotherapy for Locally Advanced Rectal Cancer. In Vivo 2021;35:977-85. [PMID: 33622892 DOI: 10.21873/invivo.12340] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
340 Ryan DP. The Increasingly Complicated Approach to Rectal Cancer. Oncologist 2019;24:728-9. [PMID: 30996011 DOI: 10.1634/theoncologist.2018-0355] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
341 Fei F, Zhang M, Li B, Zhao L, Wang H, Liu L, Li Y, Ding P, Gu Y, Zhang X, Jiang T, Zhu S, Zhang S. Formation of Polyploid Giant Cancer Cells Involves in the Prognostic Value of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer. J Oncol 2019;2019:2316436. [PMID: 31558902 DOI: 10.1155/2019/2316436] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
342 罗琪, 张颂恩, 魏黎煜. 新辅助化放疗在局部进展期低位直肠癌保留肛门括约肌作用的研究. 世界华人消化杂志 2006; 14(22): 2247-2250 [DOI: 10.11569/wcjd.v14.i22.2247] [Reference Citation Analysis]
343 Jeong JH, Cho IH, Chun KA, Kong EJ, Kwon SD, Kim JH. Correlation Between Apparent Diffusion Coefficients and Standardized Uptake Values in Hybrid (18)F-FDG PET/MR: Preliminary Results in Rectal Cancer. Nucl Med Mol Imaging 2016;50:150-6. [PMID: 27275364 DOI: 10.1007/s13139-015-0390-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
344 Aquina CT, Ejaz A, Tsung A, Pawlik TM, Cloyd JM. National Trends in the Use of Neoadjuvant Therapy Before Cancer Surgery in the US From 2004 to 2016.JAMA Netw Open. 2021;4:e211031. [PMID: 33688961 DOI: 10.1001/jamanetworkopen.2021.1031] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
345 Zuo ZG, Zhang XF, Wang H, Liu QZ, Ye XZ, Xu C, Wu XB, Cai JH, Zhou ZH, Li JL, Song HY, Luo ZQ, Li P, Ni SC, Jiang L. Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision. Medicine (Baltimore) 2016;95:e2988. [PMID: 26945418 DOI: 10.1097/MD.0000000000002988] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 2.2] [Reference Citation Analysis]
346 Jayanand SB, Seshadri RA, Tapkire R. Signet ring cell histology and non-circumferential tumors predict pathological complete response following neoadjuvant chemoradiation in rectal cancers. Int J Colorectal Dis. 2011;26:23-27. [PMID: 21046123 DOI: 10.1007/s00384-010-1082-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
347 Koizumi M, Yamada T, Shinji S, Yokoyama Y, Takahashi G, Iwai T, Takeda K, Hara K, Ohta K, Uchida E, Yoshida H. Feasibility of Neoadjuvant FOLFOX Therapy Without Radiotherapy for Baseline Resectable Rectal Cancer. In Vivo. 2018;32:937-943. [PMID: 29936483 DOI: 10.21873/invivo.11332] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
348 Hong TS, Mamon H. Short-course versus standard chemoradiation in T3 rectal cancer. Oncologist 2011;16:717-21. [PMID: 21586661 DOI: 10.1634/theoncologist.2011-0052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
349 Cui J, Zhang L, Yang L, Zhu YL, Fang H, Chen B, Ning Y, Zhang HZ. The prognostic significance of the treatment response of regional lymph nodes and the refinement of the current TNM staging system in locally advanced rectal cancer after neoadjuvant chemoradiotherapy. Cancer Med 2020;9:9373-84. [PMID: 33079470 DOI: 10.1002/cam4.3553] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
350 Warschkow R, Ebinger SM, Brunner W, Schmied BM, Marti L. Survival after Abdominoperineal and Sphincter-Preserving Resection in Nonmetastatic Rectal Cancer: A Population-Based Time-Trend and Propensity Score-Matched SEER Analysis. Gastroenterol Res Pract 2017;2017:6058907. [PMID: 28197206 DOI: 10.1155/2017/6058907] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
351 Hu YH, Wei JW, Chang H, Xiao WW, Lin JZ, Cai MY, Cai PQ, Kong LH, Chen G, Pan ZZ, Zeng ZF, Ding PR, Gao YH. The high pCR rate of sandwich neoadjuvant treatment in locally advanced rectal cancer may translate into a better long-term survival benefit: 5-year outcome of a Phase II clinical trial. Cancer Manag Res 2018;10:4363-9. [PMID: 30349369 DOI: 10.2147/CMAR.S168573] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
352 Charlton ME, Mattingly-Wells LR, Marcet JE, McMahon Waldschmidt BC, Cromwell JW. Association between surgeon characteristics and their preferences for guideline-concordant staging and treatment for rectal cancer. Am J Surg. 2014;208:817-823. [PMID: 24997492 DOI: 10.1016/j.amjsurg.2014.03.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
353 Jung SM, Yu CS, Park IJ, Kim TW, Kim JH, Yoon YS, Lim SB, Kim JC. Oncologic Safety of Local Excision Compared With Total Mesorectal Excision for ypT0-T1 Rectal Cancer: A Propensity Score Analysis. Medicine (Baltimore) 2016;95:e3718. [PMID: 27196490 DOI: 10.1097/MD.0000000000003718] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
354 Tunio MA, Rafi M, Hashmi A, Mohsin R, Qayyum A, Hasan M, Sattar A, Mubarak M. High-dose-rate intraluminal brachytherapy during preoperative chemoradiation for locally advanced rectal cancers. World J Gastroenterol 2010; 16(35): 4436-4442 [PMID: 20845511 DOI: 10.3748/wjg.v16.i35.4436] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
355 Ding L, Liu GW, Zhao BC, Zhou YP, Li S, Zhang ZD, Guo YT, Li AQ, Lu Y, Yao HW, Yuan WT, Wang GY, Zhang DL, Wang L. Artificial intelligence system of faster region-based convolutional neural network surpassing senior radiologists in evaluation of metastatic lymph nodes of rectal cancer. Chin Med J (Engl). 2019;132:379-387. [PMID: 30707177 DOI: 10.1097/cm9.0000000000000095] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
356 Audisio RA, Papamichael D. Treatment of colorectal cancer in older patients. Nat Rev Gastroenterol Hepatol. 2012;9:716-725. [PMID: 23045000 DOI: 10.1038/nrgastro.2012.196] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
357 Law WL, Foo DC. Surgical Results and Oncologic Outcomes for Rectal Cancer with Tailored Mesorectal Excision over Two Decades. World J Surg 2016;40:1500-8. [PMID: 26801507 DOI: 10.1007/s00268-016-3408-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
358 Ruiz-Garcia H, Ramirez-Loera C, Malouff TD, Seneviratne DS, Palmer JD, Trifiletti DM. Novel Strategies for Nanoparticle-Based Radiosensitization in Glioblastoma. Int J Mol Sci 2021;22:9673. [PMID: 34575840 DOI: 10.3390/ijms22189673] [Reference Citation Analysis]
359 Zhang LN, Xiao W, OuYang PY, You K, Zeng ZF, Ding PR, Pan ZZ, Xu RH, Gao YH. The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy. Tumour Biol 2015;36:8213-9. [PMID: 25994571 DOI: 10.1007/s13277-015-3560-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
360 Zaanan A, Park JM, Tougeron D, Huang S, Wu TT, Foster NR, Sinicrope FA. Association of beclin 1 expression with response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal carcinoma. Int J Cancer. 2015;137:1498-1502. [PMID: 25708267 DOI: 10.1002/ijc.29496] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
361 Formica V, Benassi M, Del Vecchio Blanco G, Doldo E, Martano L, Portarena I, Nardecchia A, Lucchetti J, Morelli C, Giudice E, Rossi P, Anselmo A, Sileri P, Sica G, Orlandi A, Santoni R, Roselli M. Hemoglobin level and XRCC1 polymorphisms to select patients with locally advanced rectal cancer candidate for neoadjuvant chemoradiotherapy with concurrent capecitabine and a platinum salt. Med Oncol 2018;35:83. [PMID: 29721745 DOI: 10.1007/s12032-018-1141-4] [Reference Citation Analysis]
362 Glimelius B. On a prolonged interval between rectal cancer (chemo)radiotherapy and surgery. Ups J Med Sci 2017;122:1-10. [PMID: 28256956 DOI: 10.1080/03009734.2016.1274806] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
363 Kang YM, Chao TF, Wang TH, Hu YW. Increased risk of pelvic fracture after radiotherapy in rectal cancer survivors: A propensity matched study. Cancer Med 2019;8:3639-47. [PMID: 31104362 DOI: 10.1002/cam4.2030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
364 Gröne J, Loch FN, Taupitz M, Schmidt C, Kreis ME. Accuracy of Various Lymph Node Staging Criteria in Rectal Cancer with Magnetic Resonance Imaging. J Gastrointest Surg 2018;22:146-53. [PMID: 28900855 DOI: 10.1007/s11605-017-3568-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 6.8] [Reference Citation Analysis]
365 Ko HM, Choi YH, Lee JE, Lee KH, Kim JY, Kim JS. Combination Assessment of Clinical Complete Response of Patients With Rectal Cancer Following Chemoradiotherapy With Endoscopy and Magnetic Resonance Imaging. Ann Coloproctol. 2019;35:202-208. [PMID: 31487768 DOI: 10.3393/ac.2018.10.15] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
366 Štor Z, Blagus R, Tropea A, Biondi A. Net survival of patients with colorectal cancer: a comparison of two periods. Updates Surg 2019;71:687-94. [PMID: 31190323 DOI: 10.1007/s13304-019-00662-z] [Reference Citation Analysis]
367 Shaverdian N, Yang Y, Hu P, Hart S, Sheng K, Lamb J, Cao M, Agazaryan N, Thomas D, Steinberg M, Low DA, Lee P. Feasibility evaluation of diffusion-weighted imaging using an integrated MRI-radiotherapy system for response assessment to neoadjuvant therapy in rectal cancer. Br J Radiol 2017;90:20160739. [PMID: 28079398 DOI: 10.1259/bjr.20160739] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
368 Peng J, Shi D, Goodman KA, Goldstein D, Xiao C, Guan Z, Cai S. Early results of quality of life for curatively treated rectal cancers in Chinese patients with EORTC QLQ-CR29. Radiat Oncol. 2011;6:93. [PMID: 21835046 DOI: 10.1186/1748-717x-6-93] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
369 Herman JM, Narang AK, Griffith KA, Zalupski MM, Reese JB, Gearhart SL, Azad NS, Chan J, Olsen L, Efron JE, Lawrence TS, Ben-Josef E. The quality-of-life effects of neoadjuvant chemoradiation in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2013;85:e15-9. [PMID: 23058059 DOI: 10.1016/j.ijrobp.2012.09.006] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
370 Pechlivanides G, Gourtsoyianni S, Gouvas N, Sougklakos J, Xynos E. Management of the adenocarcinoma of the upper rectum: a reappraisal. Updates Surg 2021;73:513-26. [PMID: 33108641 DOI: 10.1007/s13304-020-00903-6] [Reference Citation Analysis]
371 Negri FV, Campanini N, Camisa R, Pucci F, Bui S, Ceccon G, Martinelli R, Fumagalli M, Losardo PL, Crafa P, Bordi C, Cascinu S, Ardizzoni A. Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy. Br J Cancer 2008;98:143-7. [PMID: 18087284 DOI: 10.1038/sj.bjc.6604131] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 4.2] [Reference Citation Analysis]
372 Tang R, Meng Q, Wang W, Liang C, Hua J, Xu J, Yu X, Shi S. Head-to-head comparison between FOLFIRINOX and gemcitabine plus nab-paclitaxel in the neoadjuvant chemotherapy of localized pancreatic cancer: a systematic review and meta-analysis. Gland Surg 2021;10:1564-75. [PMID: 34164301 DOI: 10.21037/gs-21-16] [Reference Citation Analysis]
373 Meyer JE, Cohen SJ, Ruth KJ, Sigurdson ER, Hall MJ. Young Age Increases Risk of Lymph Node Positivity in Early-Stage Rectal Cancer. J Natl Cancer Inst 2016;108. [PMID: 26719881 DOI: 10.1093/jnci/djv284] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
374 Du CZ, Li J, Cai Y, Sun YS, Xue WC, Gu J. Effect of multidisciplinary team treatment on outcomes of patients with gastrointestinal malignancy. World J Gastroenterol 2011; 17(15): 2013-2018 [PMID: 21528081 DOI: 10.3748/wjg.v17.i15.2013] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 38] [Article Influence: 4.5] [Reference Citation Analysis]
375 Bhamre R, Mitra A, Tamankar A, Desouza A, Saklani A. Impact of Length of Distal Margin on Outcomes Following Sphincter Preserving Surgery for Middle and Lower Third Rectal Cancers. Indian J Surg Oncol 2019;10:335-41. [PMID: 31168259 DOI: 10.1007/s13193-019-00888-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
376 Leow YC, Roslani AC, Xavier RG, Lee FY. Pathological Complete Response After Neoadjuvant Therapy in Rectal Adenocarcinoma: a 5-Year Follow-up. Indian J Surg 2021;:1-8. [PMID: 34075282 DOI: 10.1007/s12262-021-02945-5] [Reference Citation Analysis]
377 Berger B, Bamberg M, Zips D, Schlunk T. Multiple malignancies in a single patient : a glimpse into 30 years of interdisciplinary oncology. Strahlenther Onkol 2013;189:155-8. [PMID: 23283588 DOI: 10.1007/s00066-012-0261-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
378 O'Neil BH, Funkhouser WK, Calvo BF, Meyers MO, Kim HJ, Goldberg RM, Bernard SA, Caskey L, Deal AM, Wright F, Baldwin AS, Tepper JE. Nuclear factor κ-light chain-enhancer of activated B cells is activated by radiotherapy and is prognostic for overall survival in patients with rectal cancer treated with preoperative fluorouracil-based chemoradiotheraphy. Int J Radiat Oncol Biol Phys 2011;80:705-11. [PMID: 20630669 DOI: 10.1016/j.ijrobp.2010.02.063] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
379 Hehlgans S, Oppermann J, Reichert S, Fulda S, Rödel C, Rödel F. The SMAC mimetic BV6 sensitizes colorectal cancer cells to ionizing radiation by interfering with DNA repair processes and enhancing apoptosis. Radiat Oncol 2015;10:198. [PMID: 26383618 DOI: 10.1186/s13014-015-0507-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
380 Kreis ME, Ruppert R, Ptok H, Strassburg J, Brosi P, Lewin A, Schön MR, Sauer J, Junginger T, Merkel S, Hermanek P; OCUM study group. Use of Preoperative Magnetic Resonance Imaging to Select Patients with Rectal Cancer for Neoadjuvant Chemoradiation--Interim Analysis of the German OCUM Trial (NCT01325649). J Gastrointest Surg 2016;20:25-32; discussion 32-3. [PMID: 26556476 DOI: 10.1007/s11605-015-3011-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
381 Sorenson E, Lambreton F, Yu JQ, Li T, Denlinger CS, Meyer JE, Sigurdson ER, Farma JM. Impact of PET/CT for Restaging Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiation. J Surg Res 2019;243:242-8. [PMID: 31229791 DOI: 10.1016/j.jss.2019.04.080] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
382 Lin SC, Chang IW, Hsieh PL, Lin CY, Sun DP, Sheu MJ, Yang CC, Lin LC, He HL, Tian YF. High Immunoreactivity of DUOX2 Is Associated With Poor Response to Preoperative Chemoradiation Therapy and Worse Prognosis in Rectal Cancers. J Cancer 2017;8:2756-64. [PMID: 28928864 DOI: 10.7150/jca.19545] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
383 Elshazly WG, Farouk M, Samy M. Preoperative concomitant radiotherapy with oral capecitabine in advanced rectal cancer within 6 cm from anal verge. Int J Colorectal Dis. 2009;24:401-407. [PMID: 19084971 DOI: 10.1007/s00384-008-0623-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
384 Chen MB, Wu XY, Yu R, Li C, Wang LQ, Shen W, Lu PH. P53 status as a predictive biomarker for patients receiving neoadjuvant radiation-based treatment: a meta-analysis in rectal cancer. PLoS One 2012;7:e45388. [PMID: 23049793 DOI: 10.1371/journal.pone.0045388] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
385 Silva VSE, Abdallah EA, Flores BCT, Braun AC, Costa DJF, Ruano APC, Gasparini VA, Silva MLG, Mendes GG, Claro LCL, Calsavara VF, Aguiar Junior S, de Mello CAL, Chinen LTD. Molecular and Dynamic Evaluation of Proteins Related to Resistance to Neoadjuvant Treatment with Chemoradiotherapy in Circulating Tumor Cells of Patients with Locally Advanced Rectal Cancer. Cells 2021;10:1539. [PMID: 34207124 DOI: 10.3390/cells10061539] [Reference Citation Analysis]
386 Wolff HA, Liersch T. [Total mesorectal excision with and without preoperative radiotherapy for patients with resectable rectal cancer: The multicentre, randomised controlled TME trial 12-year follow-up]. Strahlenther Onkol 2012;188:634-5. [PMID: 22659943 DOI: 10.1007/s00066-012-0132-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
387 Liu GC, Yan JP, He Q, An X, Pan ZZ, Ding PR. Effect of Neoadjuvant Chemoradiotherapy with Capecitabine versus Fluorouracil for Locally Advanced Rectal Cancer: A Meta-Analysis. Gastroenterol Res Pract 2016;2016:1798285. [PMID: 27891147 DOI: 10.1155/2016/1798285] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
388 Jeans EB, Jethwa KR, Harmsen WS, Neben-Wittich M, Ashman JB, Merrell KW, Giffey B, Ito S, Kazemba B, Beltran C, Haddock MG, Hallemeier CL. Clinical Implementation of Preoperative Short-Course Pencil Beam Scanning Proton Therapy for Patients With Rectal Cancer. Adv Radiat Oncol 2020;5:865-70. [PMID: 33083648 DOI: 10.1016/j.adro.2020.05.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
389 Yahya JB, Herzig DO, Farrell MJ, Degnin CR, Chen Y, Holland J, Brown S, Jaboin J, Tsikitis VL, Lu K, Thomas CR Jr, Mitin T. Does a fine line exist between regional and metastatic pelvic lymph nodes in rectal cancer-striking discordance between national guidelines and treatment recommendations by US radiation oncologists.J Gastrointest Oncol. 2018;9:441-447. [PMID: 29998009 DOI: 10.21037/jgo.2018.02.05] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
390 D'Alimonte L, Bao QR, Spolverato G, Capelli G, Del Bianco P, Albertoni L, De Paoli A, Guerrieri M, Mantello G, Gambacorta MA, Canzonieri V, Valentini V, Coco C, Pucciarelli S. Long-Term Outcomes of Local Excision Following Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer. Ann Surg Oncol 2021;28:2801-8. [PMID: 33125570 DOI: 10.1245/s10434-020-09243-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
391 Yeo SG. Association of pretreatment serum carcinoembryonic antigen levels with chemoradiation-induced downstaging and downsizing of rectal cancer. Mol Clin Oncol 2016;4:631-5. [PMID: 27073681 DOI: 10.3892/mco.2016.740] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
392 Arezzo A, Bianco F, Agresta F, Coco C, Faletti R, Krivocapic Z, Rotondano G, Santoro GA, Vettoretto N, De Franciscis S, Belli A, Romano GM; Italian Society of Colorectal Surgery. Practice parameters for early rectal cancer management: Italian Society of Colorectal Surgery (Società Italiana di Chirurgia Colo-Rettale; SICCR) guidelines. Tech Coloproctol 2015;19:587-93. [PMID: 26408174 DOI: 10.1007/s10151-015-1362-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
393 Zhao J, Liu X, Wang W, Hu K, Zhang F, Hou X, Meng Q. Concomitant dose escalation with image-guided Tomotherapy in locally advanced mid-low rectal cancer: a single-center study. Cancer Manag Res 2019;11:1579-86. [PMID: 30863168 DOI: 10.2147/CMAR.S193657] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
394 Denlinger CS, Barsevick AM. The challenges of colorectal cancer survivorship. J Natl Compr Canc Netw 2009;7:883-93; quiz 894. [PMID: 19755048 DOI: 10.6004/jnccn.2009.0058] [Cited by in Crossref: 157] [Cited by in F6Publishing: 142] [Article Influence: 13.1] [Reference Citation Analysis]
395 Cassidy RJ, Liu Y, Patel K, Zhong J, Steuer CE, Kooby DA, Russell MC, Gillespie TW, Landry JC. Can we eliminate neoadjuvant chemoradiotherapy in favor of neoadjuvant multiagent chemotherapy for select stage II/III rectal adenocarcinomas: Analysis of the National Cancer Data base. Cancer 2017;123:783-93. [PMID: 27780316 DOI: 10.1002/cncr.30410] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
396 Yasuda K, Nirei T, Sunami E, Nagawa H, Kitayama J. Density of CD4(+) and CD8(+) T lymphocytes in biopsy samples can be a predictor of pathological response to chemoradiotherapy (CRT) for rectal cancer. Radiat Oncol 2011;6:49. [PMID: 21575175 DOI: 10.1186/1748-717X-6-49] [Cited by in Crossref: 62] [Cited by in F6Publishing: 39] [Article Influence: 6.2] [Reference Citation Analysis]
397 Conrad C, Vauthey JN, Masayuki O, Sheth RA, Yamashita S, Passot G, Bailey CE, Zorzi D, Kopetz S, Aloia TA, You YN. Individualized Treatment Sequencing Selection Contributes to Optimized Survival in Patients with Rectal Cancer and Synchronous Liver Metastases. Ann Surg Oncol 2017;24:3857-64. [PMID: 28929463 DOI: 10.1245/s10434-017-6089-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
398 Foo M, Leong T. Adjuvant therapy for gastric cancer: Current and future directions. World J Gastroenterol 2014; 20(38): 13718-13727 [PMID: 25320509 DOI: 10.3748/wjg.v20.i38.13718] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
399 Lee KH, Song MS, Park JB, Kim JS, Kang DY, Kim JY. A Phase II Study of Additional Four-Week Chemotherapy With Capecitabine During the Resting Periods After Six-Week Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer. Ann Coloproctol 2013;29:192-7. [PMID: 24278857 DOI: 10.3393/ac.2013.29.5.192] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
400 de Lacy FB, van Laarhoven JJEM, Pena R, Arroyave MC, Bravo R, Cuatrecasas M, Lacy AM. Transanal total mesorectal excision: pathological results of 186 patients with mid and low rectal cancer. Surg Endosc 2018;32:2442-7. [PMID: 29101570 DOI: 10.1007/s00464-017-5944-8] [Cited by in Crossref: 46] [Cited by in F6Publishing: 33] [Article Influence: 11.5] [Reference Citation Analysis]
401 Habrgama A, Perez R, Proscurshim I, Campos F, Nadalin W, Kiss D, Gamarodrigues J. Patterns of Failure and Survival for Nonoperative Treatment of Stage c0 Distal Rectal Cancer Following Neoadjuvant Chemoradiation Therapy. Journal of Gastrointestinal Surgery 2006;10:1319-29. [DOI: 10.1016/j.gassur.2006.09.005] [Cited by in Crossref: 270] [Cited by in F6Publishing: 213] [Article Influence: 18.0] [Reference Citation Analysis]
402 Wan JF, Zhu J, Li GC, Sun WJ, Zhang Z. Implications for determining the optimal treatment for locally advanced rectal cancer in elderly patients aged 75 years and older. Oncotarget 2015;6:30377-83. [PMID: 26160846 DOI: 10.18632/oncotarget.4599] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
403 Glimelius B. Optimal Time Intervals between Pre-Operative Radiotherapy or Chemoradiotherapy and Surgery in Rectal Cancer? Front Oncol. 2014;4:50. [PMID: 24778990 DOI: 10.3389/fonc.2014.00050] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
404 Motson RW, Khan JS, Arulampalam TH, Austin RC, Lacey N, Sizer B. Laparoscopic total mesorectal excision following long course chemoradiotherapy for locally advanced rectal cancer. Surg Endosc. 2011;25:1753-1760. [PMID: 21533976 DOI: 10.1007/s00464-010-1353-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
405 Sprenger T, Rothe H, Beissbarth T, Conradi LC, Kauffels A, Homayounfar K, Behnes CL, Rödel C, Liersch T, Ghadimi M. [Lymph node metastases in ypT1/2 rectal cancer after neoadjuvant chemoradiotherapy : The Achilles heel of organ-preserving operative procedures?]. Chirurg 2016;87:593-601. [PMID: 27106241 DOI: 10.1007/s00104-016-0170-9] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
406 Jonas J, Bähr R. Neoadjuvant chemoradiation treatment impairs accuracy of MRI staging in rectal carcinoma. Gut 2006;55:1214-5. [PMID: 16849361 DOI: 10.1136/gut.2006.095034] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
407 Dapper H, Oechsner M, Münch S, Borm K, Peeken J, Mayinger M, Combs SE, Habermehl D. Dosimetric analysis and comparison of reduced longitudinal cranial margins of VMAT-IMRT of rectal cancer. Radiat Oncol 2018;13:169. [PMID: 30189877 DOI: 10.1186/s13014-018-1120-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
408 Cristóbal I, Rubio J, Santos A, Torrejón B, Caramés C, Imedio L, Mariblanca S, Luque M, Sanz-Alvarez M, Zazo S, Madoz-Gúrpide J, Rojo F, García-Foncillas J. MicroRNA-199b Downregulation Confers Resistance to 5-Fluorouracil Treatment and Predicts Poor Outcome and Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients. Cancers (Basel) 2020;12:E1655. [PMID: 32580513 DOI: 10.3390/cancers12061655] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
409 Germer CT. [Staging of rectal cancer]. Chirurg 2012;83:421-2. [PMID: 22526932 DOI: 10.1007/s00104-011-2201-x] [Reference Citation Analysis]
410 Song C, Chung JH, Kang SB, Kim DW, Oh HK, Lee HS, Kim JW, Lee KW, Kim JH, Kim JS. Impact of Tumor Regression Grade as a Major Prognostic Factor in Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy: A Proposal for a Modified Staging System. Cancers (Basel). 2018;10. [PMID: 30205529 DOI: 10.3390/cancers10090319] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
411 Mok H, Crane CH, Palmer MB, Briere TM, Beddar S, Delclos ME, Krishnan S, Das P. Intensity modulated radiation therapy (IMRT): differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma. Radiat Oncol. 2011;6:63. [PMID: 21651775 DOI: 10.1186/1748-717X-6-63] [Cited by in Crossref: 58] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
412 O'Connell MJ, Colangelo LH, Beart RW, Petrelli NJ, Allegra CJ, Sharif S, Pitot HC, Shields AF, Landry JC, Ryan DP, Parda DS, Mohiuddin M, Arora A, Evans LS, Bahary N, Soori GS, Eakle J, Robertson JM, Moore DF Jr, Mullane MR, Marchello BT, Ward PJ, Wozniak TF, Roh MS, Yothers G, Wolmark N. Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04. J Clin Oncol. 2014;32:1927-1934. [PMID: 24799484 DOI: 10.1200/jco.2013.53.7753] [Cited by in Crossref: 267] [Cited by in F6Publishing: 117] [Article Influence: 38.1] [Reference Citation Analysis]
413 Li J, Liu H, Yin J, Liu S, Hu J, Du F, Yuan J, Lv B, Fan J, Leng S, Zhang X. Wait-and-see or radical surgery for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy: a cohort study. Oncotarget 2015;6:42354-61. [PMID: 26472284 DOI: 10.18632/oncotarget.6093] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 7.6] [Reference Citation Analysis]
414 Polignano FM, Quyn AJ, Sanjay P, Henderson NA, Tait IS. Totally laparoscopic strategies for the management of colorectal cancer with synchronous liver metastasis. Surg Endosc. 2012;26:2571-2578. [PMID: 22437957 DOI: 10.1007/s00464-012-2235-2.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
415 Corrò C, Dutoit V, Koessler T. Emerging Trends for Radio-Immunotherapy in Rectal Cancer. Cancers (Basel) 2021;13:1374. [PMID: 33803620 DOI: 10.3390/cancers13061374] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
416 Zhang RX, Zhou ZG, Lu SX, Lu ZH, Wan DS, Pan ZZ, Wu XJ, Chen G. Pim-3 as a potential predictor of chemoradiotherapy resistance in locally advanced rectal cancer patients. Sci Rep 2017;7:16043. [PMID: 29167471 DOI: 10.1038/s41598-017-16153-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
417 Krishnamurty DM, Hawkins AT, Wells KO, Mutch MG, Silviera ML, Glasgow SC, Hunt SR, Dharmarajan S. Neoadjuvant Radiation Therapy in Locally Advanced Colon Cancer: a Cohort Analysis. J Gastrointest Surg 2018;22:906-12. [PMID: 29427227 DOI: 10.1007/s11605-018-3676-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
418 Fitzgerald TL, Biswas T, O’brien K, Zervos EE, Wong JH. Neoadjuvant Radiotherapy for Rectal Cancer: Adherence to Evidence-Based Guidelines in Clinical Practice. World J Surg 2013;37:639-45. [DOI: 10.1007/s00268-012-1862-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
419 Gunther JR, Chadha AS, Shin US, Park IJ, Kattepogu KV, Grant JD, Weksberg DC, Eng C, Kopetz SE, Das P, Delclos ME, Kaur H, Maru DM, Skibber JM, Rodriguez-Bigas MA, You YN, Krishnan S, Chang GJ. Preoperative radiation dose escalation for rectal cancer using a concomitant boost strategy improves tumor downstaging without increasing toxicity: A matched-pair analysis. Adv Radiat Oncol 2017;2:455-64. [PMID: 29114614 DOI: 10.1016/j.adro.2017.04.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
420 Xin KY, Ng DW, Tan GH, Teo MC. Role of pelvic exenteration in the management of locally advanced primary and recurrent rectal cancer. J Gastrointest Cancer 2014;45:291-7. [PMID: 24563189 DOI: 10.1007/s12029-014-9586-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
421 Velenik V, Oblak I, Anderluh F. Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancer. Radiat Oncol 2010;5:88. [PMID: 20920276 DOI: 10.1186/1748-717X-5-88] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
422 Zijp JVDVV, Hoekstra HJ, Basson MD. Evolving management of colorectal cancer. World J Gastroenterol 2008; 14(25): 3956-3967 [PMID: 18609678 DOI: 10.3748/wjg.14.3956] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
423 Bellows CF, Jaffe B, Bacigalupo L, Pucciarelli S, Gagliardi G. Clinical significance of magnetic resonance imaging findings in rectal cancer. World J Radiol 2011; 3(4): 92-104 [PMID: 21532870 DOI: 10.4329/wjr.v3.i4.92] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
424 Bottarelli L, De' Angelis GL, Azzoni C, Di Mario F, De' Angelis N, Leandro G, Fornaroli F, Gaiani F, Negri F. Potential predictive biomarkers in locally advanced rectal cancer treated with preoperative chemo-radiotherapy. Acta Biomed 2018;89:102-6. [PMID: 30561402 DOI: 10.23750/abm.v89i9-S.7881] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
425 Zhang Y, Wu Y, Gong ZY, Ye HD, Zhao XK, Li JY, Zhang XM, Li S, Zhu W, Wang M, Liang GY, Liu Y, Guan X, Zhang DY, Shen B. Distinguishing Rectal Cancer from Colon Cancer Based on the Support Vector Machine Method and RNA-sequencing Data. Curr Med Sci 2021;41:368-74. [PMID: 33877555 DOI: 10.1007/s11596-021-2356-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
426 Huang CM, Huang MY, Chen YC, Chen PJ, Su WC, Chang TK, Li CC, Huang CW, Tsai HL, Wang JY. miRNA-148a Enhances the Treatment Response of Patients with Rectal Cancer to Chemoradiation and Promotes Apoptosis by Directly Targeting c-Met. Biomedicines 2021;9:1371. [PMID: 34680492 DOI: 10.3390/biomedicines9101371] [Reference Citation Analysis]
427 Grade M, Ghadimi BM, Varma S, Simon R, Wangsa D, Barenboim-Stapleton L, Liersch T, Becker H, Ried T, Difilippantonio MJ. Aneuploidy-dependent massive deregulation of the cellular transcriptome and apparent divergence of the Wnt/beta-catenin signaling pathway in human rectal carcinomas. Cancer Res 2006;66:267-82. [PMID: 16397240 DOI: 10.1158/0008-5472.CAN-05-2533] [Cited by in Crossref: 44] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
428 Partl R, Magyar M, Hassler E, Langsenlehner T, Kapp KS. Clinical parameters predictive for sphincter-preserving surgery and prognostic outcome in patients with locally advanced low rectal cancer. Radiat Oncol 2020;15:99. [PMID: 32375894 DOI: 10.1186/s13014-020-01554-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
429 Yeom SS, Park IJ, Yang DH, Lee JL, Yoon YS, Kim CW, Lim SB, Park SH, Kim HJ, Yu CS, Kim JC. Variation in the Height of Rectal Cancers According to the Diagnostic Modalities. Ann Coloproctol 2019;35:24-9. [PMID: 30879281 DOI: 10.3393/ac.2018.07.31] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
430 Deorukhkar A, Ahuja N, Mercado AL, Diagaradjane P, Raju U, Patel N, Mohindra P, Diep N, Guha S, Krishnan S. Zerumbone increases oxidative stress in a thiol-dependent ROS-independent manner to increase DNA damage and sensitize colorectal cancer cells to radiation. Cancer Med 2015;4:278-92. [PMID: 25450478 DOI: 10.1002/cam4.367] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.6] [Reference Citation Analysis]
431 Smith FM, Gallagher WM, Fox E, Stephens RB, Rexhepaj E, Petricoin EF 3rd, Liotta L, Kennedy MJ, Reynolds JV. Combination of SELDI-TOF-MS and data mining provides early-stage response prediction for rectal tumors undergoing multimodal neoadjuvant therapy. Ann Surg 2007;245:259-66. [PMID: 17245180 DOI: 10.1097/01.sla.0000245577.68151.bd] [Cited by in Crossref: 57] [Cited by in F6Publishing: 46] [Article Influence: 4.1] [Reference Citation Analysis]
432 Lee JW, Lee JH, Shim BY, Kim SH, Chung MJ, Kye BH, Kim HJ, Cho HM, Jang HS. KRAS Mutation Status Is Not a Predictor for Tumor Response and Survival in Rectal Cancer Patients Who Received Preoperative Radiotherapy With 5-Fluoropyrimidine Followed by Curative Surgery. Medicine (Baltimore) 2015;94:e1284. [PMID: 26252300 DOI: 10.1097/MD.0000000000001284] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
433 Allemani C, Rachet B, Weir HK, Richardson LC, Lepage C, Faivre J, Gatta G, Capocaccia R, Sant M, Baili P. Colorectal cancer survival in the USA and Europe: a CONCORD high-resolution study. BMJ Open. 2013;3:e003055. [PMID: 24022388 DOI: 10.1136/bmjopen-2013-003055] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 6.8] [Reference Citation Analysis]
434 Toiyama Y, Inoue Y, Kawamura M, Kawamoto A, Okugawa Y, Hiro J, Saigusa S, Tanaka K, Mohri Y, Kusunoki M. Elevated platelet count as predictor of recurrence in rectal cancer patients undergoing preoperative chemoradiotherapy followed by surgery. Int Surg 2015;100:199-207. [PMID: 25692418 DOI: 10.9738/INTSURG-D-13-00178.1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
435 VanderWalde NA, Williams GR. Developing an electronic geriatric assessment to improve care of older adults with cancer receiving radiotherapy. Tech Innov Patient Support Radiat Oncol 2020;16:24-9. [PMID: 33385071 DOI: 10.1016/j.tipsro.2020.09.002] [Reference Citation Analysis]
436 Oh SG, Park IJ, Seo JH, Kim YI, Lim SB, Kim CW, Yoon YS, Lee JL, Yu CS, Kim JC. Beware of Early Relapse in Rectal Cancer Patients Treated With Preoperative Chemoradiotherapy. Ann Coloproctol 2020;36:382-9. [PMID: 32674549 DOI: 10.3393/ac.2020.06.11] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
437 Nguyen P, Wuthrick E, Chablani P, Robinson A, Simmons L, Wu C, Arnold M, Harzman AE, Husain S, Schmidt C, Abdel-Misih S, Bekaii-Saab T, Chakravarti A, Williams TM. Does Delaying Surgical Resection After Neoadjuvant Chemoradiation Impact Clinical Outcomes in Locally Advanced Rectal Adenocarcinoma?: A Single-Institution Experience. Am J Clin Oncol 2018;41:140-6. [PMID: 26535992 DOI: 10.1097/COC.0000000000000248] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
438 Huebner M, Wolff BG, Smyrk TC, Aakre J, Larson DW. Partial pathologic response and nodal status as most significant prognostic factors for advanced rectal cancer treated with preoperative chemoradiotherapy. World J Surg. 2012;36:675-683. [PMID: 22270980 DOI: 10.1007/s00268-011-1409-8] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 4.8] [Reference Citation Analysis]
439 Kokelaar RF, Jones H, Beynon J, Evans ME, Harris DA. Meta-analysis of the prognostic value of CpG island methylator phenotype in rectal cancer. Int J Colorectal Dis 2018;33:995-1000. [PMID: 29926233 DOI: 10.1007/s00384-018-3108-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
440 Saklani A, Sugoor P, Bhandare M, Jatal S, Desouza A, Ostwal V. Chemo-Radiation After Upfront Rectal Resections-a Clinical Dilemma. Indian J Surg Oncol 2018;9:495-500. [PMID: 30538378 DOI: 10.1007/s13193-018-0805-z] [Reference Citation Analysis]
441 Glynne-Jones R, Kronfli M. Locally advanced rectal cancer: a comparison of management strategies. Drugs. 2011;71:1153-1177. [PMID: 21711061 DOI: 10.2165/11591330-000000000-00000] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
442 Hathout L, Williams TM, Jabbour SK. The Impact of Novel Radiation Treatment Techniques on Toxicity and Clinical Outcomes In Rectal Cancer. Curr Colorectal Cancer Rep 2017;13:61-72. [PMID: 29445322 DOI: 10.1007/s11888-017-0351-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
443 Kim CA, Ahmed S, Ahmed S, Brunet B, Chalchal H, Deobald R, Doll C, Dupre MP, Gordon V, Lee-Ying RM, Lim H, Liu D, Loree JM, McGhie JP, Mulder K, Park J, Yip B, Wong RP, Zaidi A; Western Canadian Gastrointestinal Cancer Group. Report from the 19th annual Western Canadian Gastrointestinal Cancer Consensus Conference; Winnipeg, Manitoba; 29-30 September 2017. Curr Oncol 2018;25:275-84. [PMID: 30111968 DOI: 10.3747/co.25.4109] [Reference Citation Analysis]
444 Duldulao MP, Lee W, Streja L, Chu P, Li W, Chen Z, Kim J, Garcia-Aguilar J. Distribution of residual cancer cells in the bowel wall after neoadjuvant chemoradiation in patients with rectal cancer. Dis Colon Rectum 2013;56:142-9. [PMID: 23303141 DOI: 10.1097/DCR.0b013e31827541e2] [Cited by in Crossref: 54] [Cited by in F6Publishing: 25] [Article Influence: 6.8] [Reference Citation Analysis]
445 Bhangu A, Nightingale P, Daniels D, Tiramula R. Neoadjuvant chemoradiotherapy, sepsis and neutrophil levels following radical excision of rectal cancer. Int J Colorectal Dis 2010;25:723-9. [PMID: 20177689 DOI: 10.1007/s00384-010-0886-9] [Reference Citation Analysis]
446 Dehdashti F, Grigsby PW, Myerson RJ, Nalbantoglu I, Ma C, Siegel BA. Positron emission tomography with [(18)F]-3'-deoxy-3'fluorothymidine (FLT) as a predictor of outcome in patients with locally advanced resectable rectal cancer: a pilot study. Mol Imaging Biol 2013;15:106-13. [PMID: 22684813 DOI: 10.1007/s11307-012-0566-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
447 Park J, Chang KJ, Seo YS, Byun BH, Choi JH, Moon H, Lim I, Kim BI, Choi CW, Lim SM. Tumor SUVmax Normalized to Liver Uptake on (18)F-FDG PET/CT Predicts the Pathologic Complete Response After Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. Nucl Med Mol Imaging 2014;48:295-302. [PMID: 26396634 DOI: 10.1007/s13139-014-0289-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
448 Noguchi M, Shitara K, Kawazoe A, Yamamoto D, Takii Y, Saito Y, Sato T, Horimatsu T, Ishikawa H, Ito Y, Ito M, Ikematsu H. Short-term safety of adjuvant chemoradiotherapy after local resection for patients with high-risk submucosal invasive rectal cancer: a single-arm, multicenter phase II trial. Jpn J Clin Oncol 2021;51:707-12. [PMID: 33558891 DOI: 10.1093/jjco/hyaa260] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
449 Tominaga T, Akiyoshi T, Yamamoto N, Taguchi S, Mori S, Nagasaki T, Fukunaga Y, Ueno M. Clinical significance of soluble programmed cell death-1 and soluble programmed cell death-ligand 1 in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. PLoS One 2019;14:e0212978. [PMID: 30807610 DOI: 10.1371/journal.pone.0212978] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
450 Kleiman A, Al-Khamis A, Farsi A, Kezouh A, Vuong T, Gordon PH, Vasilevsky CA, Morin N, Faria J, Ghitulescu G, Boutros M. Normalization of CEA Levels Post-Neoadjuvant Therapy is a Strong Predictor of Pathologic Complete Response in Rectal Cancer. J Gastrointest Surg. 2015;19:1106-1112. [PMID: 25859755 DOI: 10.1007/s11605-015-2814-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
451 Hotchi M, Shimada M, Kurita N, Iwata T, Sato H, Morimoto S, Yoshikawa K, Higashijima J, Miyatani T. microRNA expression is able to predict response to chemoradiotherapy in rectal cancer. Mol Clin Oncol. 2013;1:137-142. [PMID: 24649136 DOI: 10.3892/mco.2012.9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
452 Bushati M, Pucciarelli S, Gennaro N, Maretto I, Toppan P, Perin A, Urso EDL, Bagatella A, Spolverato G. Local excision in rectal cancer patients with major or complete clinical response after neoadjuvant therapy: a case-matched study. Int J Colorectal Dis 2019;34:2129-36. [PMID: 31724079 DOI: 10.1007/s00384-019-03420-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
453 Chen Z, Duldulao MP, Li W, Lee W, Kim J, Garcia-Aguilar J. Molecular diagnosis of response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer. J Am Coll Surg 2011;212:1008-1017.e1. [PMID: 21458303 DOI: 10.1016/j.jamcollsurg.2011.02.024] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
454 Binefa G, Rodríguez-Moranta F, Teule &, Medina-Hayas M. Colorectal cancer: From prevention to personalized medicine. World J Gastroenterol 2014; 20(22): 6786-6808 [PMID: 24944469 DOI: 10.3748/wjg.v20.i22.6786] [Cited by in CrossRef: 155] [Cited by in F6Publishing: 146] [Article Influence: 22.1] [Reference Citation Analysis]
455 Kim K, Yeo SG, Yoo BC. Identification of hypoxanthine and phosphoenolpyruvic Acid as serum markers of chemoradiotherapy response in locally advanced rectal cancer. Cancer Res Treat. 2015;47:78-89. [PMID: 25143052 DOI: 10.4143/crt.2013.127] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
456 Carsin AE, Sharp L, Cronin-Fenton DP, Céilleachair AO, Comber H. Inequity in colorectal cancer treatment and outcomes: a population-based study. Br J Cancer 2008;99:266-74. [PMID: 18594530 DOI: 10.1038/sj.bjc.6604467] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
457 Peterson CY, Weiser MR. Robotic colorectal surgery. J Gastrointest Surg 2014;18:398-403. [PMID: 23949476 DOI: 10.1007/s11605-013-2313-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
458 Meng Y, Zhang C, Zou S, Zhao X, Xu K, Zhang H, Zhou C. MRI texture analysis in predicting treatment response to neoadjuvant chemoradiotherapy in rectal cancer. Oncotarget. 2018;9:11999-12008. [PMID: 29552288 DOI: 10.18632/oncotarget.23813] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
459 Roh MS, Colangelo LH, O'Connell MJ, Yothers G, Deutsch M, Allegra CJ, Kahlenberg MS, Baez-Diaz L, Ursiny CS, Petrelli NJ. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol. 2009;27:5124-5130. [PMID: 19770376 DOI: 10.1200/JCO. 2009.22.0467] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
460 Cho YB, Chun H, Kim MJ, Choi JY, Park C, Kim B, Lee SJ, Yun SH, Kim HC, Lee WY. Accuracy of MRI and 18F-FDG PET/CT for Restaging After Preoperative Concurrent Chemoradiotherapy for Rectal Cancer. World J Surg 2009;33:2688-94. [DOI: 10.1007/s00268-009-0248-3] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 3.2] [Reference Citation Analysis]
461 Tsoulfas G, Pramateftakis MG, Kanellos I. Surgical treatment of hepatic metastases from colorectal cancer. World J Gastrointest Oncol 2011; 3(1): 1-9 [PMID: 21267397 DOI: 10.4251/wjgo.v3.i1.1] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
462 Yang X, Yang S, Hu T, Gu C, Wei M, Deng X, Wang Z, Zhou Z. What is the role of lateral lymph node dissection in rectal cancer patients with clinically suspected lateral lymph node metastasis after preoperative chemoradiotherapy? A meta-analysis and systematic review. Cancer Med 2020;9:4477-89. [PMID: 32352659 DOI: 10.1002/cam4.2643] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
463 Hiroishi K, Inomata M, Kashima K, Yasuda K, Shiraishi N, Yokoyama S, Kitano S. Cancer stem cell-related factors are associated with the efficacy of pre-operative chemoradiotherapy for locally advanced rectal cancer. Exp Ther Med 2011;2:465-70. [PMID: 22977526 DOI: 10.3892/etm.2011.243] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
464 Das P, Eng C, Rodriguez-Bigas MA, Chang GJ, Skibber JM, You YN, Maru DM, Munsell MF, Clemons MV, Kopetz SE, Garrett CR, Shureiqi I, Delclos ME, Krishnan S, Crane CH. Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal cancer: a phase 1 trial. Int J Radiat Oncol Biol Phys 2014;88:301-5. [PMID: 24315563 DOI: 10.1016/j.ijrobp.2013.10.034] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
465 Mihmanlı M, Kabul Gürbulak E, Akgün İE, Celayir MF, Yazıcı P, Tunçel D, Bek TT, Öz A, Ömeroğlu S. Delaying surgery after neoadjuvant chemoradiotherapy improves prognosis of rectal cancer. World J Gastrointest Oncol 2016; 8(9): 695-706 [PMID: 27672428 DOI: 10.4251/wjgo.v8.i9.695] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
466 Rovers KP, Bakkers C, Simkens GAAM, Burger JWA, Nienhuijs SW, Creemers GM, Thijs AMJ, Brandt-Kerkhof ARM, Madsen EVE, Ayez N, de Boer NL, van Meerten E, Tuynman JB, Kusters M, Sluiter NR, Verheul HMW, van der Vliet HJ, Wiezer MJ, Boerma D, Wassenaar ECE, Los M, Hunting CB, Aalbers AGJ, Kok NFM, Kuhlmann KFD, Boot H, Chalabi M, Kruijff S, Been LB, van Ginkel RJ, de Groot DJA, Fehrmann RSN, de Wilt JHW, Bremers AJA, de Reuver PR, Radema SA, Herbschleb KH, van Grevenstein WMU, Witkamp AJ, Koopman M, Haj Mohammad N, van Duyn EB, Mastboom WJB, Mekenkamp LJM, Nederend J, Lahaye MJ, Snaebjornsson P, Verhoef C, van Laarhoven HWM, Zwinderman AH, Bouma JM, Kranenburg O, van 't Erve I, Fijneman RJA, Dijkgraaf MGW, Hemmer PHJ, Punt CJA, Tanis PJ, de Hingh IHJT; Dutch Peritoneal Oncology Group (DPOG)., Dutch Colorectal Cancer Group (DCCG). Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6). BMC Cancer 2019;19:390. [PMID: 31023318 DOI: 10.1186/s12885-019-5545-0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 18.0] [Reference Citation Analysis]
467 García Cabezas S, Palacios Eito A, Martínez Paredes M, Rivin del Campo E. Radiotherapy in rectal cancer: development, adequacy and radiotherapy utilisation rate. A comparative analysis with the most frequent tumour sites. Clin Transl Oncol 2011;13:115-20. [PMID: 21324800 DOI: 10.1007/s12094-011-0628-7] [Reference Citation Analysis]
468 Guimas V, Boustani J, Schipman B, Lescut N, Puyraveau M, Bosset JF, Servagi-Vernat S. Preoperative Chemoradiotherapy for Rectal Cancer in Patients Aged 75 Years and Older: Acute Toxicity, Compliance with Treatment, and Early Results. Drugs Aging 2016;33:419-25. [PMID: 27138958 DOI: 10.1007/s40266-016-0367-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
469 Gröne J, Kreis ME. [Personalized treatment of colorectal cancer in old age]. Chirurg 2013;84:305-9. [PMID: 23494055 DOI: 10.1007/s00104-012-2452-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
470 Yoon HI, Koom WS, Kim TH, Ahn JB, Jung M, Kim TI, Kim H, Shin SJ, Kim NK. Upfront Systemic Chemotherapy and Short-Course Radiotherapy with Delayed Surgery for Locally Advanced Rectal Cancer with Distant Metastases: Outcomes, Compliance, and Favorable Prognostic Factors. PLoS One 2016;11:e0161475. [PMID: 27536871 DOI: 10.1371/journal.pone.0161475] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
471 Huang CW, Su WC, Yin TC, Chen PJ, Chang TK, Chen YC, Li CC, Hsieh YC, Tsai HL, Wang JY. Time interval between the completion of radiotherapy and robotic-assisted surgery among patients with stage I-III rectal cancer undergoing preoperative chemoradiotherapy. PLoS One 2020;15:e0240742. [PMID: 33064768 DOI: 10.1371/journal.pone.0240742] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
472 Pham TT, Liney G, Wong K, Henderson C, Rai R, Graham PL, Borok N, Truong MX, Lee M, Shin JS, Hudson M, Barton MB. Multi-parametric magnetic resonance imaging assessment of whole tumour heterogeneity for chemoradiotherapy response prediction in rectal cancer. Phys Imaging Radiat Oncol 2021;18:26-33. [PMID: 34258404 DOI: 10.1016/j.phro.2021.03.003] [Reference Citation Analysis]
473 Bisschop C, van Dijk TH, Beukema JC, Jansen RLH, Gelderblom H, de Jong KP, Rutten HJT, van de Velde CJH, Wiggers T, Havenga K, Hospers GAP. Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer: Long-Term Results of a Phase II Study. Ann Surg Oncol 2017;24:2632-8. [PMID: 28560600 DOI: 10.1245/s10434-017-5897-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
474 Yang J, Lin Y, Huang Y, Jin J, Zou S, Zhang X, Li H, Feng T, Chen J, Zuo Z, Zheng J, Li Y, Gao G, Wu C, Tan W, Lin D. Genome landscapes of rectal cancer before and after preoperative chemoradiotherapy. Theranostics 2019;9:6856-66. [PMID: 31660073 DOI: 10.7150/thno.37794] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
475 Conradi LC, Bleckmann A, Schirmer M, Sprenger T, Jo P, Homayounfar K, Wolff HA, Rothe H, Middel P, Becker H, Ghadimi MB, Beissbarth T, Liersch T. Thymidylate synthase as a prognostic biomarker for locally advanced rectal cancer after multimodal treatment. Ann Surg Oncol 2011;18:2442-52. [PMID: 21347782 DOI: 10.1245/s10434-011-1608-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
476 Ryan ÉJ, Creavin B, Sheahan K. Delivery of Personalized Care for Locally Advanced Rectal Cancer: Incorporating Pathological, Molecular Genetic, and Immunological Biomarkers Into the Multimodal Paradigm. Front Oncol 2020;10:1369. [PMID: 32923389 DOI: 10.3389/fonc.2020.01369] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
477 Peng JH, Lin JZ, Rong YM, Zhu Y, Deng YX, Zhao YJ, Lu ZH, Wu XJ, Pan ZZ. Oxaliplatin-containing adjuvant chemotherapy improves the survival of locally advanced rectal cancer patients with pathological complete response after pre-operative chemoradiotherapy. Gastroenterol Rep (Oxf) 2018;6:195-201. [PMID: 30151204 DOI: 10.1093/gastro/goy009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
478 Peng HH, Liao ZW, Lin XD, Qiu XS, You KY. Definitive radiotherapy or chemoradiotherapy for distal rectal cancer with early stage of cT1-2N0. Cancer Manag Res 2019;11:5221-9. [PMID: 31354342 DOI: 10.2147/CMAR.S198113] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
479 Yang XH, Li KG, Wei JB, Wu CH, Liang SX, Mo XW, Chen JS, Tang WZ, Qu S. Retrospective study of preoperative chemoradiotherapy with capecitabine versus capecitabine plus oxaliplatin for locally advanced rectal cancer. Sci Rep 2020;10:12539. [PMID: 32719436 DOI: 10.1038/s41598-020-69573-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
480 Däster S, Eppenberger-Castori S, Hirt C, Zlobec I, Delko T, Nebiker CA, Soysal SD, Amicarella F, Iezzi G, Sconocchia G. High frequency of CD8 positive lymphocyte infiltration correlates with lack of lymph node involvement in early rectal cancer. Dis Markers. 2014;2014:792183. [PMID: 25609852 DOI: 10.1155/2014/792183] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
481 Schwaab J, Horisberger K, Ströbel P, Bohn B, Gencer D, Kähler G, Kienle P, Post S, Wenz F, Hofmann WK, Hofheinz RD, Erben P. Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy. BMC Cancer 2011;11:363. [PMID: 21854597 DOI: 10.1186/1471-2407-11-363] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
482 Loftås P, Sturludóttir M, Hallböök O, Almlöv K, Arbman G, Blomqvist L. Assessment of remaining tumour involved lymph nodes with MRI in patients with complete luminal response after neoadjuvant treatment of rectal cancer. Br J Radiol 2018;91:20170938. [PMID: 29668301 DOI: 10.1259/bjr.20170938] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
483 Salazar R, Capdevila J, Laquente B, Manzano JL, Pericay C, Villacampa MM, López C, Losa F, Safont MJ, Gómez A, Alonso V, Escudero P, Gallego J, Sastre J, Grávalos C, Biondo S, Palacios A, Aranda E. A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features. BMC Cancer 2015;15:60. [PMID: 25886378 DOI: 10.1186/s12885-015-1053-z] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
484 Ott OJ, Gani C, Lindner LH, Schmidt M, Lamprecht U, Abdel-Rahman S, Hinke A, Weissmann T, Hartmann A, Issels RD, Zips D, Belka C, Grützmann R, Fietkau R. Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer. Cancers (Basel) 2021;13:1279. [PMID: 33805731 DOI: 10.3390/cancers13061279] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
485 Wittekind C, Oberschmid B. [Pathological staging and response evaluation of rectal carcinoma]. Chirurg 2012;83:423-9. [PMID: 22422083 DOI: 10.1007/s00104-011-2205-6] [Reference Citation Analysis]
486 Ng SY, Colborn KL, Cambridge L, Cercek A, Reidy-Lagunes DL, Segal N, Stadler Z, Saltz LB, Paty PB, Guillem J, Weiser MR, Nash G, Garcia-Aguilar J, Goodman KA. Induction Chemotherapy Reduces Patient-reported Toxicities During Neoadjuvant Chemoradiation with Intensity Modulated Radiotherapy for Rectal Cancer. Clin Colorectal Cancer 2019;18:167-74. [PMID: 31104990 DOI: 10.1016/j.clcc.2019.04.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
487 Kim CW, Kang BM, Kim IY, Kim JY, Park SJ, Park WC, Bae KB, Bae BN, Baek SK, Baik SH, Son GM, Lee YS, Lee SH. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE). BMC Cancer 2018;18:538. [PMID: 29739356 DOI: 10.1186/s12885-018-4466-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
488 Richardson DP, Porter GA, Johnson PM. Self-reported practice patterns and knowledge of rectal cancer care among Canadian general surgeons. Can J Surg 2014;57:385-90. [PMID: 25421080 DOI: 10.1503/cjs.001814] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
489 Colbert LE, Hall WA, Nickleach D, Switchenko J, Kooby DA, Liu Y, Gillespie T, Lipscomb J, Kauh J, Landry JC. Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base. Cancer 2014;120:499-506. [PMID: 24390739 DOI: 10.1002/cncr.28530] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
490 Moreno García V, Cejas P, Blanco Codesido M, Feliu Batlle J, de Castro Carpeño J, Belda-iniesta C, Barriuso J, Sánchez JJ, Larrauri J, González-barón M, Casado E. Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapy. Int J Colorectal Dis 2009;24:741-8. [DOI: 10.1007/s00384-009-0682-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
491 Wang H, Du K, Qu J, Chandarana H, Das IJ. Dosimetric evaluation of magnetic resonance-generated synthetic CT for radiation treatment of rectal cancer. PLoS One 2018;13:e0190883. [PMID: 29304105 DOI: 10.1371/journal.pone.0190883] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
492 Croner RS, Sevim M, Metodiev MV, Jo P, Ghadimi M, Schellerer V, Brunner M, Geppert C, Rau T, Stürzl M, Naschberger E, Matzel KE, Hohenberger W, Lottspeich F, Kellermann J. Identification of Predictive Markers for Response to Neoadjuvant Chemoradiation in Rectal Carcinomas by Proteomic Isotope Coded Protein Label (ICPL) Analysis. Int J Mol Sci 2016;17:209. [PMID: 26861291 DOI: 10.3390/ijms17020209] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
493 Ishikawa D, Nishi M, Takasu C, Kashihara H, Tokunaga T, Higashijima J, Yoshikawa K, Shimada M. The Role of Neutrophil-to-lymphocyte Ratio on the Effect of CRT for Patients With Rectal Cancer. In Vivo 2020;34:863-8. [PMID: 32111796 DOI: 10.21873/invivo.11850] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
494 Oh SY, Heo J, Noh OK, Chun M, Cho O, Oh YT. Absolute Lymphocyte Count in Preoperative Chemoradiotherapy for Rectal Cancer: Changes Over Time and Prognostic Significance. Technol Cancer Res Treat 2018;17:1533033818780065. [PMID: 29909729 DOI: 10.1177/1533033818780065] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
495 Wang X, Jin J, Yang Y, Liu WY, Ren H, Feng YR, Xiao Q, Li N, Deng L, Fang H, Jing H, Lu NN, Tang Y, Wang JY, Wang SL, Wang WH, Song YW, Liu YP, Li YX. Adjuvant treatment may benefit patients with high-risk upper rectal cancer: A nomogram and recursive partitioning analysis of 547 patients. Oncotarget 2016;7:66160-9. [PMID: 27449095 DOI: 10.18632/oncotarget.10718] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
496 Kessler H, Hohenberger W. Extended lymphadenectomy in colon cancer is crucial. World J Surg 2013;37:1789-98. [PMID: 23754141 DOI: 10.1007/s00268-013-2130-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
497 Tie J, Cohen JD, Wang Y, Li L, Christie M, Simons K, Elsaleh H, Kosmider S, Wong R, Yip D, Lee M, Tran B, Rangiah D, Burge M, Goldstein D, Singh M, Skinner I, Faragher I, Croxford M, Bampton C, Haydon A, Jones IT, S Karapetis C, Price T, Schaefer MJ, Ptak J, Dobbyn L, Silliman N, Kinde I, Tomasetti C, Papadopoulos N, Kinzler K, Volgestein B, Gibbs P. Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study. Gut 2019;68:663-71. [PMID: 29420226 DOI: 10.1136/gutjnl-2017-315852] [Cited by in Crossref: 101] [Cited by in F6Publishing: 103] [Article Influence: 33.7] [Reference Citation Analysis]
498 Saigusa S, Toiyama Y, Tanaka K, Inoue Y, Mori K, Ide S, Imaoka H, Kawamura M, Mohri Y, Kusunoki M. Prognostic relevance of stromal CD26 expression in rectal cancer after chemoradiotherapy. Int J Clin Oncol 2016;21:350-8. [PMID: 26370256 DOI: 10.1007/s10147-015-0902-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
499 Jacobi N, Gieseler F. [Diagnosis and treatment of rectal cancer]. Med Klin (Munich) 2010;105:730-6. [PMID: 20981593 DOI: 10.1007/s00063-010-1125-7] [Reference Citation Analysis]
500 Kim H, Myoung S, Koom WS, Kim NK, Kim MJ, Ahn JB, Hur H, Lim JS. MRI Risk Stratification for Tumor Relapse in Rectal Cancer Achieving Pathological Complete Remission after Neoadjuvant Chemoradiation Therapy and Curative Resection. PLoS One 2016;11:e0146235. [PMID: 26730717 DOI: 10.1371/journal.pone.0146235] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
501 Aghili M, Khalili N, Khalili N, Babaei M, Farhan F, Haddad P, Salarvand S, Keshvari A, Fazeli MS, Mohammadi N, Ghalehtaki R. Short-course versus long-course neoadjuvant chemoradiotherapy in patients with rectal cancer: preliminary results of a randomized controlled trial. Radiat Oncol J 2020;38:119-28. [PMID: 33012155 DOI: 10.3857/roj.2020.00115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
502 Keilholz L, Mese M, Henneking K, Willner J. Effect of total mesorectal excision on the outcome of rectal cancer after standardized postoperative radiochemotherapy: do randomized studies translate into clinical routine? Strahlenther Onkol 2009;185:364-70. [PMID: 19506819 DOI: 10.1007/s00066-009-1940-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
503 Yamashita H, Takenaka R, Sakumi A, Haga A, Otomo K, Nakagawa K. Analysis of motion of the rectum during preoperative intensity modulated radiation therapy for rectal cancer using cone-beam computed tomography. Radiat Oncol 2015;10:2. [PMID: 25566869 DOI: 10.1186/s13014-014-0311-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
504 Siegel R, Cuesta MA, Targarona E, Bader FG, Morino M, Corcelles R, Lacy AM, Påhlman L, Haglind E, Bujko K, Bruch HP, Heiss MM, Eikermann M, Neugebauer EA; European Association for Endoscopic Surgery (EAES). Laparoscopic extraperitoneal rectal cancer surgery: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc 2011;25:2423-40. [PMID: 21701921 DOI: 10.1007/s00464-011-1805-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
505 Lin JC, Tsai JT, Chen LJ, Li MH, Liu WH. Compared planning dosimetry of TOMO, VMAT and IMRT in rectal cancer with different simulated positions. Oncotarget 2017;8:42020-9. [PMID: 28159930 DOI: 10.18632/oncotarget.14923] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
506 Puglisi C, Giuffrida R, Borzì G, Di Mattia P, Costa A, Colarossi C, Deiana E, Picardo MC, Colarossi L, Mare M, Marino L, Di Grazia A, Forte S. Radiosensitivity of Cancer Stem Cells Has Potential Predictive Value for Individual Responses to Radiotherapy in Locally Advanced Rectal Cancer. Cancers (Basel) 2020;12:E3672. [PMID: 33297488 DOI: 10.3390/cancers12123672] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
507 Sung S, Son SH, Kay CS, Lee YS. Prognosis Can Be Predicted More Accurately Using Pre- and Postchemoradiotherapy Carcinoembryonic Antigen Levels Compared to Only Prechemoradiotherapy Carcinoembryonic Antigen Level in Locally Advanced Rectal Cancer Patients Who Received Neoadjuvant Chemoradiotherapy. Medicine (Baltimore) 2016;95:e2965. [PMID: 26962798 DOI: 10.1097/MD.0000000000002965] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
508 Sprenger T, Rothe H, Homayounfar K, Beissbarth T, Ghadimi BM, Becker H, Liersch T. Preoperative chemoradiotherapy does not necessarily reduce lymph node retrieval in rectal cancer specimens--results from a prospective evaluation with extensive pathological work-up. J Gastrointest Surg 2010;14:96-103. [PMID: 19830503 DOI: 10.1007/s11605-009-1057-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
509 Velenik V, Zadnik V, Omejc M, Grosek J, Tuta M. Influence of concurrent capecitabine based chemoradiotherapy with bevacizumab on the survival rate, late toxicity and health-related quality of life in locally advanced rectal cancer: a prospective phase II CRAB trial. Radiol Oncol 2020;54:461-9. [PMID: 32738130 DOI: 10.2478/raon-2020-0043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
510 Finlay I. Preoperative staging for rectal cancer. BMJ 2006;333:766-7. [PMID: 17038713 DOI: 10.1136/bmj.38996.423102.BE] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
511 Popek S, Tsikitis VL. Neoadjuvant vs adjuvant pelvic radiotherapy for locally advanced rectal cancer: Which is superior? World J Gastroenterol 2011; 17(7): 848-854 [PMID: 21412494 DOI: 10.3748/wjg.v17.i7.848] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
512 Glimelius B. Adjuvant chemotherapy. Eur J Cancer Suppl. 2013;11:72-79. [PMID: 26217115 DOI: 10.1016/j.ejcsup.2013.07.034] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
513 Piraux E, Caty G, Aboubakar Nana F, Reychler G. Effects of exercise therapy in cancer patients undergoing radiotherapy treatment: a narrative review. SAGE Open Med 2020;8:2050312120922657. [PMID: 32595968 DOI: 10.1177/2050312120922657] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
514 Ogura A, Konishi T, Beets GL, Cunningham C, Garcia-Aguilar J, Iversen H, Toda S, Lee IK, Lee HX, Uehara K, Lee P, Putter H, van de Velde CJH, Rutten HJT, Tuynman JB, Kusters M; Lateral Node Study Consortium. Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated With Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or Radiotherapy. JAMA Surg 2019;154:e192172. [PMID: 31268504 DOI: 10.1001/jamasurg.2019.2172] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 22.0] [Reference Citation Analysis]
515 Marquardt F, Rödel F, Capalbo G, Weiss C, Rödel C. Molecular targeted treatment and radiation therapy for rectal cancer. Strahlenther Onkol. 2009;185:371-378. [PMID: 19506820 DOI: 10.1007/s00066-009-1936-5] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
516 Kim SH, Kim JH, Jung SH. Comparison of oncologic outcomes of metastatic rectal cancer patients with or without neoadjuvant chemoradiotherapy.Int J Colorectal Dis. 2015;30:1193-1199. [PMID: 26072129 DOI: 10.1007/s00384-015-2272-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
517 Miyakita H, Sadahiro S, Suzuki T, Chan LF, Ogimi T, Okada K, Yamamoto S, Kajiwara H. Tumor-Infiltrating Lymphocytes in Biopsy Specimens Obtained 7 Days after Starting Chemoradiotherapy for Rectal Cancer Are Predictors of the Response to Chemoradiotherapy. Oncology 2020;98:869-75. [PMID: 32799200 DOI: 10.1159/000508922] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
518 Ugidos L, Delgado S, Conill C, Ginés A, Gallego R, Ayuso JR, Miquel R, Tosca M, de Lacy A, Castells A. Phase I trial of neoadjuvant chemoradiotherapy (CRT) with capecitabine and weekly irinotecan followed by laparoscopic total mesorectal excision (LTME) in rectal cancer patients. Invest New Drugs. 2009;27:262-268. [PMID: 18923810 DOI: 10.1007/s10637-008-9192-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
519 Chang JS, Yoon HI, Cha HJ, Chung Y, Cho Y, Keum KC, Koom WS. Bladder filling variations during concurrent chemotherapy and pelvic radiotherapy in rectal cancer patients: early experience of bladder volume assessment using ultrasound scanner. Radiat Oncol J 2013;31:41-7. [PMID: 23620868 DOI: 10.3857/roj.2013.31.1.41] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
520 Wong CS, Chu W, Ashamalla S, Fenech D, Berry S, Kiss A, Koritzinsky M. Metformin with neoadjuvant chemoradiation to improve pathologic response in rectal cancer: A pilot phase I/II trial. Clin Transl Radiat Oncol 2021;30:60-4. [PMID: 34401534 DOI: 10.1016/j.ctro.2021.07.001] [Reference Citation Analysis]
521 Zhu J, Liu A, Sun X, Liu L, Zhu Y, Zhang T, Jia J, Tan S, Wu J, Wang X, Zhou J, Yang J, Zhang C, Zhang H, Zhao Y, Cai G, Zhang W, Xia F, Wan J, Zhang H, Shen L, Cai S, Zhang Z. Multicenter, Randomized, Phase III Trial of Neoadjuvant Chemoradiation With Capecitabine and Irinotecan Guided by UGT1A1 Status in Patients With Locally Advanced Rectal Cancer. J Clin Oncol 2020;38:4231-9. [PMID: 33119477 DOI: 10.1200/JCO.20.01932] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
522 Pepek JM, Chino JP, Willett CG, Palta M, Blazer Iii DG, Tyler DS, Uronis HE, Czito BG. Preoperative chemoradiotherapy for locally advanced gastric cancer. Radiat Oncol 2013;8:6. [PMID: 23286735 DOI: 10.1186/1748-717X-8-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
523 Yoon WH, Kim HJ, Kim CH, Joo JK, Kim YJ, Kim HR. Oncologic impact of pathologic response on clinical outcome after preoperative chemoradiotherapy in locally advanced rectal cancer. Ann Surg Treat Res 2015;88:15-20. [PMID: 25553320 DOI: 10.4174/astr.2015.88.1.15] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
524 Yu M, Jang HS, Jeon DM, Cheon GS, Lee HC, Chung MJ, Kim SH, Lee JH. Dosimetric evaluation of Tomotherapy and four-box field conformal radiotherapy in locally advanced rectal cancer. Radiat Oncol J 2013;31:252-9. [PMID: 24501715 DOI: 10.3857/roj.2013.31.4.252] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
525 Zhang J, Cai Y, Hu H, Lan P, Wang L, Huang M, Kang L, Wu X, Wang H, Ling J, Xiao J, Wang J, Deng Y. Nomogram basing pre-treatment parameters predicting early response for locally advanced rectal cancer with neoadjuvant chemotherapy alone: a subgroup efficacy analysis of FOWARC study. Oncotarget. 2016;7:5053-5062. [PMID: 26646794 DOI: 10.18632/oncotarget.6469] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
526 Tang M, Lu X, Zhang C, Du C, Cao L, Hou T, Li Z, Tu B, Cao Z, Li Y, Chen Y, Jiang L, Wang H, Wang L, Liu B, Xu X, Luo J, Wang J, Gu J, Wang H, Zhu WG. Downregulation of SIRT7 by 5-fluorouracil induces radiosensitivity in human colorectal cancer. Theranostics 2017;7:1346-59. [PMID: 28435470 DOI: 10.7150/thno.18804] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 9.3] [Reference Citation Analysis]
527 Keller DS, Berho M, Perez RO, Wexner SD, Chand M. The multidisciplinary management of rectal cancer.Nat Rev Gastroenterol Hepatol. 2020;17:414-429. [PMID: 32203400 DOI: 10.1038/s41575-020-0275-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 11.0] [Reference Citation Analysis]
528 Bohanes P, Rankin CJ, Blanke CD, Winder T, Ulrich CM, Smalley SR, Rich TA, Martensen JA, Benson AB, Mayer RJ. Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation. Clin Cancer Res. 2015;21:1583-1590. [PMID: 25589620 DOI: 10.1158/1078-0432.ccr-14-0857] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
529 Saklani AP, Lim DR, Hur H, Min BS, Baik SH, Lee KY, Kim NK. Robotic versus laparoscopic surgery for mid-low rectal cancer after neoadjuvant chemoradiation therapy: comparison of oncologic outcomes. Int J Colorectal Dis. 2013;28:1689-1698. [PMID: 23948968 DOI: 10.1007/s00384-013-1756-z] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 6.0] [Reference Citation Analysis]
530 Kuo YH, Lai CH, Huang CY, Chen CJ, Huang YC, Huang WS, Chin CC. Monthly tegafur-uracil maintenance for increasing relapse-free survival in ypStage III rectal cancer patients after preoperative radiotherapy, radical resection, and 12 postoperative chemotherapy cycles: a retrospective study. BMC Cancer 2019;19:815. [PMID: 31419963 DOI: 10.1186/s12885-019-6019-0] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
531 Yin TC, Su WC, Chen PJ, Chang TK, Chen YC, Li CC, Hsieh YC, Tsai HL, Huang CW, Wang JY. Oncological Outcomes of Robotic-Assisted Surgery With High Dissection and Selective Ligation Technique for Sigmoid Colon and Rectal Cancer. Front Oncol 2020;10:570376. [PMID: 33194663 DOI: 10.3389/fonc.2020.570376] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
532 Zheng C, Jiang F, Lin H, Li S. Clinical characteristics and prognosis of different primary tumor location in colorectal cancer: a population-based cohort study. Clin Transl Oncol 2019;21:1524-31. [PMID: 30875062 DOI: 10.1007/s12094-019-02083-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
533 Rouleau-Fournier F, Brown CJ. Can less be more? Organ preservation strategies in the management of rectal cancer. Curr Oncol 2019;26:S16-23. [PMID: 31819706 DOI: 10.3747/co.26.5841] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
534 Kuipers EJ, Grady WM, Lieberman D, Seufferlein T, Sung JJ, Boelens PG, van de Velde CJ, Watanabe T. Colorectal cancer. Nat Rev Dis Primers. 2015;1:15065. [PMID: 27189416 DOI: 10.1038/nrdp.2015.65] [Cited by in Crossref: 485] [Cited by in F6Publishing: 484] [Article Influence: 80.8] [Reference Citation Analysis]
535 Tey J, Leong CN, Cheong WK, Sze TG, Yong WP, Tham IWK, Lee KM. A phase II trial of preoperative concurrent chemotherapy and dose escalated intensity modulated radiotherapy (IMRT) for locally advanced rectal cancer. J Cancer 2017;8:3114-21. [PMID: 29158782 DOI: 10.7150/jca.21237] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
536 Grim J, Hroch M, Chládek J, Petera J, Martínková J. Kinetically guided neoadjuvant chemoradiotherapy based on 5-Fluorouracil in patients with locally advanced rectal cancer. Clin Pharmacokinet 2015;54:503-15. [PMID: 25503423 DOI: 10.1007/s40262-014-0216-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
537 Ahn BH, Lee KH, Park JB, Song MS, Kim JY, Kim JS. Short-term outcomes after laparoscopic surgery following preoperative chemoradiotherapy for rectal cancer. J Korean Surg Soc 2012;83:281-7. [PMID: 23166887 DOI: 10.4174/jkss.2012.83.5.281] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
538 Zhang JW, Cai Y, Xie XY, Hu HB, Ling JY, Wu ZH, Lan P, Wu XJ, Huang MJ, Wang H, Kang L, Zhou ZY, Wang JP, Deng YH. Nomogram for predicting pathological complete response and tumor downstaging in patients with locally advanced rectal cancer on the basis of a randomized clinical trial. Gastroenterol Rep (Oxf) 2020;8:234-41. [PMID: 32665855 DOI: 10.1093/gastro/goz073] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
539 Liersch T, Grade M, Gaedcke J, Varma S, Difilippantonio MJ, Langer C, Hess CF, Becker H, Ried T, Ghadimi BM. Preoperative chemoradiotherapy in locally advanced rectal cancer: correlation of a gene expression-based response signature with recurrence. Cancer Genet Cytogenet 2009;190:57-65. [PMID: 19380020 DOI: 10.1016/j.cancergencyto.2008.11.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
540 Eich HT, Stepien A, Zimmermann C, Hellmich M, Metzger R, Hölscher A, Müller RP. Neoadjuvant radiochemotherapy and surgery for advanced rectal cancer: prognostic significance of tumor regression. Strahlenther Onkol. 2011;187:225-230. [PMID: 21424305 DOI: 10.1007/s00066-011-2113-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
541 Heafner TA, Glasgow SC. A critical review of the role of local excision in the treatment of early (T1 and T2) rectal tumors. J Gastrointest Oncol. 2014;5:345-352. [PMID: 25276407 DOI: 10.3978/j.issn.2078-6891.2014.066jgo-05-05-345] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
542 Nair RM, Siegel EM, Chen DT, Fulp WJ, Yeatman TJ, Malafa MP, Marcet J, Shibata D. Long-term results of transanal excision after neoadjuvant chemoradiation for T2 and T3 adenocarcinomas of the rectum. J Gastrointest Surg. 2008;12:1797-1805; discussion 1805-1806. [PMID: 18709419 DOI: 10.1007/s11605-008-0647-z] [Cited by in Crossref: 73] [Cited by in F6Publishing: 62] [Article Influence: 5.6] [Reference Citation Analysis]
543 Kalyan A, Rozelle S, Benson A 3rd. Neoadjuvant treatment of rectal cancer: where are we now? Gastroenterol Rep (Oxf). 2016;4:206-209. [PMID: 27412436 DOI: 10.1093/gastro/gow017] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
544 Takeda D, Nitta H, Takahara T, Hasegawa Y, Itou N, Wakabayashi G. Effect of preoperative chemotherapy on postoperative liver regeneration following hepatic resection as estimated by liver volume. World J Surg Oncol 2013;11:65. [PMID: 23497123 DOI: 10.1186/1477-7819-11-65] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
545 Koukourakis GV. Role of radiation therapy in neoadjuvant era in patients with locally advanced rectal cancer. World J Gastrointest Oncol 2012; 4(12): 230-237 [PMID: 23443049 DOI: 10.4251/wjgo.v4.i12.230] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
546 Yu JI, Lee H, Park HC, Choi DH, Choi YL, Do IG, Kim HC, Lee WY, Yun SH, Cho YB, Huh JW, Park YA, Park YS, Park JO, Kim ST, Park W. Prognostic significance of survivin in rectal cancer patients treated with surgery and postoperative concurrent chemo-radiation therapy. Oncotarget 2016;7:62676-86. [PMID: 27391438 DOI: 10.18632/oncotarget.10445] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
547 Vonk DT, Hazard LJ. Do all locally advanced rectal cancers require radiation? A review of literature in the modern era. J Gastrointest Oncol. 2010;1:45-54. [PMID: 22811804 DOI: 10.3978/j.issn.2078-] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
548 Russell MC, You YN, Hu CY, Cormier JN, Feig BW, Skibber JM, Rodriguez-Bigas MA, Nelson H, Chang GJ. A novel risk-adjusted nomogram for rectal cancer surgery outcomes. JAMA Surg. 2013;148:769-777. [PMID: 23803722 DOI: 10.1001/jamasurg.2013.2136] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
549 Yun JA, Huh JW, Kim HC, Park YA, Cho YB, Yun SH, Lee WY, Chun HK. Local recurrence after curative resection for rectal carcinoma: The role of surgical resection. Medicine (Baltimore). 2016;95:e3942. [PMID: 27399067 DOI: 10.1097/md.0000000000003942] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 4.8] [Reference Citation Analysis]
550 Shi C, Zhou H, Li X, Cai Y. A Retrospective Analysis on Two-week Short-course Pre-operative Radiotherapy in Elderly Patients with Resectable Locally Advanced Rectal Cancer. Sci Rep 2016;6:37866. [PMID: 27886277 DOI: 10.1038/srep37866] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
551 Freischlag K, Sun Z, Adam MA, Kim J, Palta M, Czito BG, Migaly J, Mantyh CR. Association Between Incomplete Neoadjuvant Radiotherapy and Survival for Patients With Locally Advanced Rectal Cancer. JAMA Surg 2017;152:558-64. [PMID: 28273303 DOI: 10.1001/jamasurg.2017.0010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
552 Wu SG, Zhang WW, Sun JY, He ZY, Su GQ, Li FY. Preoperative radiotherapy improves survival in rectal signet-ring cell carcinoma-a population-based study. Radiat Oncol 2017;12:141. [PMID: 28835256 DOI: 10.1186/s13014-017-0874-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
553 Cerezo L, Ciria JP, Arbea L, Liñán O, Cafiero S, Valentini V, Cellini F. Current treatment of rectal cancer adapted to the individual patient. Rep Pract Oncol Radiother 2013;18:353-62. [PMID: 24416579 DOI: 10.1016/j.rpor.2013.08.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
554 Millard T, Kunk PR, Ramsdale E, Rahma OE. Current debate in the oncologic management of rectal cancer. World J Gastrointest Oncol 2016; 8(10): 715-724 [PMID: 27795811 DOI: 10.4251/wjgo.v8.i10.715] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
555 Taira T, Nozawa H, Kawai K, Sasaki K, Murono K, Kaneko M, Emoto S, Iida Y, Ishii H, Yokoyama Y, Anzai H, Sonoda H, Ishihara S. Oncological Outcomes of Pathological T1 Lower Rectal Cancer Patients With or Without Preoperative Chemoradiotherapy. In Vivo 2020;34:3559-64. [PMID: 33144468 DOI: 10.21873/invivo.12199] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
556 Wang CC, Liang JT, Tsai CL, Chen YH, Lin YL, Shun CT, Cheng JC. Neoadjuvant bevacizumab and chemoradiotherapy in locally advanced rectal cancer: early outcome and technical impact on toxicity. World J Surg Oncol 2014;12:329. [PMID: 25373828 DOI: 10.1186/1477-7819-12-329] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
557 Wu F, Wang G, Wang J, Zhou C, Yang C, Niu W, Zhang J, Wang G, Yang Y. Analysis of influencing factors of no/low response to preoperative concurrent chemoradiotherapy in locally advanced rectal cancer. PLoS One 2020;15:e0234310. [PMID: 32520954 DOI: 10.1371/journal.pone.0234310] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
558 Paskeviciute B, Bölling T, Brinkmann M, Rudykina G, Ernst I, Stegger L, Schober O, Willich N, Weckesser M, Könemann S. Impact of (18)F-FDG-PET/CT on staging and irradiation of patients with locally advanced rectal cancer. Strahlenther Onkol 2009;185:260-5. [PMID: 19370430 DOI: 10.1007/s00066-009-1962-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
559 Kim JY, Chung SM, Choi BO, Lee IK, An CH, Won JM, Ryu MR. Prognostic significance of the lymph node ratio regarding recurrence and survival in rectal cancer patients treated with postoperative chemoradiotherapy. Gut Liver 2012;6:203-9. [PMID: 22570749 DOI: 10.5009/gnl.2012.6.2.203] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
560 Chow OS, Patil S, Keskin M, Smith JJ, Widmar M, Smith DD, Avila K, Shia J, Chu P, Garcia-Aguilar J. Variation in the Thoroughness of Pathologic Assessment and Response Rates of Locally Advanced Rectal Cancers After Chemoradiation. J Gastrointest Surg 2019;23:794-9. [PMID: 30719677 DOI: 10.1007/s11605-019-04119-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
561 Siegel R, Burock S, Wernecke KD, Kretzschmar A, Dietel M, Loy V, Koswig S, Budach V, Schlag PM. Preoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: a multi-centre prospectively randomised study of the Berlin Cancer Society. BMC Cancer. 2009;9:50. [PMID: 19200365 DOI: 10.1186/1471-2407-9-501471-2407-9-50] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
562 Goldberg N, Kundel Y, Purim O, Bernstine H, Gordon N, Morgenstern S, Idelevich E, Wasserberg N, Sulkes A, Groshar D. Early prediction of histopathological response of rectal tumors after one week of preoperative radiochemotherapy using 18 F-FDG PET-CT imaging. A prospective clinical study. Radiat Oncol. 2012;7:124. [PMID: 22853868 DOI: 10.1186/1748-717X-7-124] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
563 Cai G, Xu Y, Zhu J, Gu WL, Zhang S, Ma XJ, Cai SJ, Zhang Z. Diffusion-weighted magnetic resonance imaging for predicting the response of rectal cancer to neoadjuvant concurrent chemoradiation. World J Gastroenterol 2013; 19(33): 5520-5527 [PMID: 24023496 DOI: 10.3748/wjg.v19.i33.5520] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
564 Arredondo J, González I, Baixauli J, Martínez P, Rodríguez J, Pastor C, Ribelles MJ, Sola JJ, Hernández-Lizoain JL. Tumor response assessment in locally advanced colon cancer after neoadjuvant chemotherapy. J Gastrointest Oncol 2014;5:104-11. [PMID: 24772338 DOI: 10.3978/j.issn.2078-6891.2014.006] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
565 Lee YY, Li CF, Lin CY, Lee SW, Sheu MJ, Lin LC, Chen TJ, Wu TF, Hsing CH. Overexpression of CPS1 is an independent negative prognosticator in rectal cancers receiving concurrent chemoradiotherapy. Tumour Biol 2014;35:11097-105. [PMID: 25099619 DOI: 10.1007/s13277-014-2425-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
566 Holman FA, Haddock MG, Gunderson LL, Kusters M, Nieuwenhuijzen GA, van den Berg HA, Nelson H, Rutten HJ. Results of intraoperative electron beam radiotherapy containing multimodality treatment for locally unresectable T4 rectal cancer: a pooled analysis of the Mayo Clinic Rochester and Catharina Hospital Eindhoven. J Gastrointest Oncol 2016;7:903-16. [PMID: 28078113 DOI: 10.21037/jgo.2016.07.01] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
567 Cai W, Ge W, Hu H, Mao J. Rectal NETs and rectosigmoid junction NETs may need to be treated differently. Cancer Med 2020;9:971-9. [PMID: 31840409 DOI: 10.1002/cam4.2779] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
568 Molnar C, Vlad-Olimpiu B, Marian B, Cornelia T, Simona G. Survival and functional and oncological outcomes following intersphincteric resection for low rectal cancer: short-term results. J Int Med Res 2018;46:1617-25. [PMID: 29490520 DOI: 10.1177/0300060518758841] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
569 Glynne-Jones R, Hava N, Goh V, Bosompem S, Bridgewater J, Chau I, Gaya A, Wasan H, Moran B, Melcher L, MacDonald A, Osborne M, Beare S, Jitlal M, Lopes A, Hall M, West N, Quirke P, Wong WL, Harrison M;  Bacchus investigators. Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum. BMC Cancer. 2015;15:764. [PMID: 26493588 DOI: 10.1186/s12885-015-1764-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
570 Winkler J, Zipp L, Knoblich J, Zimmermann F. Simultaneous neoadjuvant radiochemotherapy with capecitabine and oxaliplatin for locally advanced rectal cancer. Treatment outcome outside clinical trials. Strahlenther Onkol. 2012;188:377-382. [PMID: 22402868 DOI: 10.1007/s00066-012-0073-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
571 Chang KH, Smith MJ, McAnena OJ, Aprjanto AS, Dowdall JF. Increased use of multidisciplinary treatment modalities adds little to the outcome of rectal cancer treated by optimal total mesorectal excision. Int J Colorectal Dis. 2012;27:1275-1283. [PMID: 22395659 DOI: 10.1007/s00384-012-1440-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
572 Dobie SA, Warren JL, Matthews B, Schwartz D, Baldwin LM, Billingsley K. Survival benefits and trends in use of adjuvant therapy among elderly stage II and III rectal cancer patients in the general population. Cancer 2008;112:789-99. [PMID: 18189291 DOI: 10.1002/cncr.23244] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 3.2] [Reference Citation Analysis]
573 Meng X, Wang R, Huang Z, Zhang J, Feng R, Xu X, Zhu K, Dou X, Chen D, Yu J. Human epidermal growth factor receptor-2 expression in locally advanced rectal cancer: association with response to neoadjuvant therapy and prognosis. Cancer Sci 2014;105:818-24. [PMID: 24730770 DOI: 10.1111/cas.12421] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
574 Roeder F, Timke C, Saleh-Ebrahimi L, Schneider L, Hackert T, Hartwig W, Kopp-Schneider A, Hensley FW, Buechler MW, Debus J, Huber PE, Werner J. Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 Gy) and intraoperative radiation therapy (15 Gy) in patients with primarily resectable pancreatic cancer - NEOPANC. BMC Cancer 2012;12:112. [PMID: 22443802 DOI: 10.1186/1471-2407-12-112] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
575 Smith JJ, Garcia-Aguilar J. Advances and challenges in treatment of locally advanced rectal cancer. J Clin Oncol. 2015;33:1797-1808. [PMID: 25918296 DOI: 10.1200/jco.2014.60.1054] [Cited by in Crossref: 98] [Cited by in F6Publishing: 48] [Article Influence: 16.3] [Reference Citation Analysis]
576 Rana N, Chakravarthy AB, Kachnic LA. Neoadjuvant Treatment for Locally Advanced Rectal Cancer: New Concepts in Clinical Trial Design. Curr Treat Options Oncol. 2017;18:13. [PMID: 28281215 DOI: 10.1007/s11864-017-0454-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
577 Jeon BH, Shin US, Moon SM, Choi JI, Kim M, Kim KH, Sung S. Neutrophil to Lymphocyte Ratio: A Predictive Marker for Treatment Outcomes in Patients With Rectal Cancer Who Underwent Neoadjuvant Chemoradiation Followed by Surgery. Ann Coloproctol 2019;35:100-6. [DOI: 10.3393/ac.2018.10.01] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
578 Spitzner M, Ebner R, Wolff HA, Ghadimi BM, Wienands J, Grade M. STAT3: A Novel Molecular Mediator of Resistance to Chemoradiotherapy. Cancers (Basel) 2014;6:1986-2011. [PMID: 25268165 DOI: 10.3390/cancers6041986] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 8.7] [Reference Citation Analysis]
579 Steele M, Voutsadakis IA. Pre-treatment platelet counts as a prognostic and predictive factor in stage II and III rectal adenocarcinoma. World J Gastrointest Oncol 2017; 9(1): 42-49 [PMID: 28144399 DOI: 10.4251/wjgo.v9.i1.42] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
580 Chen ST, Lee TY, Tsai TH, Lin YC, Lin CP, Shieh HR, Hsu ML, Chi CW, Lee MC, Chang HH, Chen YJ. The Traditional Chinese Medicine DangguiBuxue Tang Sensitizes Colorectal Cancer Cells to Chemoradiotherapy. Molecules 2016;21:E1677. [PMID: 27929437 DOI: 10.3390/molecules21121677] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
581 Mizukami Y, Ueda S, Mizumoto A, Sasada T, Okumura R, Kohno S, Takabayashi A. Diffusion-weighted magnetic resonance imaging for detecting lymph node metastasis of rectal cancer. World J Surg. 2011;35:895-899. [PMID: 21327602 DOI: 10.1007/s00268-011-0986-x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 61] [Article Influence: 7.0] [Reference Citation Analysis]
582 Ulrich A, Weitz J, Büchler MW. [Rectal cancer. How much radiotherapy do surgery patients need?]. Chirurg 2009;80:266-73. [PMID: 19271158 DOI: 10.1007/s00104-008-1618-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
583 Han KS, Sohn DK, Kim DY, Kim BC, Hong CW, Chang HJ, Kim SY, Baek JY, Park SC, Kim MJ, Oh JH. Endoscopic Criteria for Evaluating Tumor Stage after Preoperative Chemoradiation Therapy in Locally Advanced Rectal Cancer. Cancer Res Treat 2016;48:567-73. [PMID: 26511812 DOI: 10.4143/crt.2015.195] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
584 Li Q, Zhuo C, Cai G, Li D, Liang L, Cai S. Increased number of negative lymph nodes is associated with improved cancer specific survival in pathological IIIB and IIIC rectal cancer treated with preoperative radiotherapy. Oncotarget 2014;5:12459-71. [PMID: 25514596 DOI: 10.18632/oncotarget.2560] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
585 Thompson MK, Poortmans P, Chalmers AJ, Faivre-Finn C, Hall E, Huddart RA, Lievens Y, Sebag-Montefiore D, Coles CE. Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie? Br J Cancer 2018;119:389-407. [PMID: 30061587 DOI: 10.1038/s41416-018-0201-z] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 16.3] [Reference Citation Analysis]
586 Choi CH, Kim WD, Lee SJ, Park WY. Clinical predictive factors of pathologic tumor response after preoperative chemoradiotherapy in rectal cancer. Radiat Oncol J 2012;30:99-107. [PMID: 23170288 DOI: 10.3857/roj.2012.30.3.99] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
587 Kılıç D, Sert F, Görken İB, Arıcan Alıcıkuş Z, Aktürk N, Kaytan Sağlam E, Kizir A, Özkök S, Yılmaz HT, Göçen F, Yalman D. Prognostic significance of early complete response in patients with locally advanced rectal cancer undergoing preoperative chemoradiotherapy: Multicentric study of Turkish Society for Radiation Oncology Group (TROD). Turk J Gastroenterol 2020;31:368-77. [PMID: 32519956 DOI: 10.5152/tjg.2020.19225] [Reference Citation Analysis]
588 Touloumtzidis A, Sostmann B, Hilgers N, Renter MA, Kühn P, Goretzki PE, Lammers BJ. Functional long-term results after rectal cancer surgery--technique of the athermal mesorectal excision. Int J Colorectal Dis 2014;29:285-92. [PMID: 24306821 DOI: 10.1007/s00384-013-1805-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
589 Seo SI, Yu CS, Kim GS, Lee JL, Yoon YS, Kim CW, Lim SB, Kim JC. The Role of Diverting Stoma After an Ultra-low Anterior Resection for Rectal Cancer. Ann Coloproctol. 2013;29:66-71. [PMID: 23700573 DOI: 10.3393/ac.2013.29.2.66] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
590 Yamashita H, Ishihara S, Nozawa H, Kawai K, Kiyomatsu T, Okuma K, Abe O, Watanabe T, Nakagawa K. Comparison of volumetric-modulated arc therapy using simultaneous integrated boosts (SIB-VMAT) of 45 Gy/55 Gy in 25 fractions with conventional radiotherapy in preoperative chemoradiation for rectal cancers: a propensity score case-matched analysis. Radiat Oncol 2017;12:156. [PMID: 28934968 DOI: 10.1186/s13014-017-0894-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
591 Cho HJ, Baek JH, Baek DW, Kang BW, Lee SJ, Kim HJ, Park SY, Park JS, Choi GS, Kim JG. Prognostic Significance of Clinicopathological and Molecular Features After Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients. In Vivo. 2019;33:1959-1965. [PMID: 31662525 DOI: 10.21873/invivo.11691] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
592 Yang TJ, Oh JH, Apte A, Son CH, Deasy JO, Goodman KA. Clinical and dosimetric predictors of acute hematologic toxicity in rectal cancer patients undergoing chemoradiotherapy. Radiother Oncol 2014;113:29-34. [PMID: 25304718 DOI: 10.1016/j.radonc.2014.09.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
593 Smith JJ, Chow OS, Gollub MJ, Nash GM, Temple LK, Weiser MR, Guillem JG, Paty PB, Avila K, Garcia-Aguilar J; Rectal Cancer Consortium. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management. BMC Cancer 2015;15:767. [PMID: 26497495 DOI: 10.1186/s12885-015-1632-z] [Cited by in Crossref: 145] [Cited by in F6Publishing: 111] [Article Influence: 24.2] [Reference Citation Analysis]
594 Tian YF, Hsieh PL, Lin CY, Sun DP, Sheu MJ, Yang CC, Lin LC, He HL, Solórzano J, Li CF, Chang IW. High Expression of Aldolase B Confers a Poor Prognosis for Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy. J Cancer 2017;8:1197-204. [PMID: 28607594 DOI: 10.7150/jca.18197] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
595 Gill A, Brunson A, Lara P Jr, Khatri V, Semrad TJ. Implications of lymph node retrieval in locoregional rectal cancer treated with chemoradiotherapy: a California Cancer Registry Study. Eur J Surg Oncol 2015;41:647-52. [PMID: 25800934 DOI: 10.1016/j.ejso.2015.01.037] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
596 Hohenberger W, Lahmer G, Fietkau R, Croner RS, Merkel S, Göhl J, Sauer R. [Neoadjuvant radiochemotherapy for rectal cancer]. Chirurg 2009;80:294-302. [PMID: 19350306 DOI: 10.1007/s00104-009-1707-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
597 Kim BC. Prognostic significance of tumor regression grade after preoperative chemoradiotherapy for rectal cancer. J Korean Soc Coloproctol 2011;27:1-2. [PMID: 21431087 DOI: 10.3393/jksc.2011.27.1.1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
598 Ouyang G, Yang X, Deng X, Meng W, Yu Y, Wu B, Jiang D, Shu P, Wang Z, Yao J, Wang X. Predicting Response to Total Neoadjuvant Treatment (TNT) in Locally Advanced Rectal Cancer Based on Multiparametric Magnetic Resonance Imaging: A Retrospective Study. Cancer Manag Res 2021;13:5657-69. [PMID: 34285586 DOI: 10.2147/CMAR.S311501] [Reference Citation Analysis]
599 Wasserberg N. Interval to surgery after neoadjuvant treatment for colorectal cancer. World J Gastroenterol 2014; 20(15): 4256-4262 [PMID: 24764663 DOI: 10.3748/wjg.v20.i15.4256] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
600 Ostwal V, Engineer R, Ramaswamy A, Sahu A, Zanwar S, Arya S, Chopra S, Bal M, Patil P, Desouza A, Saklani A. Surgical outcomes of post chemoradiotherapy unresectable locally advanced rectal cancers improve with interim chemotherapy, is FOLFIRINOX better than CAPOX? J Gastrointest Oncol 2016;7:958-67. [PMID: 28078119 DOI: 10.21037/jgo.2016.08.11] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
601 Sato H, Shimada M, Kurita N, Iwata T, Yoshikawa K, Higashigima J, Chikakio M, Kashihara H, Takasu C, Matsumoto N, Eto S. Phase I trial of neoadjuvant preoperative chemotherapy with S-1, oxaliplatin, and bevacizumab plus radiation in patients with locally advanced rectal cancer. Int J Clin Oncol 2015;20:543-8. [PMID: 25080061 DOI: 10.1007/s10147-014-0733-z] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
602 Saigusa S, Inoue Y, Tanaka K, Okugawa Y, Toiyama Y, Uchida K, Mohri Y, Kusunoki M. Lack of M30 expression correlates with factors reflecting tumor progression in rectal cancer with preoperative chemoradiotherapy. Mol Clin Oncol 2014;2:99-104. [PMID: 24649315 DOI: 10.3892/mco.2013.189] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
603 McCulloch M, Broffman M, van der Laan M, Hubbard A, Kushi L, Abrams DI, Gao J, Colford JM Jr. Colon cancer survival with herbal medicine and vitamins combined with standard therapy in a whole-systems approach: ten-year follow-up data analyzed with marginal structural models and propensity score methods. Integr Cancer Ther 2011;10:240-59. [PMID: 21964510 DOI: 10.1177/1534735411406539] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
604 Jo P, Azizian A, Salendo J, Kramer F, Bernhardt M, Wolff HA, Gruber J, Grade M, Beißbarth T, Ghadimi BM, Gaedcke J. Changes of Microrna Levels in Plasma of Patients with Rectal Cancer during Chemoradiotherapy. Int J Mol Sci 2017;18:E1140. [PMID: 28554991 DOI: 10.3390/ijms18061140] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
605 Klautke G, Küchenmeister U, Foitzik T, Ludwig K, Prall F, Klar E, Fietkau R. Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: results from a phase I/II study. Br J Cancer. 2006;94:976-981. [PMID: 16552435 DOI: 10.1038/sj.bjc.6603053] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 3.2] [Reference Citation Analysis]
606 Dennis K, Zeng L, De Angelis C, Chung H, Coburn N, Chow E, Wong CS. A prospective cohort study of patient-reported vomiting, retching, nausea and antiemetic use during neoadjuvant long-course radiation therapy and concurrent 5-fluorouracil-based chemotherapy for rectal adenocarcinoma. Clin Transl Radiat Oncol 2018;10:42-6. [PMID: 29682620 DOI: 10.1016/j.ctro.2018.04.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
607 Aghili M, Sotoudeh S, Ghalehtaki R, Babaei M, Farazmand B, Fazeli MS, Keshvari A, Haddad P, Farhan F. Preoperative short course radiotherapy with concurrent and consolidation chemotherapies followed by delayed surgery in locally advanced rectal cancer: preliminary results. Radiat Oncol J 2018;36:17-24. [PMID: 29621870 DOI: 10.3857/roj.2017.00185] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
608 Horvat N, Veeraraghavan H, Khan M, Blazic I, Zheng J, Capanu M, Sala E, Garcia-Aguilar J, Gollub MJ, Petkovska I. MR Imaging of Rectal Cancer: Radiomics Analysis to Assess Treatment Response after Neoadjuvant Therapy. Radiology. 2018;287:833-843. [PMID: 29514017 DOI: 10.1148/radiol.2018172300] [Cited by in Crossref: 116] [Cited by in F6Publishing: 104] [Article Influence: 38.7] [Reference Citation Analysis]
609 Araujo-Mino EP, Patt YZ, Murray-Krezan C, Hanson JA, Bansal P, Liem BJ, Rajput A, Fekrazad MH, Heywood G, Lee FC. Phase II Trial Using a Combination of Oxaliplatin, Capecitabine, and Celecoxib with Concurrent Radiation for Newly Diagnosed Resectable Rectal Cancer. Oncologist 2018;23:2-e5. [PMID: 29158365 DOI: 10.1634/theoncologist.2017-0474] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
610 Zhang L, Zheng W, Cui J, Wu YL, Xu TL, Zhang HZ. Risk factors for nonclosure of defunctioning stoma and stoma-related complications among low rectal cancer patients after sphincter-preserving surgery. Chronic Dis Transl Med 2020;6:188-97. [PMID: 32908969 DOI: 10.1016/j.cdtm.2020.02.004] [Reference Citation Analysis]
611 Song C, Song S, Kim JS, Oh HK, Kim DW, Lee KW, Kim JH, Eom KY, Kim IA, Kang SB. Impact of Postoperative Chemoradiotherapy versus Chemotherapy Alone on Recurrence and Survival in Patients with Stage II and III Upper Rectal Cancer: A Propensity Score-Matched Analysis. PLoS One 2015;10:e0123657. [PMID: 25902069 DOI: 10.1371/journal.pone.0123657] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
612 Chua TC, Chong CH, Liauw W, Morris DL. Approach to rectal cancer surgery. Int J Surg Oncol 2012;2012:247107. [PMID: 22792451 DOI: 10.1155/2012/247107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
613 Levine RA, Chawla B, Bergeron S, Wasvary H. Multidisciplinary management of colorectal cancer enhances access to multimodal therapy and compliance with National Comprehensive Cancer Network (NCCN) guidelines. Int J Colorectal Dis. 2012;27:1531-1538. [PMID: 22645076 DOI: 10.1007/s00384-012-1501-z] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
614 Cristóbal I, Santos A, Rubio J, Caramés C, Zazo S, Sanz-Álvarez M, Luque M, Madoz-Gúrpide J, Rojo F, García-Foncillas J. Validation of microRNA-199b as A Promising Predictor of Outcome and Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer Patients. Cancers (Basel) 2021;13:5003. [PMID: 34638487 DOI: 10.3390/cancers13195003] [Reference Citation Analysis]
615 Li S, Gong Y, Yang Y, Guo Q, Qian J, Tian Y. Evaluation of small bowel motion and feasibility of using the peritoneal space to replace bowel loops for dose constraints during intensity-modulated radiotherapy for rectal cancer. Radiat Oncol 2020;15:211. [PMID: 32873308 DOI: 10.1186/s13014-020-01650-z] [Reference Citation Analysis]
616 Fürst A, Schwandner O, Heiligensetzer A, Iesalnieks I, Agha A. Laparoscopic TME in rectal cancer--electronic supplementary: op-video. Langenbecks Arch Surg 2010;395:181-3. [PMID: 20076969 DOI: 10.1007/s00423-009-0556-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
617 Passardi A, Rapposelli IG, Scarpi E, Neri E, Parisi E, Ghigi G, Ercolani G, Avanzolini A, Cavaliere D, Rudnas B, Valgiusti M, Barone D, Ferroni F, Frassineti GL, Romeo A. Neoadjuvant treatment (FOLFOX4 plus hypofractionated tomotherapy) for patients with locally advanced rectal cancer: a multicenter phase II trial. Ther Adv Med Oncol 2020;12:1758835920977139. [PMID: 33343722 DOI: 10.1177/1758835920977139] [Reference Citation Analysis]
618 Serna G, Ruiz-Pace F, Hernando J, Alonso L, Fasani R, Landolfi S, Comas R, Jimenez J, Elez E, Bullman S, Tabernero J, Capdevila J, Dienstmann R, Nuciforo P. Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer. Ann Oncol 2020;31:1366-75. [PMID: 32569727 DOI: 10.1016/j.annonc.2020.06.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
619 Bhudia J, Glynne-Jones R, Smith T, Hall M. Neoadjuvant Chemotherapy without Radiation in Colorectal Cancer. Clin Colon Rectal Surg 2020;33:287-97. [PMID: 32968364 DOI: 10.1055/s-0040-1713746] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
620 Kong M, Hong SE, Choi WS, Kim SY, Choi J. Preoperative concurrent chemoradiotherapy for locally advanced rectal cancer: treatment outcomes and analysis of prognostic factors. Cancer Res Treat 2012;44:104-12. [PMID: 22802748 DOI: 10.4143/crt.2012.44.2.104] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
621 Hildebrandt B, Rau B, Löffel J, Wust P, Nicolaou A, Gellermann J, Le Coutre P, Neuhaus P, Felix R, Wernecke KD, Dörken B, Riess H. Adjuvant chemotherapy with folinic acid and 5-fluorouracil in patients with locally advanced rectal cancer previously treated by preoperative radiochemotherapy and curative tumor resection. Int J Colorectal Dis 2006;21:582-9. [PMID: 16416134 DOI: 10.1007/s00384-005-0054-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
622 Sadrizadeh A, Bagheri R, Soltani E, Anvari K, Toussi MS, Moadikhah S. The Comparison of the Advantages of Neoadjuvant Chemoradiotherapy versus Postoperative Chemoradiotherapy: Outcomes in Esophageal Cancer Patients. J Gastrointest Cancer 2018;49:50-6. [PMID: 28025816 DOI: 10.1007/s12029-016-9899-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
623 McCulloch M, Ly H, Broffman M, See C, Clemons J, Chang R. Chinese Herbal Medicine and Fluorouracil-Based Chemotherapy for Colorectal Cancer: A Quality-Adjusted Meta-Analysis of Randomized Controlled Trials. Integr Cancer Ther 2016;15:285-307. [PMID: 27151587 DOI: 10.1177/1534735416638738] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
624 Kendziorra E, Ahlborn K, Spitzner M, Rave-Fränk M, Emons G, Gaedcke J, Kramer F, Wolff HA, Becker H, Beissbarth T, Ebner R, Ghadimi BM, Pukrop T, Ried T, Grade M. Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapy. Carcinogenesis 2011;32:1824-31. [PMID: 21983179 DOI: 10.1093/carcin/bgr222] [Cited by in Crossref: 69] [Cited by in F6Publishing: 60] [Article Influence: 6.9] [Reference Citation Analysis]
625 Geng J, Zhang Y, Gao Q, Neumann K, Dong H, Porter H, Potter M, Ren H, Argyle D, Bradley M. Switching on prodrugs using radiotherapy. Nat Chem 2021;13:805-10. [PMID: 34112990 DOI: 10.1038/s41557-021-00711-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
626 Newman NB, Moss RA, Maloney-Patel N, Donohue K, Brown TV, Nissenblatt MJ, Lu SE, Jabbour SK. Bone marrow tolerance during postoperative chemotherapy in colorectal carcinomas. J Gastrointest Oncol 2017;8:547-55. [PMID: 28736641 DOI: 10.21037/jgo.2017.01.19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
627 Yang Y, Liu Q, Jia B, Du X, Dai G, Liu H, Chen J, Zeng M, Wen K, Zhu Y, Wang Y, Feng L. Preoperative Volumetric Modulated Arc Therapy With Simultaneous Integrated Boost for Locally Advanced Distal Rectal Cancer. Technol Cancer Res Treat 2019;18:1533033818824367. [PMID: 30803368 DOI: 10.1177/1533033818824367] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
628 Vikram R, Iyer RB. PET/CT imaging in the diagnosis, staging, and follow-up of colorectal cancer. Cancer Imaging 2008;8 Spec No A:S46-51. [PMID: 18852081 DOI: 10.1102/1470-7330.2008.9009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
629 Horvat N, Carlos Tavares Rocha C, Clemente Oliveira B, Petkovska I, Gollub MJ. MRI of Rectal Cancer: Tumor Staging, Imaging Techniques, and Management. Radiographics. 2019;39:367-387. [PMID: 30768361 DOI: 10.1148/rg.2019180114] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 27.5] [Reference Citation Analysis]
630 Damin DC, Lazzaron AR. Evolving treatment strategies for colorectal cancer: A critical review of current therapeutic options. World J Gastroenterol 2014; 20(4): 877-887 [PMID: 24574762 DOI: 10.3748/wjg.v20.i4.877] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
631 Junginger T, Maurer CA, Ruppert R, Ptok H, Strassburg J. Comment on the editorial of Sautter-Bihl et al. in Strahlentherapie und Onkologie 2013 189:105-110. Strahlenther Onkol 2013;189:697-9. [PMID: 23700208 DOI: 10.1007/s00066-013-0353-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
632 Park IJ, Yu CS, Lim SB, Lee JL, Kim CW, Yoon YS, Park SH, Kim JC. Is Preoperative Chemoradiotherapy Beneficial for Sphincter Preservation in Low-Lying Rectal Cancer Patients? Medicine (Baltimore) 2016;95:e3463. [PMID: 27149445 DOI: 10.1097/MD.0000000000003463] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
633 Nocera F, Angehrn F, von Flüe M, Steinemann DC. Optimising functional outcomes in rectal cancer surgery. Langenbecks Arch Surg 2021;406:233-50. [PMID: 32712705 DOI: 10.1007/s00423-020-01937-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
634 Lavan NA, Kavanagh DO, Martin J, Small C, Joyce MR, Faul CM, Kelly PJ, O'Riordain M, Gillham CM, Armstrong JG, Salib O, McNamara DA, McVey G, O'Neill BD. The curative management of synchronous rectal and prostate cancer. Br J Radiol 2016;89:20150292. [PMID: 26539631 DOI: 10.1259/bjr.20150292] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
635 Häfner MF, Debus J. Radiotherapy for Colorectal Cancer: Current Standards and Future Perspectives. Visc Med 2016;32:172-7. [PMID: 27493944 DOI: 10.1159/000446486] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
636 Alvarez-Aguilera M, Jimenez-Rodriguez RM. Watch and wait in locally advance rectal cancer: Past, present and future. World J Meta-Anal 2021; 9(4): 327-332 [DOI: 10.13105/wjma.v9.i4.327] [Reference Citation Analysis]
637 Hernando-Requejo O, López M, Cubillo A, Rodriguez A, Ciervide R, Valero J, Sánchez E, Garcia-Aranda M, Rodriguez J, Potdevin G, Rubio C. Complete pathological responses in locally advanced rectal cancer after preoperative IMRT and integrated-boost chemoradiation. Strahlenther Onkol 2014;190:515-20. [PMID: 24715243 DOI: 10.1007/s00066-014-0650-0] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 6.0] [Reference Citation Analysis]
638 Dudani S, Marginean H, Tang PA, Monzon JG, Raissouni S, Asmis TR, Goodwin RA, Gotfrit J, Cheung WY, Vickers MM. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation. BMC Cancer. 2019;19:664. [PMID: 31277604 DOI: 10.1186/s12885-019-5892-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
639 Tian YF, Chen TJ, Lin CY, Chen LT, Lin LC, Hsing CH, Lee SW, Sheu MJ, Lee HH, Shiue YL. SKP2 overexpression is associated with a poor prognosis of rectal cancer treated with chemoradiotherapy and represents a therapeutic target with high potential. Tumour Biol. 2013;34:1107-1117. [PMID: 23328995 DOI: 10.1007/s13277-013-0652-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
640 Ortega CD, Perez RO. Role of magnetic resonance imaging in organ-preserving strategies for the management of patients with rectal cancer. Insights Imaging 2019;10:59. [PMID: 31147789 DOI: 10.1186/s13244-019-0742-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
641 Li C, E C, Zhou Y, Yu W. Candidate genes and potential mechanisms for chemoradiotherapy sensitivity in locally advanced rectal cancer. Oncol Lett 2019;17:4494-504. [PMID: 30944639 DOI: 10.3892/ol.2019.10087] [Reference Citation Analysis]
642 Combs SE, Kieser M, Habermehl D, Weitz J, Jäger D, Fossati P, Orrechia R, Engenhart-Cabillic R, Pötter R, Dosanjh M, Jäkel O, Büchler MW, Debus J. Phase I/II trial evaluating carbon ion radiotherapy for the treatment of recurrent rectal cancer: the PANDORA-01 trial. BMC Cancer 2012;12:137. [PMID: 22472035 DOI: 10.1186/1471-2407-12-137] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
643 Shin SJ, Yoon HI, Kim NK, Lee KY, Min BS, Ahn JB, Keum KC, Koom WS. Upfront systemic chemotherapy and preoperative short-course radiotherapy with delayed surgery for locally advanced rectal cancer with distant metastases. Radiat Oncol 2011;6:99. [PMID: 21864368 DOI: 10.1186/1748-717X-6-99] [Cited by in Crossref: 28] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
644 Chiang JS, Yu NY, Sheedy JT, Hayden RE, Lemish PR, Karlin NJ, Mishra N, Sio TT. Radiotherapeutic Management of Synchronous Prostate and Rectal Cancers Using Proton Beam Therapy. Int J Part Ther 2021;8:82-8. [PMID: 34722814 DOI: 10.14338/IJPT-20-00087.1] [Reference Citation Analysis]
645 Sinukumar S, Patil P, Engineer R, Desouza A, Saklani A. Clinical outcome of patients with complete pathological response to neoadjuvant chemoradiotherapy for locally advanced rectal cancers: the Indian scenario. Gastroenterol Res Pract 2014;2014:867841. [PMID: 25610460 DOI: 10.1155/2014/867841] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
646 Li LH, Chen ZF, Wang XF, Liu X, Jiang WZ, Zhuo SM, Jiang LW, Guan GX, Chen JX. Monitoring neoadjuvant therapy responses in rectal cancer using multimodal nonlinear optical microscopy. Oncotarget 2017;8:107323-33. [PMID: 29291032 DOI: 10.18632/oncotarget.22366] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
647 Janssen QP, O'Reilly EM, van Eijck CHJ, Groot Koerkamp B. Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer.Front Oncol. 2020;10:41. [PMID: 32083002 DOI: 10.3389/fonc.2020.00041] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
648 Huang CM, Huang MY, Tsai HL, Huang CW, Ma CJ, Lin CH, Huang CJ, Wang JY. A retrospective comparison of outcome and toxicity of preoperative image-guided intensity-modulated radiotherapy versus conventional pelvic radiotherapy for locally advanced rectal carcinoma. J Radiat Res 2017;58:247-59. [PMID: 27738080 DOI: 10.1093/jrr/rrw098] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
649 De Felice F, Crocetti D, Petrucciani N, Belgioia L, Sapienza P, Bulzonetti N, Marampon F, Musio D, Tombolini V. Treatment in locally advanced rectal cancer: a machine learning bibliometric analysis. Therap Adv Gastroenterol 2021;14:17562848211042170. [PMID: 34671421 DOI: 10.1177/17562848211042170] [Reference Citation Analysis]
650 Chen Z, Liu Z, Deng X, Warden C, Li W, Garcia-Aguilar J. Chromosomal copy number alterations are associated with persistent lymph node metastasis after chemoradiation in locally advanced rectal cancer. Dis Colon Rectum 2012;55:677-85. [PMID: 22595848 DOI: 10.1097/DCR.0b013e31824f873f] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
651 Tchelebi LT, Romesser PB, Feuerlein S, Hoffe S, Latifi K, Felder S, Chuong MD. Magnetic Resonance Guided Radiotherapy for Rectal Cancer: Expanding Opportunities for Non-Operative Management. Cancer Control 2020;27:1073274820969449. [PMID: 33118384 DOI: 10.1177/1073274820969449] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
652 Jomrich G, Silberhumer GR, Marian B, Beer A, Müllauer L. Programmed death-ligand 1 expression in rectal cancer. Eur Surg 2016;48:352-6. [PMID: 28058043 DOI: 10.1007/s10353-016-0447-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
653 Kim MJ, Hur BY, Lee ES, Park B, Joo J, Kim MJ, Park SC, Baek JY, Chang HJ, Kim DY, Oh JH. Prediction of lateral pelvic lymph node metastasis in patients with locally advanced rectal cancer with preoperative chemoradiotherapy: Focus on MR imaging findings. PLoS One 2018;13:e0195815. [PMID: 29649321 DOI: 10.1371/journal.pone.0195815] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
654 Páez D, Paré L, Altés A, Sancho-Poch FJ, Petriz L, Garriga J, Monill JM, Salazar J, del Rio E, Barnadas A. Thymidylate synthase germline polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy based on 5-fluorouracil. J Cancer Res Clin Oncol. 2010;136:1681-1689. [PMID: 20165956 DOI: 10.1007/s00432-010-0826-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
655 George TJ, Allegra CJ, Yothers G. Neoadjuvant Rectal (NAR) Score: a New Surrogate Endpoint in Rectal Cancer Clinical Trials. Curr Colorectal Cancer Rep. 2015;11:275-280. [PMID: 26321890 DOI: 10.1007/s11888-015-0285-2] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 10.2] [Reference Citation Analysis]
656 Chen P, Yao Y, Gu J. Rectal cancer patients after neoadjuvant radiotherapy (30Gy/10f) with negative lymph node may not benefit from postoperative adjuvant chemotherapy: a retrospective study. Int J Colorectal Dis 2015;30:1695-704. [PMID: 26278877 DOI: 10.1007/s00384-015-2358-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
657 Fan WH, Xiao J, An X, Jiang W, Li LR, Gao YH, Chen G, Kong LH, Lin JZ, Wang JP, Pan ZZ, Ding PR. Patterns of recurrence in patients achieving pathologic complete response after neoadjuvant chemoradiotherapy for rectal cancer. J Cancer Res Clin Oncol 2017;143:1461-7. [PMID: 28386648 DOI: 10.1007/s00432-017-2383-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
658 Chang GJ, You YN, Park IJ, Kaur H, Hu CY, Rodriguez-Bigas MA, Skibber JM, Ernst RD. Pretreatment high-resolution rectal MRI and treatment response to neoadjuvant chemoradiation. Dis Colon Rectum. 2012;55:371-377. [PMID: 22426259 DOI: 10.1097/dcr.0b013e31824678e3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
659 Chen TJ, He HL, Shiue YL, Yang CC, Lin LC, Tian YF, Chen SH. High chloride channel accessory 1 expression predicts poor prognoses in patients with rectal cancer receiving chemoradiotherapy. Int J Med Sci 2018;15:1171-8. [PMID: 30123054 DOI: 10.7150/ijms.26685] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
660 Saelen MG, Flatmark K, Folkvord S, de Wijn R, Rasmussen H, Fodstad Ø, Ree AH. Tumor kinase activity in locally advanced rectal cancer: angiogenic signaling and early systemic dissemination. Angiogenesis 2011;14:481-9. [PMID: 21833622 DOI: 10.1007/s10456-011-9231-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
661 Baek DW, Kim G, Kang BW, Kim HJ, Park SY, Park JS, Choi GS, Kang MK, Hur K, Kim JG. High expression of microRNA-199a-5p is associated with superior clinical outcomes in patients with locally advanced rectal cancer. J Cancer Res Clin Oncol 2020;146:105-15. [PMID: 31781865 DOI: 10.1007/s00432-019-03099-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
662 Habr-Gama A, Perez RO, São Julião GP, Proscurshim I, Fernandez LM, Figueiredo MN, Gama-Rodrigues J, Buchpiguel CA. Consolidation chemotherapy during neoadjuvant chemoradiation (CRT) for distal rectal cancer leads to sustained decrease in tumor metabolism when compared to standard CRT regimen. Radiat Oncol 2016;11:24. [PMID: 26911200 DOI: 10.1186/s13014-016-0598-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
663 Herrmann K, Bundschuh RA, Rosenberg R, Schmidt S, Praus C, Souvatzoglou M, Becker K, Schuster T, Essler M, Wieder HA. Comparison of different SUV-based methods for response prediction